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CHAPTER I 
 
BACKGROUND AND LITERATURE REVIEW 
 
Introduction 
 
The recent emergence of positive-strand RNA viruses including West Nile Virus 
(WNV), Chikungunya virus, and SARS-CoV demonstrates a need for understanding 
positive-strand RNA virus biology, evolution, and pathogenesis. Coronaviruses (CoVs) 
are positive-strand RNA viruses whose genomes range from 27 to 32 kb in size and infect 
a wide range of hosts. Currently, six human coronaviruses have been identified including 
the emergence of four viruses in the last ten years. During the 2002 – 2003 outbreak of 
Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), over 8000 individuals 
contracted the disease, which was associated with a 10% mortality rate (Drosten et al., 
2003). Recently, Middle East Respiratory Syndrome coronavirus (MERS-CoV) has been 
identified in patients in the Middle East and has been associated with nearly a 50% 
mortality rate (Zaki et al., 2012). These coronavirus outbreaks highlight the importance 
of understanding mechanisms of viral emergence to facilitate vaccine and antiviral 
development (Drosten et al., 2003; Zaki et al., 2012).  
 A key hallmark of positive-strand RNA virus infection is the early translation of 
the viral genome in the host cytoplasm and subsequent maturation processing steps 
mediated by viral and host proteases. During infection, the coronavirus genome is 
translated into two large polyproteins that must be proteolytically processed by virus-
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encoded proteases (Brierley et al., 1989; Lee et al., 1991; Perlman and Netland, 2009). 
The coronavirus protease nonstructural protein 5 (nsp5 or 3CLpro) is responsible for 
catalyzing the maturation processing at 11 cleavage sties and is required for replication 
(Lee et al., 1991; Perlman and Netland, 2009). Despite a wealth of biochemical and 
biophysical data at the initiation of this research, very little was known about the 
mechanism of nsp5 protease action in the context of virus infection in cells. Furthermore, 
studies to develop nsp5-specific inhibitors have been largely focused on substrate peptide 
analogs and have not yet resulted in effective antivirals (Jacobs et al., 2013).  
 This project focused on identifying the key structural and functional determinants 
of coronavirus nsp5 protease that govern activity and regulate specificity, studies in 
Chapter II describe the recovery and characterization of MHV nsp5 temperature-sensitive 
and second-site suppressor mutants and the biochemical characterization of the mutant 
proteases in vitro. Studies in Chapter III evaluate the extent of nsp5 functional 
conservation through substitution of other coronavirus nsp5 proteases into the 
background of murine hepatitis virus (MHV). The implications for this work are 
discussed in Chapter IV and future directions are examined in Chapter V. 
 
Coronavirus classification 
 
Coronaviruses are members of the order Nidovirales, family Coronaviridae, 
subfamily Coronavirinae, and genus Coronavirus. They were originally named due to 
their virion structure resembling that of the corona of the sun (Figure 1.1). The first 
coronaviruses were identified in 1932 in cloaca samples of chicken (Hudson and 
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Beaudette, 1932). These viruses were later identified as infectious bronchitis virus (IBV). 
Initial classification of coronaviruses was performed by serotype analyses. However, with  
the advent of facile sequencing and in silico analyses, coronaviruses classification has 
transformed with the continual discovery of new coronavirus species. Recently, 
coronaviruses have been reorganized into four distinct phylogenetic genera based upon 
genomic organization and phylogenetic analyses: alphacoronaviruses, betacoronaviruses, 
gammacoronaviruses, and deltacoronaviruses (Figure 1.1) (Woo et al., 2012).  
Known alphacoronaviruses include human coronaviruses 229E and NL63, canine 
and feline coronaviruses, porcine viruses epidemic diarrhea virus (PEDV) and 
transmissible gastroenteritis (TGEV), as well as several bat coronaviruses (BtCoVs) 
including Miniopterus BtCoV1 and BtHKU8, Rhinolophus BtHKU2, and Scotophilus 
BtCoV 512. Among the known betacoronaviruses are four human coronaviruses (HKU1, 
OC43, SARS-CoV, and MERS-CoV), murine hepatitis virus (MHV), and three distinct 
BtCoV species (Rousettus BtHKU9, Pipistrellus BtHKU5, and Tylonycteris BtHKU4). 
To date, all six known human coronaviruses have been either alpha- or betacoronaviruses 
and only recently has the first non-avian coronavirus been identified outside of these 
phylogenetic groups (Mihindukulasuriya et al., 2008). Gammacoronaviruses and 
Deltacoronaviruses largely consist of avian coronaviruses including infectious bronchitis 
virus (IBV), bulbul HKU11, thrush HKU12, munia HKU13 as well as a beluga whale 
coronavirus SW1 (Mihindukulasuriya et al., 2008; Woo et al., 2012). 
  The majority of all coronaviruses that have been identified to date have been 
found circulating asymptomatically in bats. Studies from our lab and others have shown 
that SARS-CoV is most likely derived from bats (Becker et al., 2008; Lau et al., 2005). In  
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Fig. 1.1. Coronavirus virion structure and phylogeny. A) Coronavirus virion schematic exhibiting the 
structural proteins spike (S), membrane (M), envelope (E) and nucleocapsid (N), which are responsible for 
forming and maintaining virion structure and genomic (+ssRNA) stability. Image modified from Jen 
Sparks. B) A negative-stain electron micrograph of SARS-CoV, the horizontal bar represents the image 
scale. Image adapted from Ksaizak et al., 2003. C) Phylogenetic trees based on the primary peptide 
sequences of nonstructural proteins 5 (nsp5 or 3CLpro) and 12 (nsp12 or RdRp). The trees were generated 
using a bootstrap alignment in ClustalX. Phylogenetic groups are denoted by brackets.  
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addition, phylogenetic analysis of the recently emerged MERS-CoV coronavirus suggests 
that the virus may also be derived from circulating myotic species (Anthony et al., 2013; 
Kindler et al., 2013). These data stress the importance for ongoing surveillance and 
understanding the mechanisms and limitations for coronavirus emergence and 
pathogenesis. 
 
Coronavirus emergence and human disease 
 
Coronaviruses infect a wide range of animal hosts and cause illnesses ranging 
from bronchiolitis to gastroenteritis. In November 2002, an outbreak of a respiratory 
pathogen was identified in the Guangdong province of China (Drosten et al., 2003). By 
the end of July 2003, the virus had spread to 37 countries infecting over 8000 individuals 
with a mortality rate of 9.6%. At the time of the identification of the causative agent as 
severe acute respiratory syndrome (SARS-CoV) coronavirus, only two other human 
coronaviruses were known (Table 1.1). Coronaviruses 229E and OC43 were first 
identified in the 1960’s and were associated with common colds and pneumonia 
(Cavallaro and Monto, 1970; McIntosh et al., 1967a; McIntosh et al., 1967b). The 
emergence of a new virulent human coronavirus led to global efforts to identify the 
zoonotic source of the virus and to understand the mechanisms of emergence, virulence 
and replication. During the SARS-CoV epidemic, the virus was identified in a number of 
animal hosts including raccoon dogs (Nyctereuteus sp.), ferret badgers (Melogale sp.), 
and palm civets (Paguna sp.) (Becker et al., 2008; Lau et al., 2005; Normile, 2005; 
Vijayanand et al., 2004). However, later studies showed that the most likely origin of 
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zoonotic spread were Chinese horseshoe bats (Rhinolophus sp.) (Becker et al., 2008; Lau 
et al., 2005).  
 
Table 1.1. Human coronavirus identification, classification and disease 
Human Coronaviruses  
Virus Group Year Identified Clinical Disease 
HCoV-229E α-CoV 1967 colds, pneumonia 
HCoV-OC43 β-CoV 1969 colds, pneumonia 
SARS-CoV β-CoV 2002 severe acute respiratory syndrome 
HCoV-NL63 α-CoV 2004 bronchiolitis, colds, pneumonia 
HCoV-HKU1 β-CoV 2005 colds, pneumonia 
MERS-CoV β-CoV 2012 pneumonia, kidney failure 
 
 
Increased surveillance during the SARS-CoV epidemic resulted in identification 
of HCoV-NL63 from a 7-month old child presenting with bronchiolitis and conjunctivitis 
in the Netherlands. The virus was similar to HCoV-229E and had spread worldwide by 
the end of 2004 (van der Hoek et al., 2004). A year later, a fifth coronavirus was 
discovered in Hong Kong in two pneumonia patients and was subsequently named 
HCoV-HKU1 (Woo et al., 2005). Surveillance studies worldwide have shown persistent 
circulation of human coronaviruses 229E, OC43, NL63, and HKU1 associated with upper 
and lower respiratory illnesses of varying severity (Dijkman et al., 2012; Mackay et al., 
2012; Prill et al., 2012). In September of 2012, a sixth human coronavirus was identified 
in Qatar and Saudi Arabia, and has since been named Middle East Respiratory Syndrome 
coronavirus (MERS-CoV) (Zaki et al., 2012). Efforts at identifying the source of the 
virus have suggested that MERS-CoV, like SARS-CoV, has a bat origin (Anthony et al., 
2013; Kindler et al., 2013). Phylogenetic analysis of MERS-CoV and known bat 
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coronaviruses have shown that MERS-CoV shares 97% identity to the RNA-dependent 
RNA polymerase of a bat coronavirus (Anthony et al., 2013). Ongoing surveillance of 
coronaviruses in nature has led to a continual expansion of the breadth of coronaviruses 
and potential for zoonotic spread and virus emergence. 
 
Coronavirus replication 
 
Coronaviruses are enveloped and initiate infection through engagement of viral 
class I fusion spike (S) attachment proteins to specific host cell surface receptors (Figure 
1.2). Receptor usage varies greatly among coronaviruses and includes carcinoembyronic 
antigen adhesion molecule 1, CEACAM1a (MHV), aminopeptidase N (229E), 
angiotensin-converting enzyme 2, ACE2 (NL63 and SARS-CoV), 9-O-acetylated sialic 
acid (OC43) and DPP4 (MERS-CoV) (Perlman and Netland, 2009; Raj et al., 2013; 
Williams et al., 1991). Following entry by either direct membrane-envelope fusion or 
receptor-mediated endocytosis, the 20 – 22 kb replicase gene (ORF1) is translated in the 
host cell cytoplasm into two large polyproteins (pp1a and pp1ab) by host ribosomes 
(Figure 1.3) (Kooi et al., 1991; Lee et al., 1991). Polyprotein 1a includes nonstructural 
proteins 1 – 11 (nsps 1 – 11) and pp1ab includes nsps 1 – 16 via a -1 ribosomal 
frameshift between nsp10 and nsp12 (Brierley et al., 1989; Lee et al., 1991; Perlman and 
Netland, 2009). The replicase polyproteins are comprise the replication machinery of the 
virus including a single-strand RNA binding protein (nsp7), a primase (nsp8), the RNA-
dependent RNA polymerase (nsp12), helicase (nsp13), an exonuclease with proofreading 
activity (nsp14), a uridylate-specific endoribonuclease (nsp15), and a ribose-2’-O- 
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Fig. 1.2. Coronavirus replication cycle. Coronaviruses initiate infection and entry through receptor-
mediated endocytosis or direct membrane fusion. Upon entry into the host cytoplasm, the replicase gene 
encoding viral replication machinery is translated by host ribosomes to yield two polyproteins (pp1a and 
pp1ab). The replicase polyproteins are proteolytically processed by virus-encoded papain-like proteases 
and nonstructural protein 5 (nsp5) to yield up to 16 nonstructural proteins (nsps) that assemble to form 
replication complexes (RCs) on host membrane-derived viral structures including double membrane 
vesicles (DMVs) and convoluted membranes (CMs). The +ssRNA genome is then used as a template to 
create genomic and subgenomic RNA to be used for generation of structural and accessory gene transcripts. 
The viral genome and structural and accessory proteins are then trafficked to the ER-Golgi Intermediate 
Compartment (ERGIC) where they assemble into virions. Virions are released through a non-lytic vesicle 
via the secretory pathway. 
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methyltransferase (nsp16) (Perlman and Netland, 2009). Other nonstructural proteins 
have been associated with host-membrane alterations (nsps 3, 4, and 6), host mRNA 
degradation and immune inactivation (nsp1), deubiquitylating activity (nsp3), and 
proteolytic processing of the polyproteins (nsp3 and nsp5) (Perlman and Netland, 2009; 
Ziebuhr et al., 2000). During and after translation, two or three virus-encoded proteases 
process polyproteins 1a and 1ab to yield mature nsps 1 – 16 (Ziebuhr et al., 2000). One or 
two papain-like proteases in nsp3 are responsible for processing nsps 1 – 3, and a 
cysteine protease, nsp5, the focus of my research, is responsible for processing nsps 4 – 
16 (Ziebuhr et al., 2000).  
During the early stages of proteolytic processing and replication complex 
formation, nsps 3, 4, and 6 are proposed to modify host ER membranes, resulting in 
intracellular virus-induced structures referred to collectively as a reticulovesicular 
networks and are composed of double membrane vesicle (DMV) and convoluted 
membrane (CM) structures (Knoops et al., 2008; van Hemert et al., 2008). Genomic 
replication is proposed to occur in association with these structures and involves two 
distinct stages: full genome replication and transcription of subgenomic mRNAs. 
Genome replication consists of generation of a full-length negative-sense genome 
intermediate, which is used as a template for generating positive-strand genome copies. 
Translation of all structural and accessory proteins including hemagglutinin-esterase 
(HE), spike (S) attachment, envelope (E), membrane (M), nucleocapsid (N) and 
additional accessory proteins occurs from subgenomic mRNAs (Pasternak et al., 2006; 
Sawicki and Sawicki, 1998).  
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After genomic replication and transcription have occurred, virions assemble in the 
endoplasmic reticulum-Golgi intermediate compartment (ERGIC) and Golgi. 
Nucleocapsid (N) associates with the genomic RNA and is transported to the sites of 
virion assembly by an unknown mechanism. The virion structure is assembled by 
interactions between M and E proteins and the ERGIC membrane. HE and S are 
integrated into the virion membrane and the virions are released via the secretory 
pathway. 
 
Proteolytic processing of coronavirus replicase polyproteins  
 
 A common feature of all positive-strand RNA virus replication is the translation 
of one or more polyproteins that must be proteolytically processed by virus- or host-
derived proteases to yield mature viral proteins. The genomes of the order Nidovirales 
(including genera Coronaviridae, Arteriviridae, Mesoniviridae, and Roniviridae) differ 
considerably in size ranging from MHV at 31.5 kb to equine arteritis virus (EAV) of a 
little less than 13 kb. However, all known nidovirus genomes include two or more virus-
encoded proteases that appear indispensible for viral replication (Ziebuhr et al., 2000). 
The first two-thirds of the nidovirus genome consists of two large overlapping replicase 
reading frames (ORF1a and ORF1ab), which are translated to yield two large polyprotein 
precursors, pp1a and pp1ab (Figure 1.3), ranging in size from 3100 to 7200 amino acids 
in length. Similar to many other positive-strand RNA viruses, these polyproteins are 
cleaved by proteinases, which resemble structurally the cellular proteases of papain and 
chymotrypsin (Ziebuhr et al., 2000). In MHV, two separate papain-like protease domains  
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Fig. 1.3. Murine hepatitis virus (MHV) translation and polyprotein processing. The MHV genome is 
32 kb in length and consists of 7 genes. The replicase gene (blue) consists of two reading frames (ORF1a 
and ORF1ab), which overlap at a ribosomal frameshift and are translated to yield polyproteins, pp1a and 
pp1ab, encoding nonstructural proteins (nsps 1 – 16). Maturation cleavage events (arrows) are mediated by 
three viral protease domains, papain-like proteases PLP1 (light gray) and PLP2 (black) and nsp5 (red). 
Known polyprotein intermediates are shown. RdRp, RNA-dependent RNA polymerase; Hel, Helicase; 
ExoN, exoribonuclease; EndoU, endoribonuclease; O-MT, O-methyltransferase; HE, hemagglutinin-
esterase; E, envelope, M, membrane, and N, nucleocapsid. 
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(PLP1 and PLP2) are responsible for processing nsps 1 – 3. Whereas, the chymotrypsin-
like cysteine protease, nsp5, is responsible for catalyzing 11 separate maturation 
cleavages between the C-terminus of nsp4 and nsp16.  
 The papain-like proteases of coronaviruses are responsible for recognizing and 
processing at two or three cleavage sites in replicase polyproteins. All known papain-like 
proteases use a Cys-His catalytic dyad and an α+β-like fold similar to the cellular papain 
enzyme (Ziebuhr et al., 2000). Some betacoronaviruses (Group 2b, such as SARS-CoV) 
and all known gamma- and deltacoronaviruses encode a single papain-like protease 
(PLpro), while all known alphacoronaviruses and remaining betacoronaviruses (Group 2a, 
such as MHV) encode two separate PLP domains (PLP1 and PLP2). Inactivation of 
PLP1, although tolerated, causes impairment of viral RNA replication (Graham and 
Denison, 2006). Similarly, deletion and substitution of the PLP1 and PLP2 cleavage sites 
in MHV is tolerated, but results in considerable replication defects (Gadlage and 
Denison, 2010; Gadlage et al., 2010; Graham and Denison, 2006). 
 Coronavirus nsp5 protease, also referred to as 3CLpro or Mpro, is indispensible 
for virus replication and catalyzes proteolytic processing at 11 different cleavage sites, 
including its own autoproteolytic liberation. Processed intermediates, such as an nsp4-10 
and nsp7-10 precursor, are detected during coronavirus infection, indicating a specific 
order and hierarchy in nsp5 proteolytic events (Sparks et al., 2008; Stobart et al., 2012). 
Additionally, several cleavage events have been shown to be dispensable for replication 
including processing between the nsp9/nsp10 and nsp10/nsp12 (Deming et al., 2007).  
Studies by Grum-Tokars et al., have suggested cleavage at the nsp4-nsp5 cleavage 
site is most efficient and alteration of either terminus of nsp5 reduces protease activity 
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(Grum-Tokars et al., 2008). Consequently, efficient autoproteolysis and early nsp5 
activity likely requires a hydrophobic milieu for optimum processing (Okamoto et al., 
2010; Pinon et al., 1997). Nsp5 is located between two clear hydrophobic membrane-
spanning regions of nsp4 and nsp6. Adjacent to the N-terminus of nsp5 are the C-
terminal hydrophobic loops of nsp3 and the hydrophobic membrane-associated nsp4 and 
adjacent to the C-terminus of nsp5 is an additional membrane spanning and associated 
protein, nsp6. The localization of nsp5 to membranes and its association with the 
replication complex is likely dependent upon its interaction with neighboring proteins 
nsp4 and nsp6, however much remains unknown of this interaction. 
 
Coronavirus protease nsp5 structure  
 
Coronavirus nsp5 is a 28 kDa protein ranging in size from 300 to 306 amino 
acids. Nsp5 (3CLpro) has been crystallized for at least seven different coronavirus 
species from three different genera including SARS-CoV, NL63, 229E, Bat HKU4, 
HKU1, IBV and recently MERS-CoV (Anand et al., 2002; Anand et al., 2003; Bacha et 
al., 2008; Xue et al., 2007; Xue et al., 2008; Zhao et al., 2008). In addition, structures of 
SARS-CoV nsp5 have been resolved for both dimeric and monomeric forms, and 
complexed with a variety of peptidomimetic inhibitors. All known crystal structures 
demonstrate tertiary and quaternary structure conservation despite considerable variation 
in primary sequences between coronaviruses (Figure 1.4). 
Nsp5 protease consists of three distinct domains (Figure 1.5). Domains 1 (MHV  
residues 1 – 100) and 2 (MHV residues 101 – 199) constitute a chymotrypsin-like fold.  
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Fig. 1.4. Primary sequence alignment of MHV and human coronavirus nsp5 sequences. Residues that 
identical to MHV are shaded. Domain breaks (red), the interdomain loop (IDL; blue), catalytic dyad 
residues (green) and substrate binding pocket residues (orange) are denoted. Percent total sequence identity 
to MHV is shown at the end of the sequence reads. 
- % Sequence Identity to MHV 
!
MHV-A59           1 SGIVKMVSPTSKVEPCIVSVTYGNMTLNGLWLDDKVYCPRHVICSSADMT  50!
HCoV HKU1         1 SGIVKMVSPTSKIEPCIVSVTYGSMTLNGLWLDDKVYCPRHVICSSSNMN  50!
HCoV OC43         1 SGIVKMVNPTSKVEPCVVSVTYGNMTLNGLWLDDKVYCPRHVICSASDMT  50!
HCoV EMC ! !1 SGLVKMSHPSGDVEACMVQVTCGSMTLNGLWLDNTVWCPRHVMCPADQLS  50!
SARS-CoV Urbani   1 SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDTVYCPRHVICTAEDML  50!
HCoV 229E         1 AGLRKMAQPSGFVEKCVVRVCYGNTVLNGLWLGDIVYCPRHVIASN-TTS  49!
HCoV NL63         1 SGLKKMAQPSGCVERCVVRVCYGSTVLNGVWLGDTVTCPRHVIAPS-TTV  49!
!
MHV-A59          51 DPDYPNLLCRVTSSDFCVMSGR---MSLTVMSYQMQGCQLVLTVTLQNPN  97!
HCoV HKU1        51 EPDYSALLCRVTLGDFTIMSGR---MSLTVVSYQMQGCQLVLTVSLQNPY  97!
HCoV OC43        51 NPDYTNLLCRVTSSDFTVLFDR---LSLTVMSYQMRGCMLVLTVTLQNSR  97!
HCoV EMC         51 DPNYDALLISMTNHSFSVQKHIGAPANLRVVGHAMQGTLLKLTVDVANPS 100!
SARS-CoV Urbani  51 NPNYEDLLIRKSNHSFLVQAGN---VQLRVIGHSMQNCLLRLKVDTSNPK  97!
HCoV 229E        50 AIDYDHEYSIMRLHNFSIISGT---AFLGVVGATMHGVTLKIKVSQTNMH  96!
HCoV NL63        50 LIDYDHAYSTMRLHNFSVSHNG---VFLGVVGVTMHGSVLRIKVSQSNVH  96!
!
MHV-A59          98 TPKYSFGVVKPGETFTVLAAYNGRPQGAFHVTLRSSHTIKGSFLCGSCGS 147!
HCoV HKU1        98 TPKYTFGNVKPGETFTVLAAYNGRPQGAFHVTMRSSYTIKGSFLCGSCGS 147!
HCoV OC43        98 TPKYTFGVVKPGETFTVLAAYNGKPQGAFHVTMRSSYTIKGSFLCGSCGS 147!
HCoV EMC !    101 TPAYTFTTVKPGAAFSVLACYNGRPTGTFTVVMRPNYTIKGSFLCGSCGS 150!
SARS-CoV Urbani  98 TPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNHTIKGSFLNGSCGS 147!
HCoV 229E        97 TPRHSFRTLKSGEGFNILACYDGCAQGVFGVNMRTNWTIRGSFINGACGS 146!
HCoV NL63        97 TPKHVFKTLKPGASFNILACYEGIASGVFGVNLRTNFTIKGSFINGACGS 146!
                !
MHV-A59         148 VGYVLTG-DSVRFVYMHQLELSTGCHTGTDFSGNFYGPYRDAQVVQLPVQ 196!
HCoV HKU1       148 VGYVLTG-DSVKFVYMHQLELSTGCHTGTDFTGNFYGPYRDAQVVQLPVK 196!
HCoV OC43       148 VGYVIMG-DCVKFVYMHQLELSTGCHTGTDFNGDFYGPYKDAQVVQLLIQ 196!
HCoV EMC !    151 VGYTKEG-SVINFCYMHQMELANGTHTGSAFDGTMYGAFMDKQVHQVQLT 199!
SARS-CoV Urbani 148 VGFNIDY-DCVSFCYMHHMELPTGVHAGTDLEGKFYGPFVDRQTAQAAGT 196!
HCoV 229E       147 PGYNLKN-GEVEFVYMHQIELGSGSHVGSSFDGVMYGGFEDQPNLQVESA 195!
HCoV NL63       147 PGYNVRNDGTVEFCYLHQIELGSGAHVGSDFTGSVYGNFDDQPSLQVESA 196!
!
MHV-A59         197 DYTQTVNVVAWLYAAIFNRCNWFVQSDSCSLEEFNVWAMTNGFSSIKADL 246!
HCoV HKU1       197 DYVQTVNVIAWLYAAILNNCAWFVQNDVCSTEDFNVWAMANGFSQVKADL 246!
HCoV OC43       197 DYIQSVNFVAWLYAAILNNCNWFVQSDKCSVEDFNVWALSNGFSQVKSDL 246!
HCoV EMC !    200 DKYCSVNVVAWLYAAILNGCAWFVKPNRTSVVSFNEWALANQFTEFVGTQ 249!
SARS-CoV Urbani 197 DTTITLNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDH 246!
HCoV 229E       196 NQMLTVNVVAFLYAAILNGCTWWLKGEKLFVEHYNEWAQANGFTAMNGED 245!
HCoV NL63       197 NLMLSDNVVAFLYAALLNGCRWWLRSTRVNVDGFNEWAMANGYTIVSSVE 246!
!
MHV-A59         247 V--LDALASMTGVTVEQVLAAIKR-LHSGFQGKQILGSCVLEDELTPSDV 293!
HCoV HKU1       247 V--LDALASMTGVSIETLLAAIKR-LYMGFQGRQILGSCTFEDELAPSDV 293!
HCoV OC43       247 V--IDALASMTGVSLETLLAAIKR-LKNGFQGRQIMGSCSFEDELTPSDV 293!
HCoV EMC        250 S--VDMLAVKTGVAIEQLLYAIQQ-LYTGFQGKQILGSTMLEDEFTPEDV 296!
SARS-CoV Urbani 247 VDILGPLSAQTGIAVLDMCAALKELLQNGMNGRTILGSTILEDEFTPFDV 296!
HCoV 229E       246 A--FSILAAKTGVCVERLLHAIQV-LNNGFGGKQILGYSSLNDEFSINEV 292!
HCoV NL63       247 C--YSILAAKTGVSVEQLLASIQH-LHEGFGGKNILGYSSLCDEFTLAEV 293!
!
MHV-A59         294 YQQLAGVKLQ 303 ! !100%!
HCoV HKU1       294 YQQLAGVKLQ 303 ! ! 85%!
HCoV OC43       294 YQQLAGIKLQ 303 ! ! 82%!
HCoV EMC        297 NMQIMGVVMQ 306 ! ! 53%!
SARS-CoV Urbani 297 VRQCSGVTFQ 306 ! ! 49%!
HCoV 229E       293 VKQMFGVNLQ 302 ! !  44%!
HCoV NL63       294 VKQMYGVNLQ 303 ! !  42%!
D1 D2 
D2 D3 
* 
* 
IDL *** 
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Fig. 1.5. Structural analysis of coronavirus protease nsp5. A) Monomeric crystal structure of HKU1 
nsp5 (PDB code 3d23; Zhao, 2008). Domains 1 (D1; red), 2 (D2; blue), and 3 (D3; gray) are labeled and 
color-coded, the catalytic dyad (black) are shown in bold, and the N-terminal finger (NF), N-terminal helix 
(NH) and interdomain loop (IDL) are labeled in italics. B) Residues that 100% conserved across 
coronavirus nsp5 protease sequences (left) are shown including outlines of the active site and dimerization 
regions (purple) and an overlay of known nsp5 crystal structures of HKU1, 229E (1P9T; Xue, 2006), IBV 
(2Q6D; Xue, 2007) and SARS-CoV (2H2Z; Anand, 2002) with a structural model generated in Modeller 
from HKU1 are shown. C) Dimeric structure of SARS-CoV nsp5 (2GT7; Lee, 2007) with two different 
views. 
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Mutagenesis in MHV, IBV, 229E and feline infectious peritonitis virus (FIPV) 
demonstrated that catalysis is mediated by a His/Cys dyad spanning the interface between 
domains 1 and 2 (Lu et al., 1996; Lu and Denison, 1997; Ziebuhr et al., 2000). Substrate 
binding is coordinated through interaction with a conserved Tyr-X-His motif and several 
conserved residue contacts surrounding the interface between the domains. A long 
conserved interdomain loop (MHV residues 184 to 199) connects the domains 1 and 2 to 
domain 3. Domain 3 (MHV residues 200 to 303) consists of five predominantly anti-
parallel α-helices and represents a unique structural element not observed in any other 
viral or cellular chymotrypsin-like proteases. 
Analyses of expressed and purified 3CLpro have demonstrated that a mixture of 
monomeric (~35%) and dimeric (~65%) states exists with continual monomer-dimer 
exchange (Chen et al., 2006; Shi and Song, 2006). The dimer structure is assembled with 
two nsp5 monomers oriented perpendicular to one another and interfacing along a N-
terminal extension or finger of domain 1 and part of domain 3. The active sites of the two 
monomers are oriented away from the dimerization interface and some in vitro studies 
have suggested that only one monomer may be functionally active in the dimer (Anand et 
al., 2002; Anand et al., 2003; Chen et al., 2006; Zhao et al., 2008). Dimerization of nsp5 
appears to be required for full proteolytic activity and specificity in vitro. Experiments 
have shown that disrupting the dimerization interface in vitro result in partial or complete 
protease inactivation. Deletion of N-terminal finger residues 1 -3 in SARS-CoV results in 
a 50% reduction in catalytic activity despite retaining dimerization (Hsu et al., 2005). 
However, deletion of residues 1 – 4 in SARS-CoV resulted in a 100-fold reduction in 
catalytic activity and a subsequent loss of dimerization. A recent finding has suggested 
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that dimerization may not be required for residual catalytic activity, as the N-terminal 
autoproteolytic cleavage appears to occur in a monomeric form in vitro (Chen et al., 
2010; Muramatsu et al., 2013). 
 
Coronavirus nsp5 substrate specificity 
 
Coronavirus nsp5 (3CLpro) is responsible for recognizing and processing at 11 
distinct cleavage sites (nsps 4 – 16 in MHV). However, the mechanism and order of  
nsp5-mediated processing during infection is unknown. Protease cleavage sites are 
designated at P5 – P5’ sites where cleavage occurs between the P1 and P1’ amino acid 
residues. Nsp5 almost exclusively cleaves following a P1-Gln, with the sole exception 
being a P1-His in the nsp13-nsp14 cleavage site of HCoV-HKU1 (Figure 1.6) (Chuck et 
al., 2011; Ziebuhr et al., 2000). There is a preference for small non-charged residues at 
the P1’ position, but Cys may also be tolerated. In addition, there is a strong preference 
for Leu at P2, but Phe, Met and Ile may also be utilized. Less conservation is observed at 
the P3, P4, P2’ and P3’ sites. Overall, the consensus nsp5 cleavage site among known 
coronaviruses is P3-LQ†(S/G/A/V)-P2’ (Grum-Tokars et al., 2008; Ziebuhr et al., 2000). 
Catalytic activity has been shown in vitro to be most active towards the autoproteolytic 
N-terminal cleavage site (nsp4-nsp5) (Grum-Tokars et al., 2008). Several studies have 
assessed which cleavage events are essential for virus replication. Deming et al, 
demonstrated that elimination of the nsp7-nsp8 and nsp8-nsp9 cleavage sites resulted in 
loss of virus recovery; elimination of the nsp9-nsp10 site was tolerated with a reduction 
in virus replication kinetics (Deming et al., 2007). Other unpublished studies from our lab  
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Fig. 1.6. Nsp5 cleavage site specificity and processing. A) MHV polyprotein 1ab (pp1ab) consists of 
nonstructural proteins 1 – 16, which are processed by viral proteases PLP1 (red), PLP2 (black) and nsp5 
(red). The relative activity as measured by the kcat/Km towards each cleavage site is shown (Grum-Tokars et 
al. 2008 and Fan et al. 2005). Predicted putative processed intermediates are shown below.  B) A canonical 
nsp5 cleavage site substrate is shown with interacting residues for SARS nsp5 (3CLpro) in the active site 
(adopted from Grum-Tokars et al. 2008). C) Table displaying the coronavirus nsp5 recognition sites for 
MHV, HKU1, OC43, and SARS-CoV. Differences from the analogous MHV recognition site are 
highlighted in red. 
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have shown that the nsp13-nsp14 and nsp14-nsp15 sites were also dispensable for virus 
replication (Eckerle, unpublished results).  
 
Intermolecular interactions of nsp5 
 
Several studies have demonstrated that intermolecular associations of nsp5 with 
other replicase polyproteins are critical for nsp5 activity. Early coronavirus studies sought 
to determine complementation groups to identify and comprehend the different 
phenotypic regions of the coronavirus genome (Baric et al., 1990; Sawicki et al., 2005). 
These studies suggested that nsp4-10 constituted a unique complementation group or 
cistron (I) (Sawicki et al., 2005). Subsequent studies have shown that an intermediate 
nsp4-10 precursor may have one or more unique functions prior to nsp5-mediated 
processing (Figure 1.7). Stokes et al, demonstrated that a temperature-sensitive (ts) 
mutant (MHV-Brts31) containing a ts allele in nsp3 had reduced processing of the nsp4-
10 precursor (p150) (Stokes et al., 2010). Another study showed that a ts mutation in 
nsp10 resulted in decreased nsp5-mediated polyprotein processing (Donaldson et al., 
2007). Lastly, the direct mutagenesis of the IBV nsp15-nsp16 cleavage site, resulted in 
compensatory mutations (P166S or P166L) in the nsp5 substrate-binding pocket (Fang et 
al., 2010). Collectively, these studies suggest that long-distance communication between 
nsp5 and other elements of the replicase gene are critical for nsp5 specificity and 
function. In Chapter III, I will describe data that begins to evaluate the conservation of 
nsp5 activity between coronaviruses and the suitability of different nsp5 proteases to 
function in a common isogenic coronavirus background. 
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Fig. 1.7. Inter- and intramolecular long-distance communication and nsp5 activity. A) Published 
studies demonstrating intermolecular long-distance communication between nsp5 and other elements (light 
blue) of the replicase polyprotein.  B) Published studies demonstrating intermolecular long-distance 
communication between residues (gold and red [ts]) of coronavirus nsp5 proteases. 
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Intramolecular long-distance communication and nsp5 function 
 
Studies from our lab and others have demonstrated that nsp5 amino acid residues 
distinct from active site, substrate binding pockets, or predicted dimerization 
determinants may be important for nsp5 proteolytic activity. Substitution of alanine at 
SARS nsp5 residue S147 (S147A) resulted in a 150-fold decrease in protease activity. 
Although the residue S147 is 9Å from the dimer interface, the mutation S147A disrupts 
dimerization of nsp5 in vitro, consistent with intramolecular long-distance 
communication, or interaction between non-adjacent residue determinants (Barrila et al., 
2006). Two follow-up studies showed that positions N28 and E166, when mutated to 
alanine, were also associated with disruption of dimerization and loss of protease activity 
(Barrila et al., 2010; Cheng et al., 2010). In 2008, Sparks et al reported the identification 
of a temperature-sensitive mutation, V148A, in domain 2 of MHV nsp5 which was 
associated with decreased viral replication and altered polyprotein processing at non-
permissive temperature of 40°C (Sparks et al., 2008).  The MHV tsV148A phenotype 
was suppressed by second-site mutations S133N or H134Y, which were greater than  
>16Å from the original ts allele. Introduction of the suppressor alleles in modeled 
structures predicted adjacent side-chain modifications, but there were no predicted 
changes that propagated to V148A. The mechanism of long-distance communication and 
its role in nsp5 stability, specificity and function remains largely unknown. In Chapters II 
and III will describe data, which provides strong evidence that coronavirus nsp5 activity 
is governed by complex intramolecular long-distance communication and that these 
residue interactions have likely diverged between coronaviruses. 
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Development of nsp5-specific coronavirus inhibitors 
 
To date, there are no commercially available coronavirus vaccines or antivirals 
despite the clear demonstrated potential for emergence of a pandemic SARS-like 
coronavirus. Coronavirus nsp5 is indispensible for virus replication and has been a 
primary target for coronavirus inhibitor design (Lu et al., 1996; Lu and Denison, 1997). 
The coronavirus nsp5 protease active site consists of a cysteine residue (Cys145 in MHV) 
which acts as the nucleophile group and a histidine (His41 in MHV) that as an acid-base 
donor (Anand et al., 2002; Anand et al., 2003; Ziebuhr et al., 2000). Numerous 
approaches have been used to develop a pan-coronavirus nsp5 inhibitor. Peptidomimetic 
inhibitors resembling the consensus P5 – P3’ cleavage site residues have been developed 
and have shown sub-µM inhibitory concentrations (Jacobs et al., 2013). Hexapeptidyl 
chloromethyl ketone inhibitors have recently been a focus of inhibitor design. Several 
inhibitors of this class have been co-crystallized with SARS-CoV nsp5 and are currently 
being optimized for broad neutralization. These compounds consist of a peptide chain 
bearing a reactive warhead group that interacts covalently with the nucleophilic Cys. 
Warhead groups that have been used include aldehydes, halo-methyl ketones, epoxy-
ketones, trifluoromethyl ketones, and several different Michael acceptors (Jacobs et al., 
2013). Other non-peptidic inhibitors have been developed including cinanserin, which 
demonstrated a reported IC50 of 5 µM. Despite encouraging results in early screens of 
compounds, many of these compounds will not be practical due to toxicity and off-target 
effects. An eventual goal of my research will be to identify key structural and functional 
determinants of nsp5, which may be targeted for inhibitor design. 
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Coronavirus reverse genetics and recombination 
 
Coronaviruses employ the largest and most complex RNA genomes. However, 
numerous groups have developed reverse genetic approaches for manipulation of the 
coronavirus genome. The first coronavirus reverse genetics methods employed targeted 
RNA recombination and selection for a virus with increased fitness at elevated 
temperatures (Koetzner et al. 1992; Masters et al. 1994). Subsequent systems have been 
developed using bacterial artificial chromosomes (BAC) or vaccinia virus-driven 
expression systems. The initial development of a robust cDNA cassette-based system in 
TGEV has led to similar reverse genetic infectious clone systems being developed for 
MHV, SARS-CoV, IBV, MERS-CoV and several recently identified Bat coronaviruses. 
For MHV, the RNA genome is reverse-transcribed and subcloned as 7 cDNA fragments 
in cloning vectors (Figure 1.8). Once manipulated, the 7 cDNA fragments named A – G 
are restriction digested and ligated together to yield a full-length cDNA copy of the viral 
genome. The cDNA copy is then transcribed in vitro to yield infectious genomic RNA, 
which is subsequently electroporated into permissive cells for virus recovery and further 
analysis. 
Coronaviruses are known to exhibit some of the highest known rates of 
recombination, which have been attributed to polymerase pausing and RNA template 
switching (Makino et al. 1986; Sawicki et al. 2007). Early studies evaluating 
recombination through mapping of complementation groups using temperature-sensitive 
lesions throughout the genome of MHV estimated a frequency of approximately 1% per 
1.3 kb or nearly 25% of the entire genome (Baric et al. 1990; Fu et al. 1992). Sawicki et  
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Fig. 1.8. MHV Infectious Clone, Reverse Genetics and Virus Recovery. The MHV genome (31.6 kb) 
has been reverse transcribed and subcloned into separated into 7 cDNA fragments in plasmid constructs. 
Alterations and mutations (star) to the genome are made in the plasmid constructs and sequence confirmed 
before the fragments are digested and ligated in vitro at 16°C overnight (O/N). After ligation, the cDNA is 
washed, precipitated and re-suspended for in vitro transcription. The resulting MHV infectious clone RNA 
genome is electroporated into baby hamster kidney cells expressing the MHV receptor (BHK-R) and these 
cells are combined with permissive murine delayed brain tumor (DBT-9) cells to recover virus. Recovered 
virus is sequenced to confirm the presence of the alterations and for any other alterations to the genome. 
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al (2005) and Stokes et al (2010) later demonstrated using complementation analysis that 
the coronavirus genome consists of at least five different complementation groups or 
cistrons (named cistrons 0, I, II, IV and VI) that contribute to unique viral phenotypes. 
Cistron I comprised of nsps 4 – 10 has been identified in several studies as a processed 
intermediate and has one or more related functions prior to maturation processing by 
nsp5 (Sawicki et al. 2005, Donaldson et al. 2007, Stokes et al. 2010, Xiao et al. 2012).  
These data suggest that the defined regions of the coronavirus genome, which 
share a common function or phenotype, may have increased capacity for recombination. 
However, no studies have directly tested the potential or limitations for coronavirus 
recombination within or across genera. More specifically, it is unknown if the extensive 
interactions of nsp5 with 11 cleavage sites as well as with alleles in nsp3 and nsp10 
constitute a barrier to genetic exchange between coronaviruses. If so, this would 
constitute limitations in over half of the coronavirus genome.  
 
Summary 
 
Coronavirus nsp5 protease is indispensible for virus replication, is a primary 
target of inhibitor design, and is responsible for catalyzing the maturation processing of 
nonstructural proteins 4 – 16. Upon beginning this project, very little was known about 
the regulatory mechanisms underlying nsp5 stability, specificity or function. Numerous 
crystal structures of the protease had been resolved and considerable focus had been 
placed on the generation of competitive inhibitors. However, there remains a dearth of 
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knowledge in regards to the connection between nsp5 structure and function in the 
context of a replicating virus.  
I hypothesize that nsp5 activity is regulated by complex networks of interacting 
residues within nsp5 and between nsp5 and other elements of the replication complex. 
Furthermore, I hypothesize that these networks are highly adapted to the individual 
frameworks of the individual viral backgrounds due to the critical role of nsp5 in 
coronavirus replication, and have diverged in function between even closely-related 
coronaviruses. In the succeeding chapters, I will describe significant contributions I have 
made to understanding how nsp5 functions during virus replication, key structural and 
functional similarities and differences between the nsp5 protease of different 
coronaviruses, and how nsp5 may affect viral evolution and zoonotic emergence. Chapter 
II describes two temperature-sensitive (ts) alleles and four second-site suppressor alleles 
that are independent of known catalytic determinants and collectively regulate nsp5-
mediated processing and impact viral replication. Biochemical data generated in 
collaboration with the Mesecar Lab demonstrates that one of the ts substitutions, V148A, 
destabilizes the protease structure in vitro and that the common second-site suppressor 
allele H134Y suppresses the ts phenotype. Chapter III explores the intra- and 
intermolecular regulation of coronavirus nsp5 through the design of chimeric nsp5 
substitution mutants and introduction of MHV ts alleles into the backgrounds of closely-
related nsp5 proteases. Chapters IV and V discuss the significance of these findings and 
the future directions of this work.   
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CHAPTER II 
 
IDENTIFICATION OF TEMPERATURE-SENSITIVE AND SUPPRESSOR 
ALLELLES CRITICAL FOR LONG-DISTANCE COMMUNICATION AND 
CORONAVIRUS NSP5 PROTEASE ACTIVITY 
 
 
Introduction 
 
 
 Positive-strand RNA viruses are responsible for a wide range of diseases in a 
broad range of vertebrate hosts including new and emerging viruses such as SARS-CoV, 
West Nile Virus, and Chikungunya virus. Rapid evolution, zoonotic movement, and 
potential lethality of positive-strand RNA virus infections demonstrate the necessity for 
developing novel strategies to prevent and treat current and new diseases. Emerging 
coronaviruses such as SARS-CoV and MERS-CoV pose a continual threat due to the lack 
of coronavirus vaccines, the lack of commercially available antiviral therapies and a 
dearth of information related to the mechanisms and limitations of viral emergence. An 
early step of Positive-strand RNA virus replication is the essential processing of 
translated polyproteins by host or virus-derived proteases. RNA virus proteases 
consequently have been primary targets for development of antiviral inhibitors, with most 
protease inhibitors targeted to active sites or substrate binding sites (Grum-Tokars et al., 
2008; Lu et al., 2011; Nguyen et al., 2011; Poordad and Khungar, 2011).  Yet, due to the 
potential for viral escape, it is critical to identify novel non-catalytic, non-substrate 
binding determinants of protease activity as putative targets for inhibition that are evade 
viral resistance.  
Coronaviruses encode the largest known positive-strand RNA genomes ranging in 
size from 26 to 32 kb in length. Murine hepatitis virus strain A59 (MHV) is an 
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established model for study of coronavirus replication and pathogenesis. The 32 kb 
genome of MHV consists of seven genes, of which the replicase gene (22 kb) encodes 16 
nonstructural proteins (nsp1-16) (Gorbalenya et al., 1989; Lee et al., 1991). Translation 
of the replicase genes yields two separate polyprotein products: polyprotein 1a (pp1a, 
nsps 1 – 11) or, via a ribosomal frameshift, pp1ab (nsps 1 – 16) (Brierley et al., 1989; Lee 
et al., 1991; Perlman and Netland, 2009). Maturation processing of pp1a and pp1ab is 
mediated by three virus-encoded proteases: two papain-like protease (PLP1 and PLP2) 
subunits of nsp4 that are responsible for cleavages of nsps 1 – 3, and an nsp5 protease, 
also known as 3CLpro or Mpro, that mediates maturation cleavages of nsps 4 to 16 and is 
required for virus replication (Perlman and Netland, 2009; Ziebuhr et al., 2000).   
Coronavirus nsp5 is a cysteine protease that has been identified in all known 
coronaviruses, and resembles the nsp4 protease of distantly related arteriviruses 
(Barrette-Ng et al., 2002; Perlman and Netland, 2009; Zhao et al., 2008). The crystal 
structure of nsp5 has been solved for divergent coronaviruses from alpha- (α-CoV), beta- 
(β-CoV), and gammacoronaviruses (γ-CoV) including NL63, 229E, SARS-CoV, human 
HCoV-HKU1 and infectious bronchitis virus (IBV). Nsp5 protease crystal structures 
demonstrate conservation of tertiary structure despite numerous differences in primary 
sequences (Anand et al., 2002; Anand et al., 2003; Bacha et al., 2008; Xue et al., 2007; 
Xue et al., 2008; Zhao et al., 2008). The X-ray crystal structure of MHV nsp5 has yet to 
be determined; however the structure of the closely related HCoV-HKU1 nsp5 (84% 
sequence identity) has been resolved to 2.5 Å (Zhao et al., 2008). All determined nsp5 
protease crystal structures exhibit a three-domain structure. Domains 1 and 2 (D1 and D2, 
respectively) form a chymotrypsin-like fold with the His41-Cys145 catalytic dyad and 
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substrate binding sites spanning the interface (Anand et al., 2002; Anand et al., 2003; 
Bacha et al., 2008; Lu and Denison, 1997; Xue et al., 2007; Xue et al., 2008). In contrast, 
domain 3 (D3) is structurally distinct among chymotrypsin-like enzymes, and also 
displays more divergence in both sequence and structural organization between 
coronaviruses. In vitro analysis indicates that domain 3 is potentially critical for 
stabilization of the chymotrypsin-like fold and may also be essential in mediating 
dimerization between nsp5 monomers (Anand et al., 2002; Lu and Denison, 1997; Shi et 
al., 2008; Shi and Song, 2006). Recent structural and biochemical studies have 
demonstrated that nsp5 dimerization is required for proteolytic activity in vitro (Chen et 
al., 2006; Chen et al., 2008; Shi et al., 2008).  
Early efforts to design coronavirus inhibitors targeting nsp5 have focused on 
competitive substrate or peptidomimetic analogs. Numerous putative inhibitor substrates 
have been co-crystallized with nsp5 protease and studies evaluating substrate specificity 
have assisted with optimizing inhibitor constructs. However, to date, the best candidates 
for nsp5 inhibition have exhibited IC50 concentrations in the low µM range (Jacobs et al., 
2013). The inability to develop inhibitors with cross-specificity and low inhibitory 
concentrations highlights the need to evaluate other non-active site, non-peptidomimetic 
substrates for coronavirus inhibition. 
Over the last ten years, several amino acid residues have been identified that may 
regulate nsp5 activity but which are distinct from active site cavity, substrate-binding 
pocket, or dimerization interface determinants. Alanine substitution of SARS-CoV nsp5 
Ser147, a conserved serine residue in MHV and HKU1, disrupts dimerization and impairs 
nsp5 proteolytic activity, despite no apparent direct connectivity to the dimerization 
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interface (Barrila et al., 2006). Other studies have shown that nsp5 activity may be altered 
by changes in replicase nonstructural proteins nsp3 and nsp10 (Donaldson et al., 2007; 
Stokes et al., 2010). Our laboratory experimentally confirmed the first temperature-
sensitive mutation (tsV148A) in MHV nsp5 (Sparks et al., 2008). This mutation results in 
impairment of viral growth and nsp5 activity at the non-permissive temperature of 40ºC 
(Sparks et al., 2008). Growth of the tsV148A mutant at 37ºC led to the emergence of two 
independent second-site suppressor mutations (S133N and H134Y), which suppressed the 
tsV148A phenotype. While the V148 residue is adjacent to the catalytic C145 residue, 
neither S133N nor H134Y have predicted direct interactions with catalytic or substrate 
residues or identified pathways for propagation of structural changes. In 2006, Sawicki et 
al identified another putative ts allele in nsp5 (F219L) at the base of unique domain 3, 
and distant from the dimerization interface, active site cavity, and substrate binding 
regions (Sawicki et al., 2005). Collectively, these findings support the hypothesis that 
residues independent from catalytic and substrate-binding sites are important for 
regulating nsp5 protease activity.  However, long-distance communication mechanisms 
between these determinants and their role in regulation of protease activity remain 
unclear.  
In this chapter, I test the hypothesis that MHV nsp5 is governed by long-distance 
communication that spans the protease structure across all three domains and is not 
limited to determinants within the active site or dimerization interface. I describe the role 
of MHV nsp5 domain 2 residues S133 and H134 and putative ts allele F219 in domain 
are described. A previously unknown MHV nsp5 ts mutation in domain 2 (tsS133A) is 
identified and the ts phenotype of F219L is experimentally confirmed. Both of these 
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mutations lead to profound replication and protein-processing defects at non-permissive 
temperatures. During passage at non-permissive temperatures, a series of second-site 
suppressor mutations emerged that were able to suppress the ts phenotypes of tsS133A 
and tsF219L. These alleles were largely distant from the cognate ts alleles, the nsp5 
active site cavity, and the dimerization interface. A single non-synonymous mutation 
resulting in a H134Y substitution suppressed the ts phenotype of all three independent ts 
alleles (S133A, V148A, and F219L) in domain 2 and 3. The ts mutations reduced but did 
not abolish nsp5 protease activity during virus infection following a shift to non-
permissive temperature, while individual and combined suppressor mutations restored 
nsp5 activity to an extent that directly correlated with increased replication.  
In collaboration with the Mesecar lab at Purdue University, MHV nsp5 proteases 
containing the ts mutation V148A with and without the second-site suppressor mutation 
H134Y were purified and evaluated for thermal stability and secondary structure. These 
studies suggest that the temperature-sensitive lesions likely destabilize the protease 
structure at elevated temperatures and that the H134Y mutation was selected as it 
hyperstabilizes domain 2. These data collectively demonstrate the presence of multiple 
interconnected long-distance communication nodes in nsp5 and suggest novel 
mechanisms of regulation of nsp5 activity during CoV replication. These findings 
establish the experimental basis further characterization in other coronavirus backgrounds 
described in Chapter III. 
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S133A is a novel temperature-sensitive mutant of MHV nsp5 
 
Initial studies by Sparks et al described two second-site suppressor mutations that 
suppressed the temperature-sensitive phenotype of MHV tsV148A; H134Y and S133N 
(Sparks et al., 2008). The residues H134 and S133 are greater than 20Å from V148, from 
the active site cavity, and from the S1 substrate-binding site in the crystal structure of 
HKU1 nsp5. The mechanism by which these residues suppress the cognate tsV148A 
virus remains unclear.  Furthermore, substitution of the H134Y or S133N alleles alone in 
the isogenic wild-type (WT) MHV background had little to no effect on virus replication 
at 37°C. Therefore, I sought to determine the roles of these residues in nsp5 activity. 
Alanine substitutions were engineered at the S133 and H134 residues in MHV nsp5. 
S133A and H134A viral mutants were recovered at 30°C and initial sequencing from the 
initial passage (P1) 30°C virus stocks confirmed the presence of mutations S133A or 
H134Y, with no other sequence changes in nsp5. These viruses were compared to 
recombinant WT MHV and tsV148A for virus titers at 30°C and 40°C, and the efficiency 
of plating (EOP) was calculated by plaque assay (titer 40°C / titer 30°C) (Table 2.1). WT 
MHV exhibited an EOP of 3.3, a 3.3-fold increase in visible plaques at 40°C compared to 
30°C. The previously described tsV148A virus exhibited an EOP of 3 x 10-5, confirming 
the ts phenotype reported by Sawicki et al (Sparks et al., 2008). The engineered H134A 
mutant had an EOP of 10-1, which is similar to previously reported engineered H134Y 
mutation in the WT MHV background (Sparks et al., 2008). However, the S133A mutant 
had an EOP of 2.7 x 10-5, consistent with an independent ts phenotype. Surprisingly, 
these data demonstrate that reversion of tsV148A had resulted in identification of an 
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allele at S133 that with an Asn substitution could suppress the V148A ts phenotype 
(S133N), yet with a conservative Ala substitution resulted in new ts phenotype (S133A). 
The H134A virus was not further examined and tsS133A was studied in subsequent 
experiments.  
 
Identification of two different suppressor mutants of tsS133A 
 
To test for revertants or suppressors of tsS133A, DBT-9 cells were initially 
infected with tsS133A at 37°C, followed by a subsequent shift to 40°C. Virus recovered 
at the non-permissive temperature was used for a plaque assay at 40°C. Ten virus plaques 
were isolated and expanded at 40°C in T25 flasks. Reverse transcription (RT) PCR 
sequencing of the nsp5 coding region from all ten clones confirmed the retention of the 
original S133A (10605AGC to GCC) engineered mutation, as well as two separate patterns 
of second-site non-synonymous mutations:  H134Y (10608CAT to 10608TAT), and T129M / 
H134Y (10593ACG to 10593ATG; 10608CAT to 10608TAT). The S133A had not reverted in all 
sequenced clones and no other mutations were detected in the nsp5 coding sequence. The 
S133A / H134Y plaque isolate had an EOP of 0.5 and the S133A / T129M / H134Y 
plaque isolate had an EOP of 2, suggesting almost complete suppression of the S133A ts 
phenotype (Table 2.1).  
To evaluate the contribution of the second-site mutations to suppression of the ts 
phenotype, we engineered the different combinations of identified mutations into the 
isogenic MHV background. Since both suppressor mutants contained H134Y and there 
were subtle differences in the EOP values, we tested the independent contribution of the 
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T129M substitution by introducing the S133A and T129M mutations in the absence of 
the H134Y mutation. All of the engineered recombinant viruses were readily recovered at 
30°C, and sequencing confirmed that the engineered changes were present and no other 
mutations had arisen in nsp5. The EOP of the recombinant S133A/H134Y and 
S133A/T129M/H134Y mutants were nearly identical to the cognate biologically 
recovered mutant, demonstrating that the identified changes in nsp5 were necessary and 
sufficient for the phenotypic reversion (Table 2.1). However, the engineered recombinant 
S133A/T129M mutant virus exhibited an EOP of 1 x 10-3, approximately 33-fold greater 
than tsS133A but still significantly ts compared to either the S133A/H134Y or 
S133A/T129M/H134Y viruses. These data demonstrated that H134Y was sufficient for 
suppression of the tsS133A, T129M was unable to suppress the ts phenotype by itself, 
and the combination of T129M and H134Y was additive or synergistic, suggesting two 
distinct mutations that could have arisen sequentially or concurrently in the same or 
different genomes.  
 
 
Table 2.1. Virus titers and EOP for WT, tsS133A and suppressor viruses 
 
 
Wild-type (WT), tsS133A and Suppressor Viruses 
Virus Titer (PFU/mL) at: Virus 
30°C 40°C 
EOP 
(Titer 40°C / 30°C) WT MHV 9 x 107 3 x 108 3 x 100 
tsS133A 6 x 106 2 x 102 3 x 10-5 
S133A/H134Y 2 x 107 1 x 107 5 x 10-1 
S133A/T129M/H134Y 3 x 107 4 x 107 2 x 100 
S133A/T129M 4 x 107 5 x 104 1 x 10-3 
H134A 5 x 108 4 x 108 7 x 10-1 
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Replication kinetics of tsS133A and Suppressor Mutants 
 
To evaluate the kinetics of viral infection and predict overall growth fitness, I 
compared the replication of WT and mutant viruses at permissive (30°C) and non-
permissive temperatures (40°C) during single cycle infections. Based on earlier single-
cycle growth studies of MHV replication, replicate plates of DBT-9 cells were infected 
with WT and recombinant mutant viruses at 30°C and a multiplicity of infection (MOI) 
of 1 PFU/cell (Gadlage and Denison, 2010; Gadlage et al., 2010). At 6 h p.i. one replicate 
for each virus was transferred to the non-permissive temperature of 40ºC and one 
remained at 30ºC, with supernatant samples obtained from 0 to 30 h p.i. during regular 
intervals for determination of viral titers. WT virus demonstrated onset of exponential 
growth at 30°C between 10 and 12 h p.i. and achieved peak virus titers of ~108 PFU/cell 
by 30 h p.i. (Figure 2.1), consistent with previous studies (Sparks et al., 2008). In 
contrast, tsS133A and all three recombinant suppressor mutant viruses demonstrated 
identical growth curves, with an approximate 10-fold reduction in titers compared to WT 
MHV from 12-24 h p.i., but achieving titers identical to WT by 30 h p.i.  
When replicating with a shift from 30°C to 40°C at 6 h p.i., WT exhibited onset of 
exponential growth within 2 h after shift and reached peak titers between 12 and 16 h p.i., 
albeit at lower titers than at 30°C due to rapid destruction of the monolayer. tsS133A 
virus demonstrated profoundly impaired growth for 10 h after temperature shift. Both 
recombinant S133A/H134Y and S133A/T129M/H134Y mutant viruses exhibited onset of 
exponential growth and peak titers similar to WT following the shift to the non- 
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Fig. 2.1. Analysis of replication of tsS133A and suppressor mutants. A and B) Growth analysis of the 
WT MHV, recombinant tsS133A, suppressor mutants (S133A/H134Y and  (S133A/T129M/H134Y), and 
engineered mutant (S133A/T129M) grown at 30°C (A) or grown at 30°C and then shifted to 40°C at 6 h 
p.i. on DBT-9 cells (B). The virus titers were determined by plaque assay on DBT-9 cells at 30°C. 
A 
B 
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permissive temperature, consistent with the EOP data.  However, the S133A/T129M 
virus showed a significant delay in exponential growth before achieving titers similar to  
WT by 6 h after temperature shift. Collectively, these results indicate that the S133A 
mutation confers a subtle replication defect at 30°C that is not further impaired nor 
complemented by the suppressor mutations, and that H134Y alone or in combination 
with T129M is sufficient for suppression of the tsS133A growth phenotype. The 
S133A/T129M virus, while demonstrating improved growth over tsS133A, remained 
impaired compared to mutants containing H134Y, a result also consistent with the EOP 
data, and supporting either that T129M arose first to be superseded by emergence of 
H134Y or arose second by conferring a subtle growth advantage of the combination over 
H134Y alone.   
 
Recovery of recombinant tsF219L 
 
Experimentation with tsS133A and previously described tsV148A demonstrated 
that the H134Y substitution was able to suppress two distinct and independently derived 
nsp5 ts alleles. These data indicate an important role for intra- or intermolecular 
communication involved in regulation of nsp5 activity. Yet, both of these ts alleles and 
their suppressor alleles are located in domain 2, and thus provide no insight into potential 
long-distance communication between domains. I next sought to determine if the H134Y 
mutation would emerge as a suppressor for another putative ts allele in domain 3. The 
10864UUU to CUU mutation resulting in the F219L substitution was predicted as a ts allele 
by Sawicki et al. using partial genome sequencing and reversion analysis of the ts mutant 
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Alb ts16 (Sawicki et al., 2005). However, this was not confirmed as the sole mutation by 
complete genome sequencing or by reverse genetic analysis. In addition, primary 
reversion rapidly occurs in biological mutants with a single nucleotide polymorphism, 
therefore possible second-site suppressors would not be identified. We introduced the 
F219L codon change as a two-nucleotide change (10864UUU to CUA) in the isogenic 
MHV clone, which would require a two-nucleotide alteration for reversion to Phe219 
(UUU or UUC). The engineered recombinant F219L mutant was obtained at 30°C, and 
complete genome sequencing confirmed the 10864UUU to CUA mutations as the only 
changes in the genome. The recombinant F219L mutant had an EOP of 3 x 10-5, 
confirming that the F219L substitution alone was sufficient to confer a ts phenotype 
(Table 2.2). The tsF219L mutant exhibited titers and plaque morphology 
indistinguishable from WT MHV at 30°C (data not shown). 
 
Identification of second-site suppressor mutations of tsF219L 
 
To test for tsF219L phenotypic revertants or suppressor mutations, DBT-9 cells 
were infected with recombinant tsF219L mutant virus at 40°C. Unfortunately, no CPE or 
productive infection occurred at 40°C despite multiple attempts and prolonged 
incubation. Accordingly, we initiated infection at 30°C for 6 h followed by shift to 37°C 
for 24 h. This stock was then passaged at 37°C with shift to 40°C, followed by passage 
and selection of 10 plaques at 40°C. Sequencing of the nsp5 coding region of ten plaque 
clones confirmed retention of the engineered 10864CUA  (F219L) codon. However all 10 
isolated plaque cloned viruses demonstrated one of two distinct patterns of second-site 
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mutations in nsp5 in the presence of tsF219L: H134Y (10608CAT to 10608TAT)/H270 
duplication (H270HH) (11016CAT to 11016CATCAT) with an EOP of 1.2; or H134Y (CAT 
to TAT)/E285V (11061GAA to 11061GTT) with an EOP of 2.9.  
To evaluate the contribution of the H134Y, E285V and H270HH changes to 
suppression of tsF219L, the identified mutations were introduced with and without 
F219L, alone or in the combination seen in the recovered viruses. Furthermore, although 
no F219L/E285V/H270HH mutant was identified among the sequenced plaques, we also 
engineered this combination to test for the capacity of this combination to suppress the ts 
phenotype. In total, nine different virus genomes were engineered: F219L/E285V; 
F219L/H134Y; F219L/H270HH; F219L/H134Y/E285V; F219L/H134Y/H270HH; 
F219L/H270HH/E285V; H134Y/E285V; H134Y/H270HH; and H270HH/E285V. All 
viruses were recovered at 30°C with the engineered mutations detected and confirmed by 
sequencing across nsp5. The EOP was determined for each of the viruses by plaque assay 
on DBT cells at 30°C and 40°C (Table 2.2). The second-site substitution combinations 
identified by reversion analysis were sufficient to suppress the F219L ts phenotype: 
H134Y/E285V, EOP = 2.9; and H134Y/H270HH; EOP = 1.2. When the second-site 
suppressor alleles were tested alone with F219L, the results showed that the individual 
substitutions either minimally or partially suppressed tsF219L: H134Y, EOP = 2 x 10-5; 
E285V, EOP = 1 x 10-5; and H270HH, EOP = 2 x 10-3. When second-site substitutions 
were introduced in the WT background, either alone or in combination, there was no 
effect on EOP, suggesting that the changes were not responsible for any replication 
defects in the presence of F219L. The non-biologically derived combination of 
F219L/E285V/H270HH also completely suppressed the tsF219L phenotype (F219L / 
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E285V / H270HH, EOP = 1.0). These EOP results demonstrated that the biologically 
identified second-site substitution combinations were both necessary and sufficient to  
suppress the tsF219L phenotype. Further, the results showed that H134Y did emerge as a 
suppressor allele for domain 3 tsF219L, but that in contrast to tsV148A and tsS133A, 
suppression of tsF219L required at least one other substitution in domain 3 in 
combination with H134Y.    
 
 
Table 2.2. Virus titers and EOP for WT, tsF219L and suppressor viruses 
 
 
Replication kinetics of tsF219L and suppressor mutants 
 
The tsF219L and recombinant suppressor viruses were grown in DBT cells at 
30°C, or with a shift from 30°C to 40°C at 6 h p.i. (Figure 2.2). At 30°C, all of the 
recombinant mutant viruses showed replication kinetics and virus yield indistinguishable 
from WT MHV. Following shift to 40°C at 6 h p.i. however, tsF219L showed no further 
replication for 10 h.  In contrast, the mutant viruses containing any two of the H134Y,  
  Wild-type (WT), tsF219L and Suppressor Viruses 
Virus Titer (PFU/mL) at: Virus 
30°C 40°C 
EOP 
(Titer 40°C / 30°C) WT MHV 9 x 107 3 x 108 3 x 100 
tsF219L 1 x 108 3 x 103 3 x 10-5 
F219L/H134Y/E285V 1 x 107 4 x 107 3 x 100 
F219L/H134Y/H270HH 2 x 107 2 x 104 1 x 100 
F219L/H270HH/E285V 3 x 107 3 x 107 1 x 100 
F219L/E285V 1 x 107 2 x 102 2 x 10-5 
F219L/H134Y 1 x 108 1 x 103 1 x 10-5 
F219L/H270HH 8 x 106 1 x 104 2 x 10-3 
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Fig. 2.2. Analysis of tsF219L and suppressor mutant EOP and replication. A and B) Growth analysis 
of WT MHV, recombinant tsF219L, suppressor mutants (F219L/H134Y/E285V and 
F219L/H134Y/H270HH), and engineered mutants (F219L/H270HH/E285V, F219L/E285V, 
F219L/H270HH, and F219L/H134Y) grown at 30°C (A) or grown at 30°C and then shifted to 40°C at 6 h 
p.i. (B) on DBT-9 cells. The virus titers were determined by plaque assay on DBT-9 cells at 30°C. 
A 
B 
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E285V and H270HH substitutions demonstrated growth after shift to 40°C similar to 
WT. In contrast, all single suppressor residues expressed with F219L demonstrated a 4 h  
lag before exponential growth compared to the double mutants, but ultimately achieved 
similar peak titers. The titers at 10 h p.i. were consistent with the EOP data (10-3 to 10-5 
compared to WT) and overall demonstrated that the individual mutations were capable of 
improved viral replication compared to the tsF219L virus yet still were ts compared to 
WT. Thus, in contrast to tsV148A and tsS133A, suppression of tsF219L appears to 
require a combination of at least two second-site mutations. These data may justify the 
tight tsF219L phenotype at 40°C, as well as for the necessity of sequential passage of the 
tsF219 mutant virus at 30°, 37° and 40°C to recover phenotypic revertants. In addition, 
these results identify H134Y as a second-site suppressor for a third ts allele in nsp5, this 
one in a domain 3.  Overall, the results show that cooperation of H134, E285, and H270 
in nsp5 is necessary for efficient virus replication, as well confirming communication 
between nsp5 domains 2 and 3.  
 
tsS133A and tsF219L exhibit temperature-sensitive impaired activity 
 
To directly compare the nsp5 protease activity of tsV148A, tsS133A, tsF219L and 
second-site suppressor mutants, DBT cells were infected at an MOI of 5 PFU/cell and 
incubated at 30°C. At 6 h p.i., replicate monolayers were maintained at 30°C or 
transferred to 40°C  and infected cells were radiolabeled with [35S]Met-Cys. Lysates from 
infected, radiolabeled cells were immunoprecipitated with antisera specific for nsp2, 
nsp5, and nsp8, to test for processing of nsp2 by PLP1 and of nsp5 and nsp8 by nsp5.   
 43 
Immunoprecipitation with antibodies specific for nsp2 of all lysates from WT and 
mutant-infected cells with labeling at 30oC and 40oC resulted in detection of mature  
processed nsp2, demonstrating that at both permissive and non-permissive temperatures 
there was similar translation of pp1a (nsp1 – 11) and normal PLP1 activity. Recently, 
Stokes et al. reported that a ts mutation in nsp3 resulted in a significant decrease in nsp5-
mediated processing (Stokes et al., 2010). In our study, I detected the nsp4-10 precursor 
polyprotein (150 kDa), which demonstrates that PLP2 is functional and is not inhibited 
by the nsp5 mutations (Figure 2.3). The presence of mature nsp2 and the p150 bands at 
non-permissive temperature indicates that both PLP1 and PLP2 domains of nsp3 are 
active and are not affected by the nsp5 mutations. Although I did not test the processing 
of nsp3 directly, detection of both p150 and mature nsp2 is consistent with normal 
processing of N- and C-termini of nsp3. Immunoprecipitation of cells infected with WT 
MHV by nsp5-specific antibodies at both 30oC and 40oC resulted in detection of mature 
processed nsp5, as well as co-immunoprecipitation of nsp8, and two distinct small protein 
bands at 10 and 12 kDa, consistent with the predicted migration of nsp7 and nsp9. 
Immunoprecipitation with nsp8-specific antibodies detected nsp8 as well as probable co-
precipitation of nsp5 and the 10 and 12 kDa proteins. These results show that expression 
and processing of pp1a proteins nsp5, nsp7, nsp8 and nsp9 are accelerated at 40°C in 
cells infected with WT MHV.   
 The temperature-sensitive viruses tsS133A and tsF219L, as well as the previously 
described tsV148A, exhibited profoundly impaired processing of nsp5 and nsp8 at 40°C 
when compared to 30°C, indicating a specific defect in processing by the nsp5 protease. 
This was consistent with decreased detection of the reciprocal co-immunoprecipitating  
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Fig. 2.3. Proteolytic processing of WT, tsS133A, tsF219L, and suppressor viruses. DBT-9 cells were 
35S radiolabeled during viral infection or mock infection. Cellular lysates were harvested from cells 
infected withWTMHV,tsS133A mutants, tsF219L mutants, and previously described tsV148A and from 
mock-infected cells. Labeled proteins were immunoprecipitated using antiserum specific for nsp2, nsp5, 
and nsp8. The temperature during virus infection is indicated above the lanes (30°C [30] or a temperature 
shift from 30° to 40°C at 6 h p.i. [40]). One hundred microliters of lysate was used for all 
immunoprecipitations. The positions of putative viral proteins are shown to the right of the gels based upon 
the predicted size, and identified bands are labeled. The positions of molecular weight standards (MW) are 
shown to the left of the gels, and sizes are shown in kilodaltons. Protein expression profiles were resolved 
by SDS-PAGE and visualized by autoradiography. α-nsp2, anti-nsp2 antibody. 
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protein (nsp8 or nsp5) as well as decreased detection of the 10 and 12 kDa proteins. 
Although the detection of nsp5-processed proteins was profoundly decreased, I was 
unable from multiple replicate experiments (>5) to demonstrate complete loss of nsp5  
activity. The results suggest that the S133A, F219L and V148A mutations do not directly 
affect the catalytic or substrate binding functions of nsp5, but rather modify protease 
activity in other ways. Alternatively, it is possible that the residual processing might be 
the result of nsp5 expressed and folded into active forms or complexes prior to the 
temperature shift, and thus still retain residual activity.  
 Viruses carrying biological and engineered suppressor mutations demonstrated 
restoration of processing by nsp5 that directly correlated with the degree of recovery of 
EOP and virus growth. Single second-site mutants S133A/T129M, F219L/H134Y, 
F219L/H270HH, and F219L/E285V showed an increase in detectable processed nsp5 and 
nsp8 only, while the double second-site suppressors restored WT-like patterns of 
processed proteins.  Collectively, the results show a direct correlation of detection of 
proteins processed by nsp5 (nsp5 and nsp8) and the extent of restored growth fitness in 
culture and EOP analysis in plaque assay. Further, these findings indicate that the 
impairment in growth at non-permissive temperatures is not due to complete inactivation 
of nsp5 protease activity.  
 
Analysis of ts and suppressor alleles in coronavirus nsp5 structures 
 
To evaluate the structural connection between the ts and second-site suppressor 
mutations, the distances between the combinations of ts and suppressor residues were 
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determined by analyzing the crystal structure of the nsp5 protease of a closely related 
human coronavirus, HKU1 (Figure 2.4). The structure of MHV nsp5 has not been 
determined despite many efforts. However, MHV and HKU1 nsp5 proteases exhibit 84% 
sequence identity, and share all of the same amino acids at the residue positions reported 
in this study with the exceptions of H134 and H270 (Y134 and Y270 in HKU1). All of 
the second-site suppressor residue positions in HKU1 nsp5 were greater than 10 Å 
distance from the ts residues in the monomeric structure with the sole exception that the 
H134 residue is 3.8 Å from the juxtaposed S133. Measurement of the distance between 
residues in different monomers of the dimeric structure of both SARS-CoV and HKU1 
nsp5 demonstrated that no two residues from this study were closer than 15.0 Å. 
Measurement of the distance between the ts and second-site suppressor mutants and the 
catalytic dyad residues, H41 and C145, showed that only V148A was within 10 Å of 
either residue. Collectively, these data demonstrate that the relationship between the ts 
and suppressor mutations cannot be explained by direct interactions between residues, 
and that nsp5 dimerization does not provide direct inter-monomer associations between 
the residues identified in this study.  
Modeling of the S133A and F219L mutations on the structure of HKU1 nsp5 
failed to predict any clear pathways of side-chain remodeling or perturbation between the 
ts residues and the protease active site (data not shown).  In contrast, analysis of residue 
conservation using an alignment of 130 non-redundant coronavirus nsp5 amino acid 
sequences identified a series of 100% identical residues that span the regions of nsp5 
between each of the ts residues (S133, V148, and F219) and the common second-site 
suppressor residue (H134) (Figure 2.5). These findings indicate that the structural and  
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Fig. 2.4. Distances between MHV temperature-sensitive and suppressor alleles. Distances between the 
ts, suppressor mutant, and catalytic dyad residues (H41 and C145) are shown in angstroms (Å) within the 
monomeric structure (top right half of table) and across the dimeric structure (bottom left half of the table). 
Calculations were performed by measurement between alpha carbons of each amino acid residue position 
in the structure of HKU1 nsp5 (Rao et al. 2008). 
 
Figure 5. Long distance communication in nsp5 protease. (A) Distances between the ts, suppressor 
mutant, and catalytic dy d residu s (H41 and C145) r  shown in angstroms (Å) within the monomeric 
structure (top right half of table) and across the dimeric structure (bottom left half of the table). 
Calculations were performed by measurement between alpha carbons of each amino acid residue position 
in the structure of HKU1 nsp5 (47). (B) Conservation map of 100% conserved nsp5 residues (black) across 
available CoV nsp5 sequences is superimposed over the monomeric structure of HKU1 nsp5 protease. The 
ts (red) and second-site suppressor mutations (green) are also shown.   
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Fig. 2.5. Structural relationship of ts and suppressor alleles to conserved MHV alleles. A conservation 
map of 100% identical nsp5 residues (black) across 130 non-redundant CoV nsp5 sequences is shown on 
the HKU1 nsp5 protease monomer structure (Rao et al 2008). The location of identified ts alleles (red) and 
suppressor alleles (green) are indicated. 
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functional perturbations on nsp5 protease of the ts mutations may span long distances 
across the protease structure through yet to be identified cooperative interactions.  
 
Residue conservation of ts and suppressor alleles is clade-specific 
 
To evaluate the conservation of the ts and suppressor alleles, a sequence logo 
(Crooks et al., 2004) was generated using a non-redundant alignment of 130 coronavirus 
nsp5 amino acid sequences, and the ts and suppressor alleles for the 17 coronavirus 
species recognized by the International Committee of Taxonomy of Viruses (ICTV) were 
analyzed (Figure 2.6). From two to eight different residues occupy each position across 
available CoV sequences. Surprisingly, the H134Y common second-site suppressor 
mutation selected for a tyrosine that is already present in several betacoronaviruses. 
Further, the S133N second-site suppressor first reported by Sparks et al. is common as an 
Asn in many coronaviruses (Sparks et al., 2008). Conservation of distinct ts and 
suppressor alleles within the three genera suggest that there may be select combinations 
of alleles that are necessary for nsp5 activity. The role of these determinants remains 
unknown, however these data suggest that non-conserved alleles located in nsp5 domains 
2 and 3, as well as potentially unidentified determinants in domain 1 are critical for 
regulating nsp5 structure, specificity, stability or function. The presence of similar alleles 
in closely-related human coronaviruses HKU1 and OC43 may indicate similar functional 
regulation and likely a strong evolutionary link between the three betacoronaviruses.  
These findings further suggest that alterations in structure attributed to these residues 
could have analogous combinations in other CoVs.  
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Fig. 2.6. Coronavirus protein sequence conservation of ts and suppressor alleles.  A) A sequence logo 
of conservation of ts and suppressor mutations across an alignment of 130 non-redundant CoV nsp5 
sequences was generated using WebLogo (13). The height of each letter corresponds to the relative 
conservation of that amino acid at the position and the height of the column corresponds to the sequence 
conservation at the position. The residue numbers are relative to the MHV amino acid positions. B) The ts 
and suppressor residues of coronavirus species by CoV genus are shown for each MHV residue position. 
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Expression and purification of codon-optimized WT MHV nsp5 
  
In order to identify the functional role of the MHV ts and second-site mutations, 
MHV nsp5 was expressed and purified for biochemical analysis. Wild-type MHV nsp5 
sequence was codon-optimized (3CLpro) for bacterial expression in E. coli and cloned 
into a pET-15b expression plasmid construct (Figure 2.7). The N-terminal end of the 
nsp5 sequence is flanked by a tobacco etch virus (TEV) cleavage site and a His tag for 
efficient purification and subsequent cleavage to yield mature native nsp5. Initial 
attempts at expression and purification of MHV nsp5 demonstrated that the protease 
retained proteolytic activity and autoprocessed the TEV cleavage site preventing Ni-
affinity chromatography for purification. The TEV cleavage site (NLYFQ†G/S) 
resembles the nsp5 consensus site (SATLQ†SG) at the P2 – P1’ and may explain the 
inadvertent auto-processing that occurred. Efforts were then directed to optimize a native 
nsp5 purification approach based upon studies described by Grum-Tokars et al describing 
substantial differences in nsp5 protease activity when tagged either amino- or carboxy-
terminally.  
 WT MHV nsp5 was overexpressed in E. coli BL21 DE3 cells following induction 
with IPTG at 37°C. The final purification procedure devised consists of a two-step 
process. First, the bacterial lysate is flowed through a hydrophobic interaction 
chromatography column (phenyl sepharose column) followed by elution from a DEAE 
anion exchange column. Upon purification, the two clear distinct bands are visualized in 
a Coomassie gel of approximately the same sizes of the monomeric (~30 kDa) and 
dimeric (~60 kDa) nsp5 proteases. The purity of the protease is approximately 95% after  
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Fig. 2.7. Expression, purification and activity of wild-type MHV nsp5. A) Expression construct for 
codon-optimized expression of MHV nsp5 in E. coli BL21 DE3 cells. The amino-terminus of nsp5 is 
flanked by a TEV site and a His tag. B) FRET-based substrate (UIVT3) containing a consensus nsp5 
cleavage site connecting a donor-quencher pair. C) Two-step purification of WT MHV on phenyl 
sepharose (PS) and DEAE anion exchange columns. Protein products are displayed on an SDS-PAGE gel 
Coomassie stained. MW, molecular weight marker in kilodaltons. D) Coomassie and western blots of 
purified wild-type MHV nsp5 protease. The western blot was performed using nsp5-specific antisera. Data 
acquired in collaboration with Sakshi Tomar and Aimee Eggler (Purdue University) 
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the two-step protocol. Protease activity was assayed using a FRET-based peptide 
substrate (UIVT3) containing a universal nsp5 consensus site flanked by a donor-
quencher pair (HilyteFluor488-ESATLQ†SGLRKAK-QXL520-NH2) which measures 
activity by emission if cleaved at 520 nm (following excitation at 488 nm). The fractions 
isolated following purification showed strong proteolytic activity against UIVT3 
indicative of active and mature nsp5 protease. 
 
Introduction of MHV ts and suppressor alleles for purification 
 
 To evaluate the role of the ts and second site suppressor alleles identified in MHV 
nsp5, I introduced the following combinations of mutations into the codon-optimized 
pET-15b expression construct: H134Y, V148A, V148A/H134Y, S133A, S133A/H134Y, 
F219L, F219L/H134Y, and F219L/H134Y/E285V (Table 2.3). The S133A, V148A and 
F219L mutations were introduced into the expression construct as they all conferred ts 
phenotypes during MHV infection. The H134Y was introduced as it had been selected as 
a second-site suppressor independently for all three viruses. However, during reversion 
analysis of the tsF219L virus, the H134Y mutation was insufficient to complete recover 
viral replication and processing at the non-permissive temperature of 40°C. 
Consequently, an additional combination containing both the H134Y and E285V was 
also introduced as this combination yielded a wild-type-like efficiency of plating (EOP) 
indicative of no apparent temperature-sensitivity, similar replication kinetics, and 
restored polyprotein processing.  
 54 
 The same approach for expression and purification of WT was employed for the 
following constructs: F219L, F219L/H134Y, F219L/H134Y/E285V, H134Y, V148A, 
S133A/H134Y. However, only H134Y and S133A/H134Y showed good expression after 
induction using IPTG at 37°C (Figure 2.8). A band migrating at the predicted size of 
monomeric nsp5 was detected in the lysed bacterial pellet for all three F219L mutant 
constructs and V148A indicating that a considerable fraction of the nsp5 expressed was 
likely mobilized to inclusion bodies. It was then decided to select one ts construct and 
second-site combination for optimization and purification.  
 
Table 2.3. Oligonucleotide primers for codon-optimized MHV nsp5 mutagenesis 
 
 
 
 
 
Oligonucleotides for generation of codon-optimized MHV nsp5 constructs 
Mutation Sequences Type Constructs 
Generated S133A 
5’ CTGCGTAGCGCACACACCATTAAAG 3’ 
5’ CTTTAATGGTGTGTGCGCTACGCAG 3’ 
 
ts Allele S133A S133A/H134Y 
H134Y 
5’ CTGCGTAGCAGCTATACCATTAAAG 3’ 
5’ CTTTAATGGTATAGCTGCTACGCAG 3’ 
 
 
 
 
Suppressor 
Allele 
H134Y 
V148A/H134Y 
S133A/H134Y 
F219L/H134Y 
F219L/H134Y/E285V 
V148A 
5’ TCCGCCGGCTATGTTCTGACTGGT 3’ 
5’ ACCAGTCAGAACATAGCCGGCGGA 3’ 
 
ts Allele V148A V148A/H134Y 
F219L 
5’ ACTGGCTGGTCCAGAGCGATTCTT 3’ 
5’ AAGAATCGCTCTGGACCAGCCAGT 3’ 
 
 
ts Allele 
F219L 
F219L/H134Y 
F219L/H134Y/E285V 
E285V 
5’ GTTCTGGTTGATGAGCTGACC 3’ 
5’ GGTCAGCTCATCAACCAGAAC 3’ 
 
Suppressor 
Allele F219L/H134Y/E285V 
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Fig. 2.8. Expression and purification of MHV nsp5 containing ts and suppressor mutations. A) 
Coomassie stain of bacterial lysates (Lys) and pellet fractions (Pel) of nsp5 containing the mutations 
F219L, F219L/H134Y, F219L/H134Y/E285V, H134, V148A, S133A/H134Y, and wild-type (WT) MHV. 
Arrows denoting the putative monomer (M) and dimer (D) bands are shown at left. B) Bacterial lysates of 
MHV nsp5 containing the V148A/H134Y mutations expressed under 0.15 mM IPTG induction at either 
25° or 37°C. A wild-type (WT) nsp5 control is also provided for comparison. C) Purified WT, 
V148A/H134Y and V148A on Coomassie gel. The monomer and dimers are marked by arrows and 
molecular weights are in kilodaltons. Data acquired by Sakshi Tomar (Purdue). 
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Purification of V148A, H134Y, and V148A/H134Y nsp5 proteases 
 
The temperature-sensitivity and suppressor phenotypes are reproducible and 
profound in the context of a replicating virus, however it remains unknown whether these 
effects are isolated to the protease or are associated with alterations to critical nsp5 
allostery with other components of the viral genome. To evaluate whether these effects 
are internal to nsp5 or are associated with allosteric interactions with other viral elements, 
the ts lesion V148A and second-site suppressor mutation H134Y were individually and in 
combination (V148A/H134Y) expressed for purification. Sparks et al demonstrated that 
the tsV148A virus exhibited reduced replication kinetics and nsp5-mediated processing at 
the non-permissive temperature of 40°C. Initially, the same purification protocol used for 
WT MHV was employed for expression and purification of the mutant constructs. 
However, very little yield of the V148A and V148A/H134Y nsp5 products was recovered 
after IPTG induction at 37°C (Figure 2.8). Since the cognate viruses were temperature-
sensitive, the temperature for expansion was lowered to 25°C to evaluate whether the 
temperature was affecting nsp5 bacterial mobilization. Upon shifting to 25°C, 
appreciably more expression was detected in the lysates. Further expression and 
purification of other mutated MHV nsp5 constructs will utilize these expression and 
bacterial growth conditions. 
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V148A reduces nsp5 protease activity at elevated temperatures 
 
 To evaluate the role of temperature on the MHV nsp5 containing V148A and 
V148A and H134Y in combination, a thermal inactivation assay was developed (Figure 
2.9). During the assay, 10 µM of purified MHV nsp5 proteases containing V148A and 
V148A/H134Y as well as a wild-type control were incubated at temperatures ranging 
from 30°C to 50°C over 2 h. At individual time points, aliquots of the enzymes were 
mixed with the UIVT3 peptide substrate to evaluate the percentage of activity remaining 
relative to before incubation.  
 At 30°C, the wild-type MHV virus exhibited an approximately 1 log greater titer 
during virus replication over either the V148A or V148A/H134Y. However, the 
replication kinetics of all three viruses were nearly identical over an infection at an MOI 
of 0.01 PFU/mL. Incubation of the corresponding proteases at 30°C resulted in no 
appreciable loss of protease activity over the entire time frame for WT or the V148A-
modified protease (Figure 2.9). Interestingly, the V148A/H134Y protease displayed a 
subtle drop in residual activity to approximately 50% of the original amount by the end of 
the time course before reaching a constant level of activity (Table 2.4). At 35°C, both 
WT and the suppressor combination of V148A/H134Y exhibited sustained activity with 
no apparent loss over the 2 h incubation period. Whereas, the V148A-modified protease 
displayed a small, but sustained decrease in activity over the entire survey associated with 
a half-life of approximately 130 min. At the non-permissive temperature for virus of 
40°C, WT and the suppressor combination, V148A/H134Y, exhibit a slight but subtle 
decline in activity over time with half-lives exceeding 2 h. In contrast, V148A nsp5  
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Fig. 2.9. Thermal inactivation of WT, V148A and V148A/H134Y nsp5 proteases. A) Thermal 
inactivation assay experimental design. B) Evaluation of wild-type (WT; black), V148A (red) and 
V148A/H134Y (green) MHV nsp5 protease activities during a 2 h incubation in temperatures ranging from 
30° to 45°C. Percent activity is measured activity by cleavage of the UIVT3 universal substrate compared 
to activity at 0 min post-incubation. Data acquired by Sakshi Tomar (Purdue). 
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exhibits a steady linear decline in activity associated with a half-life of 55 min. When 
incubated at 45°C above biological conditions, WT and V148A/H134Y both exhibit a 
subtle loss of activity over 2 h time with an approximate half-lives of 90 and 75 min 
respectively. However, V148A nsp5 demonstrates a profound sensitivity to the 
temperature with an abrupt decline in activity and a half-life of approximately 2 - 5 min 
at the temperature. Collectively, these data correlate directly with the viral EOP data and 
indicate that the mutation V148A results in a decline in nsp5 protease activity at elevated 
temperatures, whereas the second-site suppressor mutation H134Y partially restores 
protease activity at these temperatures. Further, these data suggest that the inherent defect 
associated with these mutations in the context of a virus is not likely due to disruption of 
critical allosteric interactions with other viral elements. 
 
Table 2.4. Approximate half-life of MHV nsp5 proteases in vitro 
*Sparks et al. 2008 J Virol 
 
V148A destabilizes and H134Y restabilizes MHV nsp5 secondary structure  
 
 To test whether the decrease in half-life is associated with structural instability, 
the proteases were subjected to circular dichroism (CD) spectroscopy. CD spectroscopy 
Half-life (in min) of MHV nsp5 proteases 
 WT MHV V148A V148A/H134Y 
Virus EOP*: 3.3 2 x 10-5 1.1 
30°C > 120 min > 120 min > 120 min 
35°C > 120 min 130 min > 120 min 
40°C > 120 min 55 min > 120 min 
45°C 90 min 3 min 45 min 
50°C 7 min <3 min < 3min 
 60 
is used to evaluate the secondary structure of proteins. Gross chains in secondary 
structure will result in modifications in the ellipticity or signal at defined wavelengths. 
WT, V148A, V148A/H134Y and H134Y MHV nsp5 proteases were evaluated by CD 
spectroscopy for differences in protease secondary structure. All four proteases exhibited 
a similar spectral curve at room temperature (25°C), which is comparable to previously 
reported nsp5 CD spectra and is reminiscent of largely β-sheet structure (Figure 2.10). 
These data indicate that the secondary structure of the proteases is indistinguishable at 
room temperature. 
 To assess the affect of temperature of protease secondary structure stability, the 
CD signal at a wavelength of 222 nm (selected due to its robust signal in the CD spectra) 
was evaluated with increasing temperature. Before 40°C, there were no apparent loss of 
signal among any of the proteases. However, at approximately 40°C, an inflection occurs 
in the spectral signal of V148A and it reaches half of its signal at approximately 47.5°C. 
The V148A/H134Y protease exhibits an approximate Tm of 49.5°C indicative of a subtle 
increase in structural stability over protease exhibiting the original ts allele. WT MHV 
exhibits a Tm of approximately 52.0°C. These data correlate strongly with the viral EOP 
data as well as the thermal inactivation assay data and suggest that phenotype associate 
with the ts lesion V148A is due to structural instability. Surprisingly, the H134Y 
demonstrated a higher Tm (54.0°C) than WT indicative of a hyperstable protease. Further 
study will need to evaluate the thermal stability of this protease in vitro. 
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Fig. 2.10. Circular dichroism (CD) spectroscopy and thermal stability of MHV nsp5 proteases. A) CD 
spectra of WT (black), V148A (red), V148A/H134Y (green) and H134Y (blue) MHV nsp5 proteases. B) 
Evaluation of secondary-structure stability as measured by ellipticity at 222 nm in millidegrees (mdeg) over 
a temperature range of 0° to 100°C. C) Melting temperatures as measured by unfolding at a wavelength of 
222 nm. The viral EOP (ratio of titers at 40° over 30°C) is provided for comparison. Data acquired by 
Sakshi Tomar (Purdue). 
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Summary 
 
This study identified a novel temperature-sensitive lesion (S133A) in domain 2 of 
MHV and confirmed an additional temperature-sensitive lesion (F219L) in domain 3. 
These ts alleles were suppressed by a series of largely non-adjacent alleles spanning 
domains 2 and 3, which recovered viral replication kinetics and nsp5-mediated 
polyprotein processing at the non-permissive temperature of 40°C. Analysis of nsp5 
structures and sequences demonstrated that communication between these alleles cannot 
be predicted by structural modeling and that none of the alleles described are conserved 
across known coronavirus sequences, but appear to be conserved within phylogenetic 
groups or clades. Codon-optimized MHV nsp5 proteases were expressed, purified and 
evaluated for thermal stability and sustained activity over time. These studies 
demonstrated that the ts allele V148A which was originally described by Sparks et al as 
having reduced viral replication and altered polyprotein processing results in a reduction 
in viral protease half-life and a decrease in thermal stability. These findings correlate 
directly with the viral replication kinetics and indicate that the defect associated with the 
ts mutations is intrinsic to nsp5 rather than due to unknown allosteric interactions with 
other viral elements. These studies provide a potential biochemical mechanism of action. 
These findings provide the basis for studies described in Chapter III. The implications of 
these findings and application of these data to other areas of coronavirus nsp5 protease 
regulation and activity are discussed in detail in Chapter IV.  
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CHAPTER III 
 
 
CHIMERIC EXCHANGE OF CORONAVIRUS NSP5 PROTEASES (3CLPRO) 
IDENTIFIES COMMON AND DIVERGENT REGULATORY DETERMINANTS OF 
PROTEASE ACTIVITY 
 
Introduction 
 
 
Human coronaviruses (CoVs) are enveloped, positive-strand RNA viruses 
responsible for causing upper and lower respiratory illnesses of varying severities ranging 
from the common cold to severe acute respiratory syndrome (SARS). In 2002 – 2003, 
SARS-CoV spread to at least 32 countries and resulted in the deaths of nearly 10% of the 
approximately 8000 individuals infected. Recently, a new coronavirus strain (HCoV-
EMC) identified in the Middle East and Europe has been associated with up to 65% 
mortality in infected individuals (Zaki et al., 2012). Phylogenetic and molecular analysis 
of known coronaviruses supports a zoonotic origin of SARS-CoV and EMC from bats 
(Anthony et al., 2013; Perlman and Zhao, 2013). However, it remains unclear what 
elements of coronavirus replication are conserved and more important the mechanisms 
and limitations of emergence of new coronavirus zoonoses. Study of SARS-CoV and 
HCoV-EMC has been aided by the ability of the viruses to replicate in culture and by 
identification of virus receptors. However, for many human and zoonotic coronaviruses, 
analysis is limited by the inability to cultivate the viruses from primary specimens. Thus, 
it is important to develop approaches to study coronavirus inhibition in the background of 
replicating viruses, as well as to understand the conservation of viral proteins as targets.  
Coronaviruses are members of the order Nidovirales, family Coronaviridae and 
subfamily Coronavirinae. Among the viruses in Coronavirinae, four main genera have 
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recently been designated (Woo et al., 2012): (i) Alphacoronaviruses (α-CoVs) which 
contain the human coronaviruses 229E and NL63, (ii) Betacoronaviruses (β-CoVs) 
containing human coronaviruses SARS-CoV, HKU1, EMC and OC43, and (iii) 
Gammacoronaviruses (γ-CoV) and (iv) Deltacoronaviruses (δ-CoV), from which no 
current human coronaviruses have been identified. Coronaviruses genomes range in size 
from 27 to 32 kb, with genome organization similar among all four genera (Woo et al., 
2012). However, co-evolution of proteins within and between diverse phylogenetic 
groups is unknown (Woo et al., 2009). Murine hepatitis virus (MHV), a β-CoV, is a well-
established model system for the study of coronavirus replication and pathogenesis. The 
genome of MHV is approximately 32 kb in size and encodes seven genes including a 
replicase gene and six structural and accessory genes (Gorbalenya et al., 1989; Lee et al., 
1991). The 22 kb viral replicase gene is translated into two large polyproteins (pp1a or 
pp1ab) containing 16 non-structural protein domains (nsps1-16) including two papain-
like protease activities (PLP1 and PLP2) in nsp3, and a chymotrypsin-like cysteine 
protease (nsp5  / 3CLpro / Mpro) that mediate all proteolytic processing of the CoV nsps 
(Brierley et al., 1989; Lee et al., 1991; Perlman and Netland, 2009; Ziebuhr et al., 2000).  
Coronavirus nsp5 proteolytic processing occurs at 11 cleavage sites between nsp4-
16 and is required for virus replication. Nsp5 protease is conserved in all known 
coronaviruses and is comprised of 3 structural domains (D1-D3), of which D1-D2 form a 
chymotrypsin-like fold containing the catalytic Cys-His catalytic dyad and substrate 
binding pocket (Anand et al., 2002; Anand et al., 2003; Bacha et al., 2008; Xue et al., 
2008; Zhao et al., 2008). Nsp5 cleaves after a P1-glutamine in all studied a, b and g 
coronaviruses (with the exception of a single site in HCoV-HKU1). Numerous studies 
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have demonstrated significant intra- and intermolecular associations within and between 
the coronavirus nsp5 protease and the rest of the replicase gene. We reported three 
different temperature-sensitive intramolecular alleles in domains 2 and 3 of MHV nsp5 as 
critical determinants of nsp5 protease activity and viral replication (Sparks et al. 2008; 
Stobart et al. 2012). Studies by others have also demonstrated that nsp5 activity was 
altered or aborted by mutations in nsp3 and nsp10 (Stokes et al. 2010; Donaldson EF et 
al. 2007). These data collectively suggest a close and crucial co-evolution between 
coronavirus nsp5 protease and the rest of the replicase gene. 
Coronaviruses are known to exhibit some of the highest known rates of 
recombination, which have been attributed to polymerase pausing and RNA template 
switching (Makino et al. 1986; Sawicki et al. 2007). The first coronavirus reverse 
genetics methods employed targeted RNA recombination and selection for a virus with 
increased fitness at elevated temperatures (Koetzner et al. 1992; Masters et al. 1994). 
Early studies evaluating the rates of coronavirus recombination through mapping of 
complementation groups using temperature-sensitive lesions throughout the genome of 
MHV estimated a frequency of approximately 1% per 1.3 kb or nearly 25% of the entire 
genome (Baric et al. 1990; Fu et al. 1992). Sawicki et al (2005) and Stokes et al (2010) 
later demonstrated using complementation analysis that the coronavirus genome consists 
of at least five different complementation groups or cistrons (named cistrons 0, I, II, IV 
and VI) that contribute to unique viral phenotypes. Cistron I comprised of nsps 4 – 10 has 
been identified in several studies as a processed intermediate and has one or more related 
functions prior to maturation processing by nsp5 (Sawicki et al. 2005, Donaldson et al. 
2007, Stokes et al. 2010, Xiao et al. 2012). These data suggest that the defined regions of 
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the coronavirus genome, which share a common function or phenotype, may have 
increased capacity for recombination. However, no studies have directly tested the 
potential or limitations for coronavirus recombination within or across genera. More 
specifically, it is unknown if the extensive interactions of nsp5 with 11 cleavage sites as 
well as with alleles in nsp3 and nsp10 constitute a barrier to genetic exchange between 
coronaviruses. If so, this would constitute limitations in over half of the coronavirus 
genome.  
In this study, I address two specific questions: 1) Does the nsp5 protease establish a 
barrier to genetic exchange between closely or distantly related coronaviruses?  2) How 
conserved is nsp5 protease activity and specificity across coronavirus genera and species? 
To answer these questions, I engineered artificial recombinant viruses of the β-CoV 
MHV by exchanging complete nsp5 coding sequences from closely-related human b-
CoVs HKU1 and OC43 and distantly-related α- and β-CoVs SARS-CoV, Bat-HKU4, 
NL63 and 229E. In this study, I demonstrate that artificial recombination of nsp5 from 
closely related HKU1 and OC43 is readily tolerated in MHV for efficient replication, but 
confers a profound loss in competitive fitness. In contrast, more distantly related 
coronavirus nsp5 proteases could not be recovered, even with exchange of the species-
specific cleavage sites. These results suggest that co-evolution of nsp5 with cleavage sites 
and other proteins is extensive within subgroups of genera, and may represent a profound 
barrier to recombination in replicase gene across genera and even between more 
divergent subgroups (such as 2a and 2b) Further nsp5 may constitute a profound but not 
absolute barrier to emergence of recombinants between closely related species due to loss 
of fitness. On the other hand, the studies also demonstrate that it is possible within 
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subgroups to establish replicating platform coronaviruses such as MHV for study of nsp5 
function and inhibition from difficult or non-cultivatable coronaviruses such as HCoV-
HKU1. This approach provides a rapid new system to test protease inhibitors against 
coronaviruses of bats such as HKU4 or other animals before they emerge as zoonotic 
infections.  
 
Generation of synthetic recombinant MHV nsp5 coronaviruses 
 
To test the differences between nsp5 proteases across coronavirus phylogenetic 
groups in a replicating virus, I generated artificial recombinant genomes of MHV-A59 
with chimeric replicase genes by exchanging the complete nsp5 coding sequence of α-
coronaviruses (α-CoVs) 229E and NL63, and β-coronaviruses (β-CoVs) HKU1, OC43, 
SARS-CoV and bat coronavirus HKU4. Previous studies have noted that the tertiary 
structure of nsp5 and cleavage site recognition sequences are largely conserved across all 
known coronavirus strains (Anand et al., 2002; Anand et al., 2003; Bacha et al., 2008; 
Woo et al., 2009; Xue et al., 2008; Zhao et al., 2008). However, primary peptide 
sequence alignments across coronaviruses show considerably less conservation between 
coronavirus groups. Peptide alignments of closely-related β-CoVs MHV, HKU1 and 
OC43 nsp5 exhibit 80 to 84% sequence identity to each other and occupy the same 2a 
subgroup.  In contrast a-CoVs 229E, NL63, and more distant β-CoVs SARS-CoV as well 
as bat coronavirus HKU4, show no greater than 53% identity (Figure 3.1). Bat CoV-
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Fig. 3.1. Phylogeny of coronavirus nsp5 protease. Phylogenetic tree generated using a bootstrap 
alignment of coronavirus nsp5 sequences among species recognized by the International Committee on 
Taxonomy of Viruses (ICTV). Bootstrap values and phylogenetic genera are identified and the percent 
conservation among amino acid sequences compared to MHV is shown in red.  
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HKU4 nsp5 was selected for study since it exhibits the highest identity (53%) among 
coronaviruses outside of β-CoV group 1 (2a) (containing MHV, HKU1, and OC43), as 
well as showing high sequence homology (81% identity) to the recently identified human 
coronavirus EMC (Zaki et al., 2012). 
Chimeric MHV-A59 viruses encoding nsp5 from HKU1 (H5-MHV) and OC43 
(O5-MHV) were recovered at 37°C and exhibited cytopathic effects and recovery 
kinetics similar to wild-type MHV (Figure 3.2).  The complete genomes of H5- and O5-
MHV were sequenced with the chimeric nsp5 intact and no additional mutations 
identified. In contrast, MHV with nsp5 from SARS-CoV, NL63, 229E, or Bat-HKU4 
could not be recovered following 3 or more independent attempts. Further, testing of total 
cell RNA by PCR did not detect transcripts of M, N or E subgenomic transcripts. These 
results demonstrated that only nsp5 from closely related of human coronaviruses HKU1 
and OC43 were compatible within the background of MHV, whereas more distant 
chimeric substitutions were not tolerated. I therefore used these viruses to test the 
functional similarity in replication, fitness, cleavage site usage and response to known 
MHV nsp5 temperature sensitive mutations.  
 
Chimeric H5-MHV and O5-MHV exhibit a subtle defect in replication kinetics 
 
To compare the replication of the chimeric H5- and O5-MHV viruses to wild-type 
MHV, replicate plates of DBT cells were infected at low multiplicity of infection (MOI 
0.01 PFU/cell) or high MOI (1 PFU/cell) (Figure 3.3). In low MOI infection, WT-MHV  
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Fig. 4.2. Generation of chimeric syntheic recombinant MHV nsp5 viruses. HKU1 (H5-MHV; green), OC43 (O5-MHV; purple), SARS-CoV (S5-MHV; 
blue), NL63 (not shown), 229E (not shown) and Bat HKU4 (not shown) nsp5 coding regions were substituted into the background of wild-type (WT) MHV. An 
additional attempt at recovery of the S5-MHV was made by substitution of all 11 cleavage sites (P5 – P2’) into the MHV background. 
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Fig. 3.3. Replication kinetics of H5-MHV and O5-MHV at high and low MOIs. Virus infections using 
wild-type (WT) MHV, H5-MHV, or O5-MHV were carried out in DBT-9 cells at 37°C and multiplicities 
of infection (MOI) of either 0.01 PFU/cell (A) or 1 PFU/cell (B). Samples were acquired in triplicate and 
titers determined by plaque assay in duplicate per sample. 
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and the O5-MHV chimeric virus exhibited indistinguishable replication, while H5-MHV 
displayed a delay in replication with an approximate 10-fold reduction in virus titers 10 h 
p.i. compared to WT MHV. During single-cycle infection (MOI 1 PFU/cell), both H5- 
and O5-MHV displayed approximately 10-fold and 30-fold reduced titers for O5-MHV 
and H5-MHV, respectively, compared to WT-MHV at 8 h p.i. These results suggested a 
subtle mismatch between the protease and virus that might be amplified in competitive 
environment.  
 
H5- and O5-MHV are profoundly impaired in competitive fitness 
 
To evaluate fitness cost of chimeric nsp5 in direct competition WT and chimeric 
viruses, or both chimeric viruses were combined at varying ratios and used at a total MOI 
of 0.01 PFU/cell to infect DBT cell monolayers. At approximately 30% monolayer 
involvement in CPE, total cell RNA was used to generate cDNA amplicons containing 
the nsp5-coding region. The amplicons were then treated using restriction enzymes that 
recognize unique sites in the nsp5 sequence of HKU1 or OC43 and quantitated following 
electrophoresis and densitometry (Graham et al., 2012). (Figure 3.4).  
 Following co-infection with MHV and H5-MHV at an initial ratio of 1:1, WT-
MHV represented >75% of supernatant infectious virus after passage 1 (P1), and little or 
no chimeric virus was detected by P3 (Figure 3.5). Even when H5-MHV or O5-MHV 
were given a 10:1 advantage over WT-MHV in the infecting inoculum, WT equaled or 
dominated the chimeric mutants by P2 and was dominant in both cases by P3. I next 
directly compared H5-MHV and O5-MHV to determine if there were differences in  
 73 
 
 
 
 
 
 
 
 
 
 
 
Comparative Fitness Assay 
nsp5 / 3CLpro 
1.6 kb 
1.3 kb 
Reverse Transcription 
PCR on Region Containing nsp5 
Gel Purification of PCR Amplicons 
Restriction Digest  
Resolve Bands on Agarose Gel 
Quantitation by Densitometry 
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.#
/01#
0(#
/01#
234#
/56#
$7$#
-.70(#
234#
/56#
$7$!#
-.70(#
8$###
$7$#
-.70(#
8%###
$7$#
-.70(#
8&###
$7$#
-.70(#
8'###
$7$#
-.70(#
8(###
$7$#
-.70(#
8$###
$7$!#
-.70(#
8%###
$7$!#
-.70(#
8&###
$7$!#
-.70(#
8'###
$7$!#
-.70(#
-.#/01#
0(#/01#
2.0 
1.5 
1.0 
!"#$%"&'
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.#
/01#
0(#
/01#
234#
/56#
$7$#
-.70(#
7
$#
7$#
.7 (#
8%##
$7$#
-.70(#
8&###
$7 #
-.70(#
8'###
$7 #
-.70(#
8(###
$7$#
-.70(#
8$###
$7$!#
-.70(#
8%###
$7$!#
-.70(#
8&###
$7$!#
-.70(#
8'###
$7$!#
-.70(#
-.#/01#
0(#/01#
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.#
/01#
0(#
/01#
234#
/56#
$7$#
-.70(#
234#
/56#
$7$!#
-.70(#
8$###
$7$#
-.70(#
8%###
$7$#
-.70(#
8&###
$7$#
-.70(#
8'###
$7$#
-.70(#
8(###
$7$#
-.70(#
8$###
$7$!#
-.70(#
8%###
$7$!#
-.70(#
8&###
$7$!#
-.70(#
8'###
$7$!#
-.70(#
-.#/01#
0(#/01#
()('*+),-''
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.
#
0(#
/01#
234#
/56#
$7$#
-.70(#
234#
/56#
$7$!#
-.70(#
8$###
$7$#
-.70(#
8% ##
7$#
-.70(#
##
$ #
-. (#
8' #
$7$#
-.70(#
##
#
(#
8$###
$7$!#
.70(#
8%###
7 !#
-.70(#
8& #
$7 #
-.7 #
8'###
$7$!#
.70(#
-.#/01#
0(#/ 1#
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.
#
0(#
/01#
234#
/56#
$7$#
-.70(#
234#
/56#
$7$!#
-.70(#
8$###
$7$#
-.70(#
8%###
$7$#
-.70(#
8&###
7$#
-.70(#
8' #
$7$#
-.70(#
##
#
(#
8$###
$7$!#
.70(#
8%###
$7 !#
-.70(#
8&###
$7$!#
-.70(#
8'###
$7$!#
-.70(#
-.#/01#
0(#/ 1#
()(.'*+),-''
/0'
12$#344'54467'
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)! #
* #
+ #
, #
$!! #
#
#
#
#
7 #
7 #
#
5 #
7 #
7 #
#
7 #
.7 #
8%#
$7$#
.7 (#
&#
7$#
.70(#
##
7 #
7 #
8(##
$7$#
.70(#
8$##
7 !#
-.70(#
8%##
$7$!#
-.70 #
8&###
$7$!#
.70(#
8 ###
$7 !#
-.70(#
-.#/01#
0(#/01#
!"#
$!"#
%!"#
&!"#
'!"#
(!"#
)!"#
*!"#
+!"#
,!"#
$!!"#
-.#
/01#
0(#
/01#
234#
/56#
$7$#
-.70(#
234#
/56#
$7$!#
-.70(#
8$###
$7$#
-.70(#
8%###
$7$#
-.70(
8&###
$7$#
-.70(#
8'###
$7$#
-.70(#
8(###
$7$#
-.70(#
8$###
$7$!#
-.70(#
8%###
$7$!#
-.70(
8&###
$7$!#
-.70(#
8'###
$7$!#
-.70(#
-.#/01#
0(#/01#
WT H5 1:1 1:10 
Co-infection at MOI = 0.01 1 
WT MHV H5-MHV 
Isolation of viral RNA 
(vRNA) 
2 
Generation of 
PCR Amplicons 
3 
Restriction 
Digest 
4 
Quantitation 5 
 
 
 
Fig. 4.4. Competitive fitness assay. Confluent monolayers of DBT-9 cells were infected with WT- or H5-MHV and viral RNA isolated. cDNA amplicons 
containing the nsp5 coding region of pure WT-MHV, H5-MHV or mixtures of either 1:1 or 1:10 of WT:H5 were generated and digested with an HKU1 nsp5-
specific restriction enzyme and resolved and quantified by gel electrophoresis. 
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MHV or mixtures of either 1:1 or 1:10 of WT:H5 were generated and digested with an HKU1 nsp5-specific 
restriction enzyme and resolved and quantified by gel electrophoresis. 
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Figure 3. Fitness analysis of H5- and O5-MHV. (A) Validation of fitness assay 
approach. Confluent monolayers of DBT-9 cells were infected with WT- or H5-MHV 
and total RNA isolated. cDNA amplicons containing the nsp5 coding region of WT MHV 
(black), H5-MHV (red) or mixtures of either 1:1 or 1:10 of WT:H5 were generated and 
digested with an HKU1 nsp5-specific restriction enzyme and resolved by gel 
electrophoresis (left) and quantified by gel electrophoresis (right). (B) Co-infections of 
either WT- and H5-MHV or WT- and O5-MHV (green) at ratios of 1:1 or 1:10 were 
carried out at 37°C and passaged three times (P1 – P3). cDNA amplicons containing the 
nsp5 coding region were subjected to either HKU1 nsp5-specific or OC43 nsp5-specific 
restriction digests and resolved by gel electrophoresis. (C) Quantification of the ratio of 
WT MHV to H5-MHV or O5-MHV as determined by the average of three replicates at 
each designated passage. 
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Fig. 4.5. Fitness analysis of WT MHV compared to H5- and O5-MHV. (A) Confluent monolayers of DBT-9 cells were infected with WT- or H5-MHV and 
viral RNA isolated. cDNA amplicons containing the nsp5 coding region of pure WT-MHV, H5-MHV or mixtures of either 1:1 or 1:10 of WT:H5 were generated 
and digested with an HKU1 nsp5-specific restriction enzyme and resolved by gel electrophoresis (left) and quantified by gel electrophoresis (right). (B) Co-
infections of either 1:1 or 1:10 of either WT- and H5-MHV or WT- and O5-MHV were carried out at 37°C and passaged three times (P1 – P3) and the generated 
cDNA amplicons subjected to either HKU1 nsp5-specific or OC43 nsp5-specific restriction digests and resolved by gel electrophoresis. (C) Quantification of the 
ratio of WT to H5-MHV or O5-MHV as determined by the average of three replicates at each designated passage. 
 
 
 
 
Fig. 3.5. Fitness analysis of WT MHV compared to H5- and O5-MHV. (A) Confluent monolayers of 
DBT-9 cells were i fected with WT- or H5-MHV and viral RNA i olate . cDNA amplicons contain ng the 
nsp5 coding region of pure WT-MHV, H5-MHV or mixtures of either 1:1 or 1:10 of WT:H5 were 
generated and digested with an HKU1 nsp5-specific restriction enzyme and resolved by gel electrophoresis 
(left) and quantified by gel electrophoresis (right). (B) Co-infections of either 1:1 or 1:10 of either WT- and 
H5-MHV or WT- and O5-MHV were carried out at 37°C and passaged three times (P1 – P3) and the 
generated cDNA amplicons subjected to either HKU1 nsp5-specific or OC43 nsp5-specific restriction 
digests and resolved by gel electrophoresis. (C) Quantification of the ratio of WT to H5-MHV or O5-MHV 
as determined by the average of three replicat s a  each designated passage. 
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competitive fitness in the chimeric viruses (Fig. 4).  At a 1:1 ratio for co-infection, the 
relative amounts of H5:O5 detected were approximately 1:1 (53%:47%) while at P2 and 
P3, O5-MHV appeared to outcompete H5-MHV (Figure 3.6). To directly test this, O5-
MHV was given a 10:1 advantage to determine whether it would drive H5-MHV to 
extinction. However, by passage 3, a small amount of H5-MHV was still detected 
indicating no absolute fitness advantage for O5-MHV over H5-MHV. These results 
demonstrated that while the replication defects of chimeric H5-MHV and O5-MHV were 
mild in single infection, introduction of even a closely related nsp5 resulted in profound 
loss of competitive fitness compared to WT. In contrast, there was a detectable but not 
absolute fitness advantage of one of the chimeric nsp5 proteins over the other.  Thus nsp5 
of very closely related viruses can mediate all required activities for replication, but in 
artificial recombinants cannot recapitulate the precise roles and interactions of the parent 
nsp5.  
In vitro nsp5 processing of polyprotein cleavage sites 
 
I next determined whether there are differences in the activity of nsp5 at replicase 
polyprotein cleavage sites that might explain differences in replication and fitness of 
chimeric viruses and the inability to recover more distantly related nsp5 chimeric MHV. 
Coronavirus nsp5 protease cleavage sites exhibit some conserved elements. The P1 
position is a glutamine (Q) in all known cleavage sites (except for the nsp13-nsp14 
cleavage site in HKU1) and the P2 and P1’ positions exhibit small variation in amino 
acid usage (Table 3.1). The native nsp5 proteases MHV, HKU1, OC43, and SARS-CoV 
(SARS) were expressed and purified as previously described and were mixed with FRET- 
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Figure 4. Determination of the relative fitness of H5- compared to O5-MHV. (A) Co-
infections of 1:1 of H5- and O5-MHV were carried out at 37°C and passaged three times 
(P1 – P3) and the generated cDNA amplicons subjected to an OC43 nsp5-specific 
restriction digests and resolved by gel electrophoresis. (B) Quantification of the ratio of 
H5-MHV (red) to O5-MHV (green) as determined by the average of three replicates at 
each designated passage. 
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Fig. 3.6. Determination of the Relative Fitness of H5- Compared to O5-MHV. (A) Co-infections of 1:1 
of H5- and O5-MHV were carried out at 37°C and passaged three times (P1 – P3) and the generated cDNA 
amplicons subjected to an OC43 nsp5-specific restriction digests and resolved by gel electrophoresis. (B) 
Quantification of the ratio of H5-MHV to O5-MHV as determined by the average of three replicates at each 
designated passage. 
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based substrates to assess the relative rates of enzymatic cleavage in vitro (Jacobs et al., 
2013). A universal substrate (UIVT3) containing a coronavirus nsp4/nsp5 consensus 
cleavage site was used to verify that all proteases exhibit proteolytic activity (Figure 3.7) 
(Grum-Tokars et al., 2008). MHV and OC43 nsp5 exhibited the greatest relative rates of 
cleavage, followed by HKU1, and with SARS-CoV nsp5 the least active. The result 
directly correlated with the ability to recover chimeric virus and the fitness rank of the 
recovered chimeric viruses.   
 
Table 3.1. Coronavirus nsp5 cleavage sites 
 
*Modified from Grum-Tokars, 2008. 
 
To determine activity towards specific coronavirus nsp5 cleavage sites, FRET-
based substrates were generated containing P8 – P8’ peptide sequences for the nsp4/nsp5 
and nsp7/nsp8 cleavage sites of MHV and SARS (Felber et al., 2004). The nsp4/nsp5 
cleavage site represents a very early step in the autoproteolytic processing of nsp5, is 
cleaved most efficiently in vitro, and is required for virus replication (Chen et al., 2010; 
Grum-Tokars et al., 2008; Lu et al., 1996; Lu and Denison, 1997). Cleavage between  
 Coronavirus nsp5 Cleavage Sites 
Junction MHV HKU1 OC43 SARS-CoV Relative kcat / Km* 
nsp4/5 TSFLQ SG TSFLQ SG TSFLQ SG SAVLQ SG 100% 
nsp5/6 GVKLQ SK GVKLQ SK GIKLQ SK GVTFQ SK 41% 
nsp6/7 VSQIQ SR VSQIQ SK VSQFQ SK VATVQ SK 3% 
nsp7/8 NTVLQ AL STVLQ AL NTVLQ AL RATLQ AI 5% 
nsp8/9 TVVLQ NN NAVMQ NN ATVLQ NN AVKLQ NN 2% 
nsp9/10 TVRLQ AG TIRLQ AG TVRLQ AG TVRLQ AG 22% 
nsp10/12 GSQFQ SK SVAVQ SK DTTVQ SK EPLMQ SA 0.2% 
nsp12/13 SAVLQ SV SAVMQ SV SAVMQ SV HTVLQ AV 8% 
nsp13/14 NPRLQ CT LPRLH CT ETKVQ CS VATLQ AE 9% 
nsp14/15 FTRLQ SL FTTLQ SL FTKLQ SL FTRLQ SL 28% 
nsp15/16 YPRLQ AA YPKMQ AT YPRLQ AA YPKLQ AS 27% 
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Fig. 3.7. Relative Rates of Coronavirus nsp5 processing in vitro. (A) FRET based substrate containing 
the coronavirus nsp4/nsp5 consensus sequence and relative rates of cleavage by coronavirus nsp5 
proteases. (B) The nsp5 cleavage site peptide sequences are engineered between a CFP-YFP FRET pair. 
Upon cleavage, increase in donor emission at 485 nm is quantified over time. (C) P8 – P8’ peptide 
sequences of MHV and SARS nsp4/5 and nsp7/8 cleavage sites. (D) Relative rates of processing by 
purified coronavirus nsp5 proteases MHV (black), OC43 (red), HKU1 (green) and SARS-CoV (blue). 
Percentage of activity relative to the cognate proteases is shown. Data obtained by Katie Molland and 
Sakshi Tomar (Purdue University). 
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nsp7/8 also is required for virus viability (Deming et al., 2007). In SARS-CoV the 
relative in vitro activity of nsp5 at the nsp7/nsp8 site is approximately 5% of the activity 
at the nsp4/5 cleavage site (Grum-Tokars et al., 2008). When the purified nsp5 proteins 
were tested against these constructs, the rates of enzymatic cleavage towards the nsp7/8 
cleavage sites by all four proteases were considerably less than that towards the nsp4/5 
cleavage sites, consistent with published studies (Grum-Tokars et al., 2008). SARS-CoV 
nsp5 had the lowest cleavage rates of all cleavage site constructs. The relative rates of 
enzymatic cleavage of the SARS nsp4/5 peptide construct by MHV, HKU1, and OC43 
nsp5 were much greater than that of SARS-CoV nsp5.  Neither the HKU1 nor OC43 
protease showed an appreciable defect in processing the MHV nsp4/5 or 7/8 cleavage 
sites. The relative rates of enzymatic cleavage of the MHV nsp4/5 peptide construct by 
MHV and OC43 nsp5 were similar and were greater than that of the proteases of HKU1 
and SARS-CoV. The OC43 nsp5 showed the fastest rate of cleavage of the MHV nsp7/8 
peptide construct. In summary, the results of specific cleavage events by the nsp5 
proteins also are consistent with the observed ability and order of recovery and fitness. 
However, only two of 11 cleavage sites were tested, and may not completely represent 
the complexity required nsp5 functions during replication.  To test whether cleavage sites 
alone are the only determinant of successful nsp5 genetic exchange, we attempted to 
recovery SARS nsp5 / MHV chimera that also contained all 11 SARS-CoV cleavage sites 
(from P5 to P2’). However, even complete cleavage site substitution did not allow 
recovery of the SARS-nsp5 chimeric MHV. Overall our results show that the ability to 
efficiently process at cleavage sites from another CoV is necessary, but is not sufficient 
for viability and fitness of genetically exchanged nsp5.  
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MHV ts mutations differ in their phenotype in chimeric H5- and O5-MHV 
 
To evaluate whether functional similarities and differences within a phylogenetic 
group are conserved, a known MHV functional pathway was selected for introduction 
into the chimeric backgrounds of H5- and O5-MHV. The identification of three different 
temperature-sensitive mutations (S133A, V148A, and F219L) located in MHV domains 2 
and 3 was reported to cause greatly reduced viral replication kinetics and diminished 
polyprotein processing at a non-permissive temperature of 40°C (Sparks et al., 2008; 
Stobart et al., 2012). HKU1 and OC43 nsp5 share the same amino acids and codons at the 
three temperature-sensitive alleles, but contain a Tyr rather than a His at the 134 and 270 
positions that were selected second-site suppressor residues in MHV (Sparks et al., 2008; 
Stobart et al., 2012). The direct mechanism by which these mutations impact the protease 
remains unknown. To further evaluate the functional differences between closely- and 
more distantly related coronaviruses, the temperature-sensitive mutations S133A, 
V148A, and F219L were introduced into the background of the chimeric H5- and O5-
MHV viruses. Identical two or three nucleotide mutations were engineered with S133A 
(10605AGU to GCC), V148A (10650GUU to GCC) and F219L (10864UUU to CUG) 
introduced into the HKU1 and OC43 nsp5 coding sequences of H5- and O5-MHV. 
Viruses were assembled as previously described, however recovery and characterization 
of the viruses was done at a temperature of 32°C. As previously shown, the temperature-
sensitive mutations did not appear to adversely affect the viruses at 30°C (Sparks et al., 
2008; Stobart et al., 2012). Since the permissive DBT-9 cell line is more tolerant of 32°C, 
this temperature was selected as a permissive temperature instead. Three different 
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chimeric viruses containing MHV temperature-sensitive alleles were successfully 
recovered at 32°C: H5-V148A (H5-MHV containing the V148A mutation), O5-V148A 
(O5-MHV containing the V148A mutation), and O5-S133A (O5-MHV containing the 
S133A mutation). Neither chimeric virus containing the F219L mutation was 
successfully recovered and introduction of the S133A mutation into the H5-MHV 
background did not permit recovery. Sequencing of the nsp5 coding regions of HKU1 
and OC43 confirmed the sole presence of the introduced S133A and V148A mutations. 
To assess temperature-sensitivity of the recovered viruses, the titers were 
determined at 32°C, 37°C, and 40°C for wild-type MHV, H5-MHV, O5-MHV, and each 
of the recovered mutants and the efficiency of plating (a ratio of titers determined by 
plaque assay) was determined for 40°C compared to 32°C and 37°C (Table 3.2). Similar 
to previous studies, WT-MHV exhibited a slight increase in detected titers at 40°C 
relative to either lower temperature of 32°C (EOP = 1.4) or 37°C (EOP = 0.9) (Sparks et 
al., 2008; Stobart et al., 2012). Both H5- and O5-MHV viruses exhibited similar subtle 
advantages in detected titers at the elevated temperature consistent with not being 
temperature-sensitive (ts). Analysis of the EOP values for the recovered mutants 
containing the MHV ts alleles yielded varying results. Introduction of the V148A 
mutation did not confer an EOP indicative of temperature-sensitivity in either the HKU1 
or OC43 chimeric virus backgrounds (EOP > 1 for either ratio of 40°C/32°C or 
40°C/37°C). Surprisingly, introduction of the S133A mutation into the OC43 background 
(O5-S133A) resulted in an EOP of 6 x 10-3 when comparing detected titers at 40°C 
relative to 32°C and an EOP of 1 x 10-2 for the ratio of titers at 40°C to 37°C consistent 
with a temperature-sensitive phenotype. 
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Based on previous studies, the sensitivity of viruses to changes in temperature has 
been shown to be independent of reduced or delayed virus replication kinetics even at 
permissive temperatures (Stobart et al., 2012). To evaluate the replication kinetics of the 
recovered MHV ts alleles in the backgrounds of the H5- and O5-MHV chimeras, 
infections were carried out in confluent flasks of DBT-9 cells at a MOI of 1 PFU/cell at 
32°C and with a temperature shift at 6 h p.i. to 40°C (Figure 3.8). Congruent with earlier 
studies, most of the viruses surveyed exhibited similar replication kinetics to WT MHV at 
32°C (Sparks et al., 2008; Stobart et al., 2012). However, the O5-S133A viruses 
exhibited a clear delay in logarithmic growth of approximately 2 hours similar to H5-
MHV suggesting a subtle replication defect at the permissive temperature. After shifting 
to the non-permissive temperature of 40°C at 6 h p.i., the H5- and O5-V148A mutants 
displayed similar replicative kinetics to the H5- and O5-MHV backgrounds consistent 
with a non-ts phenotype and supporting the EOP data. Consistent with the MHV ts 
mutant viruses, the O5-S133A showed a clear delay and reduction in virus replication 
kinetics after shifting to the non-permissive temperature (Stobart et al., 2012). These data 
correlate directly with the calculated EOP (6 x 10-3) and are consistent with a ts 
phenotype at 40°C. 
 
Table 3.2. Temperature-sensitivity of H5- and O5-MHV containing MHV ts alleles 
*Average titer, N > 4 
EOP and Titers of H5- and O5-MHV viruses containing MHV ts alleles 
Virus Titers (PFU/mL)* EOP (Ratio of Titers) Virus 32°C 37°C 40°C 40°/32° 40°/37° 
WT-MHV 5.1 x 107 8.3 x 107 7.2 x 107 1.4 0.9 
H5-MHV 2.0 x 107 1.2 x 108 1.1 x 108 5.7 1.0 
O5-MHV 1.1 x 107 2.0 x 107 2.0 x 107 1.7 1.0 
H5-V148A 3.1 x 106 2.0 x 107 8.7 x 106 2.8 0.4 
O5-V148A 1.2 x 107 3.7 x 107 2.1 x 107 1.7 0.6 
O5-S133A 1.5 x 107 7.5 x 106 8.8 x 104 6 x 10-3 1 x 10-2 
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Fig. 3.8. Replication kinetics of H5- and O5-MHV viruses at 32°C and 40°C. A & B) DBT-9 cells were 
infected at an MOI of 1 PFU/cell. Samples were acquired from triplicate infections at various time points 
and the temperature either remained at 32°C (A) or was shifted to 40°C (B) at 6 hours post infection (h 
p.i.). Titers determined by plaque assay in duplicate per sample. 
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Expansion of the MHV temperature-sensitive viral mutants at 40°C resulted in the 
emergence of five separate second-site suppressor mutations in tandem that spanned 
domains 2 and 3 of MHV. To determine whether OC43 shares similar pathways of ts 
suppression, a plaque assay was performed at 32°C and 10 plaques were expanded 
directly at 40°C (Figure 3.9). Once signs of cytopathic effects (CPE) were visualized and 
the infection reached approximately 30 to 50% syncytial involvement, the RNA was 
isolated and the viral nsp5 coding regions were sequenced. Of the 10 plaques, one of the 
viruses failed to expand at the non-permissive temperature, 8 of the viruses contained the 
original ts S133A mutation in addition to either an A116V (8/9 clones) or N8Y (1/9 
clones) and one of the viruses exhibited a primary reversion (A133S). Neither the A116 
nor the N8 residues had previously been selected for by any of the MHV ts viruses. These 
data suggest that similar to MHV, OC43 may also utilize pathways of suppression 
throughout Domain 2, but that these pathways may not be identical to MHV. 
  
Nsp5 allele Y134 provides resistance to the ts phenotype in OC43 
 
The selection of an Y134 allele in MHV conferred partial or complete resistance 
to the ts phenotype associated with mutations V148A, S133A, or F219L. To test the 
hypothesis that the Y134 allele may play a similar role in the wild-type backgrounds of 
HKU1 and OC43, the Y134H mutation was engineered into the H5- and O5-MHV 
backgrounds in the presence of the S133A and V148A mutations. Only one virus was 
successfully recovered: O5-V148A/Y134H (O5-MHV containing V148A and Y134H 
mutations). Despite multiple attempts at recovery, the H5-V148A/Y134H, H5- 
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Fig. 3.9. Reversion analysis and temperature-sensitivity of O5-MHV mutants. (A) 10 plaques were 
selected from a plaque assay of O5-S133A at 32°C and were expanded in 25 cm2 flasks at 40°C. At ~30 – 
50% monolayer involvement in syncytia, the viral RNA was isolated and the nsp5 coding region 
sequenced. (B) Of the 9 clones sequenced, 8 contained the original S133A mutation and a second-site 
mutation at either A116V (7/9 clones) or N8Y (1/9) and 1 clone exhibited a primary reversion. (C) The 
location of the original S133A ts allele (red) and the identified second-site suppressor mutations (green) on 
a model of OC43 nsp5 generated using the crystal structure of HKU1 nsp5 (PDB code 3D23) and 
Modeller. (D) Virus titers for WT-MHV, MHV tsV148A, and O5-MHV virus containing V148A and 
Y134H mutations were determined by plaque assay on DBT-9 cells at either 32°C or 40°C. The efficiency 
of plating (EOP) was determined by the ratio of the average titers (N ≥ 2) for either 40°C over 32°C. 
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S133A/Y134H, and O5-S133A/Y134H viruses could not be recovered. 
Sequencing of the nsp5 coding region of the O5-V133A/Y134H confirmed the presence 
of both the V148A (10650GUU to GCC) and Y134H (10608CAU to UAU) mutations and no 
other changes. To evaluate the ability of the viruses to infect and expand at the non-
permissive temperature, a plaque assay was conducted at 32°C and 40°C using the MHV 
ts V148A virus and the O5-V148A/Y134H to determine the efficiency of plating for the 
viruses. The MHV V148A virus exhibited an EOP of 1.1 x 10-3, consistent with 
previously published findings of temperature-sensitivity at the 40°C. Surprisingly, 
introduction of the Y134H mutation into the O5-V148A background resulted in an EOP 
similar to that of V148A (Figure 3.9). These data suggest that the Y134H mutation 
confers sensitivity to elevated temperatures in the presence of the MHV ts alleles in the 
background of the O5-MHV virus and plays an important role in both MHV and OC43 
proteases. 
 
Summary 
 
In this chapter, alpha- and betacoronavirus nsp5 proteases were substituted into 
the wild-type background of MHV. Only closely-related HKU1 and OC43 substitutions 
were tolerated and were associated with reduced viral replication kinetics and substantial 
fitness costs. Analysis of nsp5-mediated processing in vitro by MHV, HKU1, OC43, and 
SARS-CoV purified nsp5 proteases indicated that critical differences exist in protease 
substrate recognition and activity. These data indicate that the nsp5 protease and the 
remainder of the replicase gene may have tightly coevolved and suggests that genetic 
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exchange of nsp5 or regions containing nsp5 cleavage sites may be limited to closely-
related viral species. Introduction of the MHV ts alleles S133A and V148A into the 
backgrounds of H5- and O5-MHV demonstrated that the function of these alleles may not 
be completely conserved indicating that even closely-related coronavirus nsp5 proteases 
may be structurally and functionally different. These studies shed light on the genetic 
relationship between coronavirus nsp5 proteases, highlight the putative limits of genetic 
exchange and identify key alleles that are functionally conserved between closely related 
betacoronaviruses MHV and OC43. The implications of these findings are discussed in 
more detail in Chapter IV and expand on themes and data discussed in Chapters II. 
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CHAPTER IV 
 
 
DISCUSSION 
 
 
Temperature-sensitivity and regulation of MHV nsp5 
 
 
Previous studies with other viruses as diverse as HIV, Sindbis virus, poliovirus 
and vaccinia virus have reported ts mutations in virus proteases that affect protein 
processing, RNA synthesis, and virus capsid assembly (Chen et al., 2010; Graham et al., 
2012; Jung et al., 2012; Vijgen et al., 2006).  Typically these studies have tested 
abrogation and reversion of targeted functions to define broad strategies by which viruses 
may complement or suppress the ts phenotype. Most of the ts alleles of viral proteases 
have been proposed to occur at conserved residues, and in some cases of mutagenic 
scanning, to occur in pairs of conserved and structurally adjacent residues. In contrast, the 
data presented in Chapter II demonstrates that multiple non-conserved, structurally 
distant residues in the CoV nsp5 protease participate in communication within and 
between domains, function cooperatively to suppress ts phenotypes, and are important for 
nsp5 activity during virus polyprotein expression and processing.  This conclusion is 
based on several lines of evidence: 1) The initially reported tsV148A mutant virus 
selected revertants at S133N and H134Y, both greater than 15 Å from V148A, the 
catalytic dyad, or from the other S133A or H134Y in the probable dimeric form (Sparks 
et al., 2008). 2) S133A constitutes a distinct ts mutant, and selected for partial 
suppression at T129M, 11 Å distant, along with directly juxtaposed H134Y. 3) The 
independent domain 3 tsF219L is greater than 40 Å from the active site cavity but had the 
same ts phenotype as S133A and V148A. 4) tsF219L also selected for suppression at 
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H134Y in domain 2 (28.8 Å distant), but of the second-site revertants identified, always 
in combination with a substitution in D3. 5) Engineering the combination of F219L with 
H270HH and E285V changes resulted in equal or greater suppression tsF219L than the 
combinations identified in the biological second-site mutant viruses. 6) The ts and 
suppressor mutations and combinations in nsp5 engineered recombinant genomes are 
necessary and sufficient to account for the observed replication and protein processing 
phenotypes. 7) The suppressor mutations alone in absence of the ts mutation have little or 
no effect on virus replication. 8) Finally, both the ts residues and second-site revertant 
residues are variable among nsp5 of over 226 unique nsp5 sequences.  Thus the results 
support the hypothesis that the residues identified by our iterative mutagenesis and 
recovery approach are interconnected, communicating, and cooperative during nsp5 
function in replication.  These results have significant implications for understanding how 
nsp5 regulates the complex cascade of proteolytic events required for successful 
replication.  
Since the SARS epidemic ten years ago, numerous studies have evaluated 
coronavirus nsp5 protease as a prime target for coronavirus inhibition due to its complex 
and essential role in the ordered processing and subsequent formation of the viral 
replication complex. Despite significant effort, however, the goal of developing a cross-
reactive coronavirus nsp5 inhibitor effective at sub-uM concentrations has not been met, 
highlighting the need to understand the key differences between coronavirus nsp5 
molecules and their relationship with the rest of the viral replication machinery. With the 
goal of better understanding the cross-reactivity of coronavirus proteases and their 
functional differences in the context of a replicating virus, we set out to substitute the 
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closely related coronavirus nsp5 proteases of HKU1 and OC43 into the MHV 
background. We have shown that permissive substitution of HKU1 and OC43 was 
associated with a clear fitness cost and that substitution of more distant coronaviruses 
was not tolerated. The recovery and characterization of chimeric nsp5 proteases provides 
a new tractable and safer system for the targeted study of nsp5 inhibitors directed against 
human coronavirus proteases in the context of a replicating virus. These findings 
demonstrate that the nsp5 protease and the 11 cleavage sites spanning the length of the 
replicase gene (nsps 4 – 16) of coronaviruses are structurally and functionally distinct and 
supports a tight co-evolution that limits viral emergence by recombination. 
 
Long-distance communication in nsp5 
 
The experiments in Chapter II were based on the observation that three 
independent and physically distant ts alleles in domains 2 and 3 resulted in emergence of 
the identical, structurally distant, revertant H134Y. The emerging data continued to 
identify structurally separate suppressor alleles and combinations, all of which would 
require additional pathways for propagation of communication. This cannot be accounted 
for by interactions across the dimeric structure, since the known orientation of monomers 
in solved dimer structures of SARS-CoV, IBV and HKU1 nsp5 allowed for calculation of 
distances between any pairs of residues (same or different) are greater in the dimer than 
the monomer.  Thus other explanations for long-distance communication must be 
considered.  Compared to a cellular protease with perhaps a single substrate or choice of 
substrates depending on environment, the CoV nsp5 must orchestrate the ordered 
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processing of 11 cleavage sites.  In addition to having to choose between closely related 
and competing cleavage sites, nsp5 confronts dynamically changing substrate and 
cleavage site concentrations and structures, since cleavage at one site likely leads to 
altered folding of the remaining intermediate precursor and presentation of new cleavage 
sites. Any explanation for nsp5 intra- or inter-molecular communication must account for 
these constantly evolving variables. A straightforward explanation would be one in which 
nsp5 interacts with substrate cleavage sites and the intermediate replicase polyproteins, 
and those interactions result in allosteric communication through residues such as those 
identified in this study, with structural changes propagated throughout nsp5. This could 
occur by two or more possible mechanisms.  The first would be a classical “induced fit 
allostery” in which interaction with the substrate results in modifications that increase the 
affinity for that substrate (Whitley and Lee, 2009). This would amplify any selection 
imparted by direct enzyme substrate specificity and favor a particular hierarchy.  It would 
also suggest a highly adaptable enzyme that could fit itself to a variety of alternative 
cleavage sites on changing structures.  A second model would be one variously referred 
to as “ensemble” or “equilibrium allostery”, where the enzyme exists as a non-negligible 
equilibrium of variable states, which in the case of nsp5, might represent conformations 
favoring different cleavage sites or intermediates (Whitley and Lee, 2009).  In this model, 
interactions with substrates or other proteins would signal through allosteric interactions 
resulting in a shift toward a conformation more favorable for the immediate environment. 
This would allow for a rapidly shifting and potentially mixed environment of substrate 
and protease.  Differentiating between these models in a biochemical in vitro system may 
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be difficult, since only in the infected cell can the dynamic of all polyprotein forms and 
local concentrations be reproduced. 
However, neither of these models identifies the mechanism by which local 
changes are propagated between communication nodes in protein structure.  Propagation 
of changes could occur and be amplified by a direct mechanical process, or by altering 
protein flexibility.  Recently, approaches have been developed to predict the most 
energetically favorable and direct pathways for connecting starting and ending nodes in 
allosteric communication, using combinations of structural data and multiple sequence 
alignments of all residues and probable direct interactions (Atilgan et al., 2004; Pyrc et 
al., 2010; Tang et al., 2007). This has been applied to known allosteric interactions, 
specifically with myosin (Tang et al., 2007).  Application of such an approach with nsp5 
might be informative in predicting possible propagation from the identified ts and 
second-site alleles to each other, the active site cavity, substrate binding residues and 
dimerization interfaces.  This in turn might identify additional residues in a 
communication network. Ranganathan and coworkers have proposed a model by which 
proteins may consist of a series of functional sectors that are connected in tertiary 
structure and exhibit unique roles in the protein (Pyrc et al., 2010). In both S1A serine 
proteases and HIV protease, regions distant from known catalytic and functional 
determinants have been shown to be critical for protease activity (Perryman et al., 2004; 
Pyrc et al., 2010). Nearly all of the biological suppressor mutations identified in this 
study contain combinations of residues rather than a single suppressor mutation, 
suggesting that the capacity of a single residue to complement or mitigate nsp5 cleavage 
defects of the ts mutation is greatly limited. These data suggest that active long-distance 
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communication between suppressor residues and functionally active residues is critical to 
restoration of nsp5 function. Finally, alteration in protein flexibility could provide an 
explanation for how nsp5 functions within the polyprotein and in rapidly changing 
partially processed intermediates. If the residues we identified in this study function as 
hinges, pivots, or axes in a flexible structure, then changes at those residues would be 
immediately manifested as changes in protein flexibility, possibly altering the range or 
type of substrate of catalysis possible. A most likely scenario is some combination of 
signal propagation, amplification and protein flexibility modification.   
 
Phenotype and mechanism of MHV nsp5 ts perturbations 
 
The phenotype of the nsp5 ts mutant viruses may be due to incomplete folding, 
thermal instability or flexibility, inability to dimerize, failure to recognize and cleave 
specific cleavage sites, or disruption of allostery in the replication complex. Analyses of 
the ts mutant viruses indicated a defect in nsp5-mediated processing and virus replication 
at the non-permissive temperature. Yet, mature nsp5 cleavage products were still detected 
for all three ts mutant viruses at non-permissive temperature, albeit at profoundly reduced 
levels, suggesting that defects in viral growth at the non-permissive temperature were not 
the result of complete loss of nsp5 activity, but may be the result of a shift in enzyme 
activity after temperature change.  These findings indicate that the source of the ts 
phenotype is not due to reduced catalysis, but on choice of substrate. We previously 
reported that nsp5 activity was not present in tsV148A at non-permissive temperature.  
However, we did not directly investigate nsp5 cleavage in that study, and thus in this 
 94 
study, we determined that tsV148A functions like tsS133A and tsF219L in exhibiting 
more impaired processing of nsp8 than nsp5 at non-permissive temperature, but not 
complete ablation of nsp5 activity (Sparks et al., 2008). This is similar to the effect of 
mutations introduced in the interdomain loop (IDL) between domains 2 and 3 of the 
arterivirus nsp4, a smaller but structural orthologue of CoV nsp5 (van Aken et al., 2006). 
Several of the recovered IDL mutant viruses of EAV did not abolish activity, but rather 
altered the substrate specificity.  It is possible that the ts mutants of nsp5 are acting in a 
similar manner.  
 
Non-conserved residues in nsp5 function. 
 
Analysis of a CoV nsp5 MSA indicates that all three currently identified residues 
that resulted in ts mutations (S133, V148, and F219) were non-conserved residues with at 
least two different amino acids occupying each position. Similarly, at each of the residues 
that were involved in a second-site reversion, at least three different amino acids occupy 
those positions in other CoVs. Both the H134 and S133 second site revertants had 
changes (Y134, N133) that were already present in numerous other CoV nsp5 sequences. 
An MSA of 226 unique CoV nsp5 sequences demonstrates that there is variability at 
every residue represented in our study and much less variability within defined CoV 
groups.  Specifically, the betacoronavirus phylogenetic group 1 (Group 2a) CoVs, 
including MHV and HCoVs HKU1 and OC43, show variability only at H134 (Y,V 
respectively) and H270 (Y, K respectively), while the phylogenetic group 2 (Group 2b) 
CoVs show variability only at H134 (Y). In contrast, alphacoronavirus phylogenetic 
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group 2 (Group 1b) CoVs show variability at all residues except P148. While the results 
have to be interpreted in light of the overall nsp5 sequence variability or conservation, it 
is possible to speculate that these residues may represent an evolutionarily adaptive 
system co-evolving with other interacting proteins or cleavage sites. Recently, it was 
reported that a mutation at the P1 position in the cleavage site between nsp15-16 of IBV 
resulted in a debilitated virus whose phenotype was compensated by a mutation in nsp5 
(Vijgen et al., 2005). This supports the concept of co-evolution of nsp5 with its cleavage 
sites.  A system of mutationally variable residues could account for the rapid emergence 
of second-site revertants of ts viruses with combinations of more than one second-site 
mutation that also function in combinations not derived during virus reversion analysis.  
 
Models for testing nsp5 long-distance communication. 
 
The findings of this study highlight a common obstacle in confirming and 
understanding the role of long-distance communication in protein function. In the 
absence of a specific mechanism for how long-distance communication alters protein 
activity, several approaches may be proposed to address the implications of these 
proposed nsp5 communication pathways. First, future studies may express, purify, and 
characterize MHV nsp5 in vitro to identify the impact of each individual ts and second-
site suppressor mutation or combinations of mutations to understand the role of each 
mutation in the function of the protease. Study of the structure or function of the ts and 
second-site mutants, ideally at different temperatures, may provide new insight into 
possible structural perturbations attributed to the mutations at the non-permissive 
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temperature. However, the optimum temperature and conditions for crystallization may 
prevent study of the protease structure in its non-functional, ts state. Second, comparative 
modeling of available nsp5 structures and use of a computational bioinformatics 
approaches may provide new insight into other potential long-distance communication 
nodes or pathways spanning nsp5 structure and its 11 respective cleavage sites. Third, 
iterative mutagenesis of the second-site residue alleles might identify additional 
interacting nodes that expand the interactions detailed in this study. Lastly, introduction 
of these mutations into other CoVs would provide evidence whether these pathways of 
perturbation are a conserved feature of CoV protease structure. Collectively, these 
findings strongly suggest that small local changes at a single residue of CoV nsp5 may 
have broad and major implications on both protease activity and viral replication. 
 
Coronavirus nsp5 proteases differ in activity and have tightly co-evolved  
 
Earlier studies have emphasized the close nsp5 recognition site homology 
between coronaviruses and the high density of conserved residues in the protease 
substrate-binding pocket (Fan et al., 2005; Goetz et al., 2007; Hegyi and Ziebuhr, 2002). 
However, the inability to recover the SARS-CoV nsp5 substitution chimera suggests that 
structural conservation of nsp5 may be limited and that the subtle differences in the 
substrate-binding pocket and other determinants of coronavirus proteases result in major 
functional differences. Analysis of substrate specificity by Chuck et al., indicated that 
clear preferences for specific amino acids in the nsp5-recognition sequence exist between 
even closely-related coronaviruses (Chuck et al., 2011). In this study, the relative rates of 
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processing of MHV and SARS nsp4/5 and 7/8 cleavage sites by all four proteases varied 
among all four sites assayed in vitro. This finding is consistent with other published 
cleavage site assays suggesting that the tertiary structure conservation across 
coronaviruses of different groups and clades does not directly equate to functional 
conservation (Chuck et al., 2011; Fan et al., 2005; Goetz et al., 2007; Hegyi and Ziebuhr, 
2002). These major differences in the relative rates of processing of the nsp5 cleavage 
sites may represent differences in the timing and ordered hierarchy of nsp5 cleavage 
events between coronaviruses. 
 Surprisingly, for all four cleavage site constructs surveyed, the purified SARS 
protease was consistently the slowest enzyme with a greater than 3-fold reduction in rate 
relative to MHV and six-fold relative to HKU1 and OC43 at the SARS nsp4/5 site. A 
similar study reported that NL63 exhibited a 2.5-fold increased rate towards the SARS 
nsp4/5 site relative to the SARS-CoV protease (Chuck et al., 2011). The relative rates of 
processing by OC43 were consistently among the highest surveyed towards each 
cleavage site construct which supports earlier findings that have suggested that the OC43 
nsp5 protease may be the most versatile in accepting changes in the recognition peptide 
sequence (Chuck et al., 2011). Similarly, the higher relative rate of processing by OC43 
compared to HKU1 may account for the higher fitness of O5-MHV in direct competition 
to H5-MHV. These findings, however, do not account for the known role of the 
intracellular milieu and differences in cell environment affecting protease activity during 
virus infection (Okamoto et al., 2010). Further studies will be needed to evaluate other 
cleavage sites and the role of the chemical environment in the activity of the proteases in 
vitro. These differences in protease activity and the inability to recover a SARS-CoV 
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nsp5 substitution chimera with substitution of all 11 SARS-CoV cleavage sites strongly 
supports the hypothesis that the processing of the replicase gene and the formation of the 
viral replication complex is dependent on the compatibility between the protease and 
replicase polyproteins. 
 
Conserved pathways of nsp5 protease function are clade-specific 
 
Recently, our lab reported the identification of three temperature-sensitive alleles 
(S133A, V148A, and F219L) in MHV that resulted in reduced viral titers and impaired 
nsp5-mediated processing at non-permissive temperatures (Sparks et al., 2008; Stobart et 
al., 2012). Growth of these viruses at the non-permissive temperature resulted in the 
emergence of five second-site suppressor alleles (T129M, S133N, H134Y, H270HH 
[duplication], and E285V), which arose largely in combinations and compensated for the 
ts phenotype. Surprisingly, the Y134 allele was independently identified as a suppressor 
allele for all three ts mutations. These studies were limited, however, to the scope of 
MHV. In this study, we show that the ts alleles S133A and V148A also result in a 
temperature-sensitive phenotype in the nsp5 backgrounds of OC43, although V148A 
necessitated the addition of the Y134H mutation. The inability to recover the H5-S133A 
mutation and the temperature-sensitivity of the O5-S133A virus highlights the 
importance of this region and specific residue in the stability and function of 
betacoronavirus-1 nsp5 proteases. The selection of the Y134 allele in the wild-type 
strains of HKU1 and OC43 and the inability to tolerate an Y134H mutation in the 
presence of either S133A or V148A mutations in HKU1 support the hypothesis that this 
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allele represents a critical structural adaptor residue that is conserved among 
betacoronaviruses but may function in subtly different ways.  
The inability to recover HKU1 and OC43 mutants containing the domain 3 F219L 
mutation supports the findings in MHV that this residue and region of the protease play 
an important role (albeit not yet entirely understood) in the coronavirus nsp5 structure. 
This is the first study to identify temperature-sensitive mutations in the nsp5 from a 
human coronavirus. These mutations indicate that there may be conserved functional 
pathways between the betacoronavirus-1 strains of MHV, HKU1, and OC43. Combined, 
these data provide new insight into conserved betacoronavirus functional pathways and 
reveal new putative targets for coronavirus inhibitor design. 
 
Nsp5 represents a genetic restriction to coronavirus recombination 
 
Numerous studies have postulated that recombination readily occurs in 
coronaviruses based upon bioinformatic analyses and the presence of regions of 
particularly high homology throughout the genome of closely related coronaviruses (Lau 
et al., 2011; Vijgen et al., 2006; Woo et al., 2009; Woo et al., 2012; Woo et al., 2006). 
The emergence of HCoV-EMC in Saudi Arabia provides a recent example of the 
potential detriment to human health created by coronavirus evolution and emergence. It is 
known that HCoV-EMC and SARS-CoV virus likely evolved from bat coronaviruses 
based upon close homology with known bat coronaviruses sequences (Becker et al., 
2008; Lu and Liu, 2012; Perlman and Netland, 2009; Perlman and Zhao, 2013). SARS-
CoV exhibits sequence homology to several identified bat coronavirus genomes including 
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Bat SARS Rp3, Bat Coronavirus 273.2005 and Bat SARS HKU3, and recent findings 
from our group and others have now shown that SARS-CoV appears to have emerged 
directly from bats (Becker et al., 2008; Perlman and Netland, 2009). HCoV-EMC also 
exhibits sequence homology to known bat coronaviruses HKU4 and HKU5 (Zaki et al., 
2012), suggesting that emergence of an HCoV directly from an animal reservoir is not an 
event isolated to SARS-CoV. Bioinformatic studies evaluating the time of emergence of 
BCoV, OC43, and PHEV suggest a recent common ancestor approximately 100 to 200 
years ago (Vijgen et al., 2006). Additional studies evaluating the genetic diversity of 
human coronavirus HKU1 and OC43 have suggested that the three HKU1 and four OC43 
genotypes likely emerged due to recombination events within the replicase gene (Lau et 
al., 2011; Woo et al., 2010; Woo et al., 2009; Woo et al., 2006). Additionally, other 
regions of the virus genomes also show a high degree of structural and functional 
homology (Dijkman et al., 2012).  
Upon cursory examination, our studies indicate that the nsp5 protease of closely-
related coronaviruses and the 11 cleavage sites of the replicase polyprotein may not 
represent a block to recombination and could support the feasibility of recombination 
described in these studies. However, no known human coronaviruses displaying 
recombination between HKU1 and OC43 have been identified to date despite several 
clinical surveys showing individuals co-infected with both viruses (Cui et al., 2011; 
Mackay et al., 2012; Prill et al., 2012),  
The recovery of the H5- and O5-MHV chimeric viruses in our investigations, 
although permissive to direct nsp5 substitution, resulted in a direct drop in virus fitness 
compared to the wild-type MHV strain indicating that there is a strong selective pressure 
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against nsp5 recombination even within these closely related coronavirus backgrounds. 
Furthermore, the inability to recover chimeric MHV viruses containing the more-distant 
human coronavirus nsp5 proteases of SARS-CoV, 229E, NL63 or with the bat 
coronavirus HKU4 (which is now known to exhibit 82% sequence identity to human 
coronavirus EMC) suggests that clear differences in the structure and function of the nsp5 
proteases and potentially cleavage sites of these coronaviruses limit viable recombination 
events within the replicase gene. More specifically, we hypothesize that the limitation 
may due to one or more of the following reasons: i) misfolding of the protease or 
polyprotein in the chimeric background, ii) disruption of dimerization due to 
inaccessibility of the dimerization interface in the background of the chimeric MHV 
polyprotein, iii) inability to recognize or process one or more critical nsp5 cleavage sites, 
or iv) disruption of essential interaction with other members of the replication complex. 
More direct study of coronavirus recombination is necessary to identify other key 
coronavirus features that permit or restrict viable recombination events. Collectively, 
these data demonstrate that although human coronaviruses HKU1 and OC43 share a 
common ancestor and many similar structural and functional features, nsp5 protease and 
possibly its cleavage sites restrict the potential for coronavirus emergence by 
recombination events even between closely related coronaviruses.  
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CHAPTER V 
 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
Introduction 
 
 Before the work described in Chapters II – IV, considerable progress had been 
made in evaluating coronavirus nsp5 protease structure, activity and specificity in vitro. 
Early virus studies demonstrated that nsp5 was required for virus replication and that it 
could be targeted with available inhibitors in vitro (Lu et al., 1996; Lu and Denison, 
1997; Ziebuhr et al., 2000). From the limited studies of nsp5 in the context of a 
replicating virus, many key questions remain regarding the critical steps of nsp5 activity 
during viral infection (Figure 5.1). Upon translation, nsp5 must first properly fold (1) and 
stabilize itself (2). Once folded and stable, it must dimerize (3) to attain full function 
before cleaving itself completely out and processing the remaining cleavage sites (4). 
Lastly, it must coordinate with the rest of the replication complex (5). However the 
mechanism of all of these crucial steps remains unclear. Several key questions remained 
unanswered: 1) How does nsp5 cleave itself from the replicase polyproteins pp1a and 
pp1ab? 2) Which regions or motifs are essential for nsp5 folding and stability? 3) How 
does nsp5 orchestrate the ordered processing of up to 11 distinct cleavage sites? 4) In the 
context of virus inhibitor design, how conserved is nsp5 function and can a pan-
coronavirus nsp5 inhibitor be developed? 5) Which determinants of nsp5 structure are 
critical for nsp5 specificity? 6) How does nsp5 associate with other members of the 
coronavirus replication complex? 7) Does nsp5 play a role in down-
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regulation of host cell responses or acquisition of host resources? My contributions to 
answering some of these critical questions are described in Chapters II – IV. In this 
chapter, I will discuss the implications of my work and future directions in the field to 
better understand the role of nsp5 protease during viral infection. To begin to address 
these critical remaining questions, my work began by building on the tsV148A mutant 
described by Jen Sparks. 
 
Coronavirus nsp5 ts viruses 
 
 In Chapter II, a series of two temperature-sensitive alleles (ts) and four second-
site suppressor alleles, all distant from known catalytic regions, are identified and 
described in work stemming from the initial characterization of the tsV148A virus. To 
understand the second-site suppressor alleles of MHV V148A, alanine mutagenesis was 
applied to generate S133A and H134A viruses. Quite surprisingly, it was discovered that 
the same residue capable of suppression of a ts phenotype (in the case of V148A) 
happened to also be a ts allele when mutated to an alanine. Furthermore, reversion 
analysis of the tsS133A resulted in the emergence of two different patterns of 
suppression: S133A/H134Y and S133A/T129M/H134Y. In a follow-up to a paper 
published by Sawicki et al., a putative domain 3 ts allele (F219L) was introduced into 
MHV and shown to also demonstrate temperature-sensitivity. Reversion analysis of 
tsF219L resulted in the identification of an additional two patterns of reversion: 
F219L/H134Y/E285V and F219L/H134Y/H270HH.  
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Fig. 6.1. Model of coronavirus nsp5 activity and key questions. The diagram demonstrates what 
currently is known regarding nsp5 activity during viral infection. Key questions that this work and others 
are actively working on are shown in the diagram. 
nsp4 
nsp5 
nsp6 
1 Folding 2 Stability 
3 Dimerization 
nsp7 
nsp8 
4 Cleavage Site Recognition 
5 Replication Complex Formation 
Nascent replicase  
polyprotein 
1.! How does nsp5 or its precursor intermediates fold? 
2.! Which regions/determinants of nsp5 are critical for folding? 
3.! How is nsp5 folding affected by temperature, pH or salt? 
1.! Which regions/determinants serve as structural 
scaffolds? 
2.! Are there coenzymes/cofactors that stabilize nsp5? 
3.! How does nsp5 stabilize as the polyprotein changes? 
4.! Which regions are flexible and what do they do? 
1.! Does dimerization occur 
during virus infection? 
2.! Why is dimerization 
essential? 
3.! How many active nsp5 
dimers are necessary for 
infection? 
4.! Which determinants in the 
interface are critical for 
dimerization? 
1.! Which regions/residues define 
specificity? 
2.! What is the order of nsp5 
cleavage events? Does it vary? 
3.! Is the order critical for viral 
replication? 
4.! Does nsp5 contort or change 
during cleavage? 
5.! Does nsp5 cleavage any host 
proteins? 
6.! Which nsp5 cleavage events are 
not essential? 
1.! Does nsp5 allosterically regulate other proteins or host factors? 
2.! Where are these allosteric binding sites on nsp5? 
3.! How many nsp5 monomers comprise the replication complex? 
4.! How long does nsp5 persist in the cell before inactivity? 
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 All three ts mutations (S133A, V148A, F219L) resulted in reduced viral 
replication kinetics at the non-permissive temperature of 40°C, altered nsp5-mediated 
polyprotein processing, and were capable of partial or full suppression by a common 
suppressor allele H134Y. These findings identified new critical determinants and regions, 
previously unknown, which are important regulators of nsp5 activity and of structural 
stability. Additionally, these residues, which are non-conserved, highlight crucial long-
distance communication nodes spanning domains 2 and 3 in the structure of nsp5. The 
significance and discussion of these results are described in Chapter IV. Future directions 
will focus on defining the role of these mutations and the structural basis for their 
interactions.  
 
Biochemical analysis of MHV nsp5 ts lesions 
 
In work described in Chapter II in collaboration with the Mesecar lab at Purdue, 
the MHV ts mutation V148A and the second-site suppressor mutation H134Y were 
introduced into an expression vector and purified for in vitro characterization to 
understand the mechanism by which the V148A lesion disrupts nsp5 function and how 
the H134Y suppresses the V148A-associated defect at non-permissive temperatures. 
Initial recovery of the V148A and V148A/H134Y proteases required lower bacterial 
incubation temperatures. Although viewed initially as a technical obstacle only, this early 
finding indicated that there were subtle differences in the protease prior to purification. 
To assess the temperature-sensitivity of the proteases, a thermal inactivation assay was 
established whereby the enzymes would be incubated at varied temperatures and 
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analyzed for residual proteolytic activity over time. These data demonstrated that at 
temperatures of at least 40°C, the V148A protease demonstrated substantially reduced 
residual activity over time relative to either WT MHV nsp5 or the suppressed 
V148A/H134Y. Subsequent analysis using circular dichroism suggested that the 
secondary structure of the V148A nsp5 mutant was considerably less stable than WT-
MHV indicated that the V148A mutation was disrupting nsp5 structural stability. 
Furthermore, the H134Y exhibited increased stability relative to WT and may highlight a 
critical interacting node for nsp5 folding or stabilization. These findings (which are 
discussed in more detail in Chapter IV) highlight key structural motifs and regions, which 
are important for maintaining nsp5 structure and stability, and may show critical regions 
involved in nsp5 folding. All of these studies were carried out in the context of MHV. An 
important future direction is to define their relevance to the nsp5 of other coronaviruses 
including distantly related alpha- and gammacoronaviruses. 
 
Coevolution of intra- and intermolecular networks in coronavirus nsp5  
 
 In Chapter III, the conservation of nsp5 structure and function was examined by 
substitution of the nsp5 coding region from alpha- and betacoronaviruses NL63, 229E, 
SARS-CoV, Bat HKU4, HKU1 and OC43 into the background of MHV. Despite 
appreciable tertiary structure conservation and similar nsp5 cleavage sites, only closely-
related betacoronavirus HKU1 (H5-MHV) and OC43 (O5-MHV) nsp5 proteases 
permitted virus recovery. Interestingly, these viruses exhibited similar replication kinetics 
(albeit slightly lower than WT MHV) and no adaptive mutations. However, in 
 107 
competitive fitness assays, neither virus demonstrated comparable fitness to WT 
indicating a clear fitness cost with genetic exchange of the nsp5 protease even between 
closely-related species. Analysis of the MHV, HKU1, OC43 and SARS-CoV nsp5 
proteases in vitro demonstrated that clear differences in activity and specificity exist 
among betacoronavirus nsp5 proteases. Introduction of the MHV ts alleles into the 
chimeric H5- and O5-MHV backgrounds showed that subtle structural differences exist 
and that the function of these alleles although similar is not necessarily conserved. 
Collectively, these data demonstrated that coronavirus nsp5 proteases are highly 
coevolved and that genetic exchange, deemed common between coronaviruses, may be 
limited in substitution of nsp5 or its associated cleavage sites to closely-related species. 
 
Generation of chimeric MHV viruses with more distant coronavirus nsp5 proteases 
 
 In Chapter III, I described my efforts to introduce the nsp5 proteases of alpha- and 
betacoronaviruses into the background of MHV. Only closely-related betacoronaviruses 
HKU1 and OC43 permitted direct substitution into the background of MHV. 
Substitutions of SARS-CoV, HCoV-229E, HCoV-NL63, and Bat Coronavirus HKU4 
were not tolerated despite at least 3 attempts with each of the designed MHV constructs. 
In addition, several approaches were used to try to recover chimeric MHV with SARS 
nsp5. In summary, these approaches include the introduction of SARS nsp5 cleavage 
sites in various mixtures, using MHV F219L in trans to aid initial replication, expression 
of MHV WT nsp5 in trans, and introduction of the ExoN mutations (knockout of nsp14-
associated proofreading activity). These approaches are summarized in this section in the 
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hopes that future generations of graduate students will know what has been tried in 
recovery of this virus and potential other directions to pursue. 
 Initial efforts at recovery of the SARS virus consisted of trying to swap only the 
SARS nsp5 protease into the background of MHV. Xiaotao initially carried out these 
studies. Despite multiple attempts, no signs of infection were observed. As I described in 
Chapter III, PCR using oligonucleotides specific for subgenomic RNA of N, M, E and S 
failed to amplify detect any signs of late stages of infection of this SARS chimera. Once 
direct recovery was deemed unlikely, we decided to substitute all 11 SARS-CoV 
cleavage sites (P5 – P2’) into the MHV infectious clone fragment sequences. The nsp5 
cleavage sites are distributed throughout the MHV infectious clone fragments as shown 
in Table 5.1. Several attempts using all of these sites combined with the SARS-CoV nsp5 
protease (with and without its flanking nsp4 and nsp6 cleavage sites) were unsuccessful. 
In addition, I have also tried to the following fragment combinations: C alone, D alone, E 
alone, F alone, C+D+F, and C+D+E alone. In each of these cases, there was no detectable 
signs of replication. 
 
Table 5.1. Locations of nsp5 cleavage sites in MHV infectious clone fragments 
MHV Infectious Clone Fragment Nsp5 Cleavage Sites 
C  nsp4/5 and nsp5/6 (2) 
D nsp6/7, nsp7/8 and nsp8/9 (3) 
E nsp9/10 and nsp10/12 (2) 
F nsp12/13, nsp13/14, nsp14/15 and nsp15/16 (4) 
 
 In addition to cleavage site substitutions, we have also tried virus recovery of the 
SARS-CoV chimera with MHV nsp5 protease transfected and stably expressed in DBT-9 
cells. Xiaotao observed initial replication of the SARS-CoV virus when nsp5 was 
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transfected in DBT-9 cells, however the virus was not able to be passaged and the 
replication remained at a low level. This observation was not able to be repeated. The 
DBT-9 cell line stably expressing nsp5 protease is available and stored for potential use. 
In an additional experiment, the chimera recovery was attempted in cells that had been 
previously infected with MHV F219L at 30°C. Upon addition of the cells, the flask was 
shifted to 40°C to inactivate the MHV F219L virus. No changes in CPE were observed 
following the temperature-shift.  
 We have begun experiments to try to express both SARS-CoV nsp5 and MHV 
nsp5 in a common virus background, swap domains of SARS-CoV nsp5 into MHV, and 
swap individual cleavage sites for virus recovery. All of these represent future potential 
directions. However, it will be critical to identify which sites are fundamentally processed 
different between the proteases and identify critical allostery or intermolecular regulation 
within the background of MHV that may have been altered or disrupted upon chimeric 
substitution.  
 
Future studies: Dimerization and nsp5 activity 
 
 Coronavirus nsp5 protease is responsible for recognizing and processing 11 
different cleavage events including its own autoproteolytic maturation cleavage. In vitro 
studies have shown that expressed and purified coronavirus nsp5 protease exists as a 
mixture of monomeric and dimeric forms. Functional assays suggest that the dimer is the 
predominant form comprising approximately 65% of the detectable protease and is the 
primary functional active form. Early studies have suggested that dimerization was 
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critical for nsp5 protease function. However, a recent publication has shown that the 
monomeric form may be capable of the amino-terminal autocleavage event prior to 
dimerization. No studies have tested this hypothesis in the context of a replicating virus. 
X-ray crystallographic studies and biochemical analyses have demonstrated that the 
dimeric form is structurally stable and have identified several important interacting 
motifs and determinants. 
 The amino terminus of coronavirus nsp5 is comprised two distinct functional 
motifs, an amino terminal finger (NF) and amino terminal helix (NH) (Figure 5.2). 
Studies using purified SARS-CoV nsp5 have demonstrated that the first ten amino acids 
(Ser1 – Thr10) comprising the amino-terminal finger are critical for dimerization and 
nsp5 activity. Several inter- and intramonomer interactions are predicted based on 
structural models including Arg4-Glu290 and Met6-Arg298. Deletion of residues 1 – 3 in 
SARS-CoV nsp5 resulted in a 50% reduction of catalytic activity while retaining 
dimerization. In contrast, deletion of the first four residues resulted in a loss of 
dimerization and 2 log reduction in enzymatic activity in vitro. Residues Thr10 – Glu14 
comprise a small α-helical region (termed the amino terminal helix, NH) and alanine 
substitution of Gly11 resulted in a complete loss of dimerization and enzymatic activity. 
Many of the residues in the NF are predicted to interact with regions of the alpha-helical 
carboxy terminus of domain 3.  
The coronavirus nsp5 amino-terminal motifs and domain 3 have been shown to 
play an important role in biochemical and in vitro studies. However the interactions and 
predicted functions of these regions have yet to be tested in the context of a replicating  
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Fig. 5.2. Amino-terminus of nsp5 Protease. A) Structure of MHV nsp5 protease (modeled on HKU1 
structure [PDB code 3D23] showing the amino-terminal residues. Putative dimerization determinants in 
domain 3 (D3) are also shown. The regions for the amino-terminal helix (NH) and amino-terminal finger 
(NF) are also designated.  B) Alignment of NF and NH residues from MHV, SARS-CoV, 229E and IBV. 
Select residue numbers are shown. 
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virus. Consequently, several key questions exist: 1) Does active mature nsp5 dimers exist 
during virus infection and how are they formed? 2) Does nsp5 dimerize before processing 
its amino-terminus or is autoproteolysis required for dimerization? 3) Which residues and 
predicted interactions are critical for nsp5 dimerization and enzymatic activity? 4) How 
structurally and functionally conserved are the dimerization interfaces of coronavirus 
nsp5 proteases? 5) Does domain 3 mediate nsp5 dimerization?  
 To address these questions, I propose the following approaches. First, mutations 
introduced into the dimerization interface, which are known to abrogate dimerization in 
vitro, may be introduced for virus recovery in the MHV, H5-MHV and O5-MHV viral 
backgrounds. Second, nsp5 may be immunoprecipitated and run on a native gel in the 
presence and absence of heat to evaluate whether active dimers can be detected by size 
and gel mobility. Third, based on studies evaluating cleavage site specificity in vitro, 
cleavage sites may be swapped at the nsp4/5 and nsp5/6 sites with less efficiently 
processed sites to identify whether: (a) reordering of sites prevents viral recovery; (b) 
alteration of polyprotein intermediates may be detected among recovered viruses; (c) 
unique pathways of reversion exist that are intrinsically tied to specific sites or processing 
events. Collectively, these approaches may shed new light on the role of the amino-
terminal region of nsp5 and the potential for dimerization during viral infection. 
 
Future studies: Role of the domain 2-domain 3 interdomain loop (IDL) 
 
Nsp5 is structurally conserved among coronaviridae and is similar to the nsp4 
protease of distantly-related arteriviruses. Domains 2 and 3 of coronavirus nsp5 and 
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arterivirus nsp4 are connected by a conserved interdomain loop (IDL) structure. Equine 
arteritis virus (EAV) nsp4 is 204 amino acids in length and uses a catalytic triad (H39-
D65-S120) for replicase polyprotein cleavage. Mutagenesis of the seven residue EAV 
nsp4 IDL resulted in reduced viral fitness or lethality and alteration in proteolytic 
processing. The MHV IDL consists of approximately 15 residues (Pro184-Thr199) and 
remains structurally conserved among all known nsp5 crystal structures (Figure 5.3). 
Two residues in the MHV IDL, D187 and Q192, are 100% conserved in all known nsp5 
sequences. Predictive modeling of these residues suggests that they play an important 
role in stabilizing the horseshoe structure at the amino terminus of the loop. However, no 
viral, structural, or biochemical studies have evaluated the functional role neither of the 
IDL nor of these residues. It has been proposed that the IDL may function as a flexible 
linker with domain 3 or a hinge to permit active protease function. These hypothesis have 
yet to be tested. Consequently, many key questions remain: 1) What is the role of the 
domain 2-domain 3 IDL? 2) How does alteration of the length or flexibility of the IDL 
impact nsp5 function in vitro and during virus infection? 3) Which residues or 
determinants of the nsp5 IDL are indispensible for protease activity and/or virus 
viability? 
 During study of the MHV ts and suppressor alleles described in Chapter II, I 
initiated mutagenesis studies of the residues of the MHV IDL in order to evaluate its 
functional role in nsp5 activity and virus replication. In all, nine different mutations were 
attempted in addition to mutagenesis for several others (Table 5.1). The following virus 
recoveries attempted were: P184A, D187A, D187Q, Q192A, Q192N, P194A, Q196A, 
Y198A and T199A. Four viruses were successfully recovered and sequence confirmed 
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Fig. 5.3. Coronavirus nsp5 domain2-domain3 interdomain loop. The interdomain loop residues (184 – 
199) are shown and labeled on a modeled structure of MHV nsp5. Domains 1 -3 are color coded and 
labeled. 
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confirmed: P184A, P194A, Q196A and T199A. However, no further analysis of these 
viruses was attempted. The inability to recover mutants of residues D187 and Q192 
demonstrate an important functional role of this loop structure. Ongoing and future work 
may evaluate the replication of these viruses and continue to mutagenize and alter the 
length of the nsp5 IDL. Efforts at identifying critical determinants and region may want 
to focus exclusively at the following areas: (a) 100% conserved residues D187 and Q192, 
(b) the horseshoe loop which is structurally conserved in all known nsp5 crystal 
structures, (c) the linker regions connecting the loop to domains 2 and 3, (d) the role of 
length and flexibility in nsp5 function. In addition to mutagenesis, other potential 
approaches to studying the loop include biochemical characterization (thermal stability, 
structural flexibility by Rosetta predictions or cryo-NMR characterization, and catalysis 
upon mutagenesis) and chimeric exchange to evaluate conservation of the structure and 
its function. 
 
Table 5.2 Site-directed mutagenesis of the MHV IDL 
 
Progress towards mutating the MHV D2-D3 IDL 
Mutation Cloning Status Virus Recovered? 
P184A Cloning complete Yes 
Y185A Mutation inserted  
D187A Cloning complete No 
D187E Cloning complete Not Attempted 
D187Q Cloning complete  
Q189A Needs to be reattempted  
V190I Needs to be reattempted  
Q192A Cloning complete No 
Q192N Mutation inserted  
P194A Cloning complete Yes 
Q196A Cloning complete Yes 
Y198A Cloning complete No 
T199A Cloning complete Yes 
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Future studies: Role of nsp5 domain 3 
 
 MHV domain 3 is comprised of five alpha helices and has no known homolog to 
any viral or cellular proteases. Domain 3 is indispensible for nsp5 activity and several 
residues in the carboxy terminus are essential for dimerization and subsequent proteolytic 
activity. Domain 3 is considerably more structurally divergent and has been proposed as a 
key determinant of nsp5 specificity. However, the functional role of domain 3 remains 
unknown. Consequently, several key questions exist: 1) What functional role does nsp5 
domain 3 play in protease structure and activity? 2) Is the function of domain 3 conserved 
across all coronavirus nsp5 proteases? 3) Which helices are essential for nsp5 protease 
activity? 4) Are there key interactions between domains 2 and 3? If so, which residues 
mediate these interactions? 
 
Future studies: nsp5 folding and flexibility 
 
 Coronavirus nsp5 protease is comprised of three distinct domains, each of which 
are approximately 100 amino acids in length. Domains 1 and 2 are β-barrels which 
constitute a chymotrypsin-like fold and domain 3 is a unique helical element of unclear 
function. Despite numerous crystal structures of nsp5, no studies to date have evaluated 
the mechanism of protease folding and flexibility. Upon translation in the context of the 
polyproteins pp1a and pp1ab, it has been postulated that nsp5 is associated with 
membranes due to its location between neighboring membrane-associated proteins nsps 
3, 4, and 6. Several studies have demonstrated that nsp5 requires a hydrophobic milieu 
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for proper function, which support this hypothesis. Interestingly, nsp5 appears to process 
the replicase polyproteins in a distinct order (as evidenced by readily detectable 
intermediate polyprotein products) and biochemical analyses of nsp5-mediated 
processing in vitro indicate that nsp5 has appreciably higher specificities for some sites 
over others. These data indicate that nsp5 exhibits a distinct hierarchy. 
Structural predictive modeling of nsp5 dynamics using a freeware platform El 
Nemo indicated that the junction between domains 2 and 3 linked by the IDL may be 
extremely dynamic. The discovery of three different temperature-sensitive mutations in 
these domains, which potentially destabilize the protease structure, may also highlight 
critical folding motifs or platforms that have been disrupted. Further biochemical analysis 
will be needed to answer this question. As previously mentioned, it remains unknown 
how nsp5 orchestrates its autoproteolytic cleavage and how it forms active dimers. 
Despite numerous crystal structures available and advances in structural modeling, very 
little continues to be known about nsp5 protease folding and flexibility raising several 
key questions: 1) Which intramolecular associations are essential for nsp5 folding and 
stability? 2) Does the nsp5 IDL regulate protease flexibility? If so, for what purpose? 3) 
How does nsp5 interact with neighboring transmembrane spanning regions in nsp4 and 
nsp6 and what role do these interactions have in nsp5 folding or flexibility? 4) Does the 
flexibility of the replicase polyproteins or nsp5 localized flexibility in the context of nsps 
3, 4, and 6 modulate its cleavage site specificity and apparent processing hierarchy? 
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Future studies: Development and testing of coronavirus nsp5 inhibitors 
 
 Since the first studies using protease inhibitor E64d showed inhibition of 
coronavirus replication, considerable energy has been put into the development of 
broadly-neutralizing coronavirus nsp5 inhibitors. Surprisingly, nearly all nsp5 inhibitors 
developed to date have been peptidomimetic active site competitive inhibitors. The data 
presented in Chapter IV demonstrated however that clear functional differences exist 
between coronaviruses, which may make development of a single silver bullet inhibitor 
for coronaviruses unfeasible. Furthermore, practically all inhibitors that have shown low 
µM inhibitory concentrations have yet to be tested against a replicating virus. 
Consequently, several key questions exist: 1) Do any current top inhibitors demonstrate 
cellular toxicity or efficacy towards replicating virus? 2) Are there any non-active site 
regions that are structurally conserved and may be targeted for inhibitor design? 3) What 
mechanisms will representative viruses of different coronavirus genera use to evade nsp5 
inhibitors? Will the pathways of virus escape be the same? Will they be genus specific? 
4) Can a combination of inhibitors be used to provide synergistic inhibition of 
coronaviruses and limit viral escape? 
 Ongoing collaboration with the Mesecar lab has led to testing of nsp5-specific 
inhibitors using the H5- and O5-MHV chimeric viruses described in Chapter III. 
Particular aims of this research are to evaluate the efficacy of these inhibitors and identify 
potential mechanisms of viral escape. These studies will provide direct feedback for 
optimization and characterization of future inhibitors being developed. 
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Future studies: Role of nsp5 in host inactivation and immune evasion 
 
The specificity of nsp5 is known to exhibit considerable plasticity based on in 
vitro biochemical analyses. During virus infection, nsp5 is readily detectable by 
immunoprecipitations. However, no studies to date have identified any host cell targets of 
coronavirus nsp5. Studies expressing nsp5 in cells have shown that it modulates the host 
cell immune response specifically decreasing NF-κB signaling and interferon expression. 
Recent data from Carolyne Coyne’s lab using coxsackievirus B 3C protease (a positive-
strand RNA virus related to polio; 3Cpro is protease similar to our nsp5 protease) has 
identified a number of interferon signaling pathway protein targets that are cleaved 
during infection including MAVS and TRIF (Mukherjee et al. 2011, PLoS Pathog). In 
2004, a study published in Denmark described an online algorithm similar to the one 
developed for identifying 3C pro targets for coronavirus 3CLpro. The algorithm 
compares protein amino acid sequences to a consensus nsp5 cleavage site and assigns a 
score to all putative sites ranging from 0 to 1 based on the increasing likelihood of 
cleavage. Using this algorithm to predict putative nsp5 cleavage targets and a list 
provided by the Coyne lab, we identified several host protein targets that may have major 
implications on host detection and immune activation to virus infection including OAS, 
IRAK, Ubiquitin-binding protein 1 (UBP1), and ApolipoproteinB 100 (ApoB-100) 
(Table 5.2). 
Intriguingly, ApoB-100 is a cholesterol carrier molecule found predominately in 
hepatic cells and has 9 putative nsp5 cleavage sites. A study of a patient with chronic 
Hepatitis C infection demonstrated that chronic viral infection elicited an acquired 
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apolipoprotein B deficiency (Gupte et al. 2006). Despite nearly 50 years of study, the 
pathogenesis of disease associated with MHV infection remains unknown. These data 
may in part explain the pathogenesis of the virus and progression of disease in the murine 
model. The use of host cell membranes by coronaviruses has been extensively described, 
which applies a motive for the virus. Yet, the mechanisms by which coronaviruses 
acquire or utilize these membranes are unknown. To date, no studies have reported any 
nsp5 host targets and identification of a host target may shed new light on the role of 
protease during virus infection. Therefore, many key questions remain: 1) Are there any 
nsp5 protease host cell targets during virus infection? If so, what are they and do they 
play a role in virus evasion, acquisition of host cell resources, or the viral replicative 
cycle? 2) Is there a connection between cleavage of ApoB-100 and the pathogenesis and 
disease associated with MHV infection? 3) Where is nsp5 protease localized during virus 
infection and does its localization impact its ability to cleave host targets? 
 
Concluding remarks 
 
 In this dissertation, I have described the contributions I have made to understand 
the structure and function of coronavirus nsp5 protease. There are many unanswered 
questions remaining. The emergence of new coronaviruses and current dearth of 
information related to the mechanism of nsp5 action demand attention for the 
development of inhibitors and understanding the limitations of virus evolution. 
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Table 5.3 Putative host cell targets of coronavirus nsp5 protease 
 
Progress towards mutating the MHV D2-D3 IDL 
(only hits above priority score of 0.7 shown) 
Protein Target Highest Priority Score (# of 
predicted sites) 
BATF2 0.932 (2) 
UBP1 0.932 (2) 
RIP1 0.927 (2) 
NAP1 0.919 (3) 
ATF6B 0.916 (1) 
IFI6 0.890 (1) 
INI2 0.890 (1) 
CUT 0.889 (2) 
OCT1 0.874 (1) 
APLB100 0.866 (9) 
VIM 0.866 (1) 
IRAK1 0.859 (1) 
CYP1B1 0.851 (1) 
SCAD 0.828 (1) 
EIF4G 0.822 (3) 
LPL 0.819 (1) 
SLC25A28 0.813 (1) 
OAS1 0.793 (1) 
p130CAS 0.790 (2) 
17AH 0.782 (1) 
P53BP3 0.782 (3) 
IRF8 0.766 (1) 
RPOLIII_C1 0.765 (3) 
SIRPA 0.742 (2) 
P53BP1 0.738 (2) 
STAT1 0.736 (1) 
IKKε 0.735 (3) 
TFIID_1 0.730 (1) 
TRIF 0.720 (4) 
 
 
 
 
 
 
 
 122 
CHAPTER VI 
 
 
MATERIALS AND METHODS 
 
 
 
Viruses, cells, and antisera.  Recombinant wild-type (WT) MHV strain A59 (GenBank 
no. AY910861) was used as a MHV wild-type control. Delayed brain tumor cells (DBT-
9), which are naturally permissive for MHV infection, and baby hamster kidney 21 cells 
expressing the MHV receptor (BHK-MHVR) were used for all experiments (Yount et al., 
2002). Dulbecco’s modified Eagle medium (DMEM) (Gibco) was supplemented with 
10% heat-inactivated fetal calf serum (FCS) for all experiments described. BHK-MHVR 
medium was supplemented with G418 (0.8 mg/mL; CellGro) to maintain selection for 
MHVR expression. All biochemical experiments were carried out using rabbit polyclonal 
antibodies previously described in the literature. The antisera used include nsp2-specific 
(VU154), nsp5-specific (VU6), and nsp8-specific (VU123) antibodies (Bost et al., 2000; 
Lu et al., 1996; Sims et al., 2000). 
 
Mutagenesis of MHV cDNA C fragment. Assembly of the complete MHV genome is 
generated through the ligation of seven cDNA fragments (A-G) digested from individual 
plasmids as previously described by Yount et al. (Yount et al., 2002). All viruses were 
engineered by inserting the specified amino acid substitution into the MHV infectious 
clone (MHVic) C fragment containing the nsp5 sequence, which was constructed by PCR 
and cloned into the XL-pSMART vector (Yount et al., 2002). Sense and antisense 
primers were designed to be overlapping with nucleotide changes within the middle of 
the primer. The primers used for mutagenesis for experiments described in Chapters II, 
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III, and IV. All mutant plasmids were sequence confirmed prior to ligation and MHVic 
assembly.  
 
Recovery of MHV mutant viruses. The MHV nsp5 mutant viruses were engineered 
through the infectious cDNA assembly strategy as described previously by Yount et al. 
(Yount et al., 2002). In brief, the seven cDNA fragments were digested, gel-purified, and 
ligated overnight at 16°C. Transcription of the extracted ligated DNA, as well as N 
cDNA which encodes the nucleocapsid protein, was performed by using the mMachine 
T7 transcription kit (Ambion) under conditions previously described in detail (Yount et 
al., 2002). The transcribed genome and N-gene were electroporated into BHK-MHVR 
cells and the electroporated cells were placed into a sub-confluent flask of DBT-9 cells 
and incubated at either 30°C for potentially ts viruses or 37°C. 
 
Cloning and recovery of chimeric and mutant viruses. Viruses were assembled and 
recovered using the MHV infectious clone protocol previously described by Yount et al 
(Yount et al., 2002). The nsp5 nucleotide sequences for human coronaviruses HKU1 
(GenBank accession number NC006577), OC43 (NC005147), and SARS-CoV Urbani 
(AY278741) were each substituted into the MHV cDNA genomic constructs (BioBasic) 
and sequence confirmed prior to attempted virus recovery (Rota et al., 2003; Vijgen et al., 
2005; Woo et al., 2005). Using the assembly protocol previously described, the genomic 
cDNA fragments were ligated, transcribed, and electroporated into BHK-MHVR cells 
which were then added to a sub-confluent flask of DBT-9 cells at 37°C (Yount et al., 
2002). 
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RNA extraction and sequencing. A confluent monolayer of DBT-9 cells in a T25 flask 
was infected with viral mutant stocks at a multiplicity of infection (MOI) of 10 plaque-
forming units (PFU) per mL and grown to approximately 30 – 50% involvement in 
syncytia. Supernatant was removed from each T25 containing isolated mutant virus and 
stored at -20°C. The cells were harvested in TRIzol reagent (Invitrogen) for isolation of 
total RNA. Reverse transcriptase PCR (RT-PCR) was performed using SuperScript III 
RT (Invitrogen) and random hexamers (Applied Biosystems) at 55°C for 1 h and the 
resulting cDNA was PCR amplified using Easy-A high-fidelity PCR cloning enzyme 
(Stratagene) and MHV genome oligonucleotides covering the nsp5 region (nucleotides 
10160 – 11799). Amplified regions were gel purified and analyzed by sequencing.  
 
Isolation and expansion of suppressor mutants. In order to isolate potential suppressor 
mutant viruses, two different types of plaque assays were performed. Reversion analysis 
of the ts viruses described in Chapter II was performed by infecting DBT-9 cells in 
duplicate using 6-well plates with serial dilutions of potential revertant samples with a 1 h 
adsorption period. The overlay contained a one to one mixture of 2% agar and 2X 
Dulbecco's Modified Eagle Medium. The plates were incubated for 48 h so plaques were 
easily visible. Ten plaques were picked for each virus sample and re-suspended in gel 
saline. Isolated plaques for each virus were used to infect separate T25s for expansion at 
40°C. Flasks were removed from non-permissive temperatures when 70-95% of cells 
were involved in syncytia, then RNA was isolated as described above. The suppressor 
mutants identified in Chapter III were acquired by plaque assay by infecting DBT-9 cells 
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in duplicate using 6-well plates with serial dilutions and a 1 h adsorption period at 32°C. 
The overlay contained a 1:1 mixture of 2% agar and 2X Dulbecco's Modified Eagle 
Medium. The plates were incubated for 48 h until plaques were easily visible. Ten 
plaques were picked for each virus sample and re-suspended in gel saline. Isolated 
plaques for each virus were used to infect separate T25s for expansion at 40°C. Flasks 
were removed from non-permissive temperatures when 70-95% of cells were involved in 
syncytia, then RNA was isolated as described above. 
 
Analysis of viral replication kinetics and nsp5 processing.  Confluent monolayers of 
DBT-9 cells in 60-mm dishes were infected at an MOI of 0.01 or 1 PFU/mL and 5 
PFU/mL for growth analysis and immunoprecipitation analyses, respectively. In the 
temperature shift experiments, the cells were shifted from 30°C or 32°C to 40°C at 6 h 
p.i. During the growth analysis, samples of supernatant were acquired and pre-warmed 
media added back to maintain a fixed volume on the cells. Virus titers were determined 
by plaque assay in duplicate or triplicate. Immunoprecipitation experiments were carried 
out as previously described (Sparks et al., 2008). Eluted proteins were resolved by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 4 to 12% 
polyacrylamide gradient Bis-Tris gels (Nu-PAGE/Invitrogen) and analyzed by 
autoradiography. A 14C-labeled high-molecular-weight standard (New England Biolabs) 
and a full range rainbow marker (RPN 800E/ Invitrogen), were used as protein mass 
standards.  
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Sequence alignments and modeling of MHV nsp5 structures. A multiple sequence 
alignment of coronavirus nsp5 sequences and a phylogenetic tree were generated using 
ClustalX and a bootstrap alignment from 1000 trials. A model of 100% conserved 
residues was determined using Consurf (Eswar et al., 2008) and a multiple sequence 
alignment (MSA) of 226 available CoV nsp5 sequences. A sequence logo was generated 
using the WebLogo server and the MSA of 226 available CoV sequences (Crooks et al., 
2004). The X-ray crystal structure of HCoV-HKU1 nsp5 (Protein Data Bank [PDB] code 
3D23) was used as a structural model of comparison (Zhao et al., 2008). Structural 
models were generated using Modeller (Stokes et al., 2010) and MacPyMol (DeLano 
Scientific). Other CoV nsp5 X-ray structures used for alignment were SARS (PDB 
2H2Z), HCoV-229E (PDB 1P9T), and IBV (PDB 2Q6D) (Anand et al., 2003; Xue et al., 
2007; Xue et al., 2008). Distance calculations were determined by measurement of the 
alpha carbon to alpha carbon in the structure of HCoV-HKU1 nsp5. 
 
Assay of virus fitness. Confluent monolayers of DBT-9 cells were co-infected in 
triplicate at ratios of 1:1 or 1:10 to a total MOI of 0.01 PFU/cell in 25 cm2 flasks. Upon 
reaching 30 to 50% involvement in syncytia, the supernatant was stored at -80°C and the 
monolayer treated with TRIzol reagent for RNA acquisition. For subsequent passages, 
the virus supernatant was thawed at 4°C and 5 µL were added to each of three confluent 
25 cm2 flasks. RNA was isolated and reverse-transcribed as previously described (Stobart 
et al., 2012). Amplicons using oligonucleotides flanking the nsp5 coding region were 
generated and treated with HKU1- (HincII) and OC43-sequence specific (BsiWI) 
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restriction enzymes, which resulted in a single cut. The bands were resolved on a 0.8% 
agarose gel containing ethidium bromide and quantified by densitometry. 
 
Creation of FRET-based substrates. The genes coding for cyan and yellow fluorescent 
proteins (CFP and YFP) joined by a multiple cloning site were synthesized (BioBasic) 
and inserted into a vector for expression in E. coli. Complimentary oligonucleotides 
representing P8 to P8’ for each nonstructural protein cleavage site were synthesized 
(BioBasic) and inserted between the CFP and YFP via recombinant cloning following 
restriction enzyme digestion of the multiple cloning site (Oliner et al., 1993). Following 
confirmation of intended clones by DNA sequencing, fluorescent resonance energy 
transfer (FRET)-based substrates consisting of cyan and yellow fluorescent proteins 
linked by the nonstructural protein cleavage sites were expressed and purified as 
previously described (Felber et al., 2004).  
 
Analysis of 3CL kinetic activity against FRET-based substrates. The nsp5 proteases 
of SARS-CoV, HKU1, OC43, and MHV were expressed and purified using an approach 
previously described (Jacobs et al., 2013). Assays were conducted in black 96-well plates 
(Corning) using a Synergy 5 plate reader (Biotek). Assays using the universal nsp5 
cleavage site substrate were performed as described previously (Grum-Tokars et al., 
2008). Emission of the FRET substrates at 485 nm was monitored over a time-course 
varying from 30 minutes to 6 hours depending on the substrate used. Based on the 
cleavage rates of each substrate, enzyme concentrations varied from 100 to 500 nM. 
Initial cleavage velocities were determined for each substrate at 1, 2, and 4 µM and 
 128 
normalized using a fluorescent extinction coefficient empirically calculated for each 
substrate. For each substrate/enzyme combination, data were adjusted for enzyme 
concentration and reaction volume, then plotted versus substrate concentration to yield a 
line whose slope represented a unique k apparent (kapp) value.  
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Temperature-Sensitive Mutants and Revertants in the Coronavirus
Nonstructural Protein 5 Protease (3CLpro) Define Residues Involved
in Long-Distance Communication and Regulation of Protease Activity
Christopher C. Stobart,b,c Alice S. Lee,a,c Xiaotao Lu,a,c and Mark R. Denisona,b,c
Departments of Pediatricsa and Pathology, Microbiology and Immunology,b and The Elizabeth B. Lamb Center for Pediatric Research,c Vanderbilt University Medical
Center, Nashville, Tennessee, USA
Positive-strand RNA virus genomes are translated into polyproteins that are processed by viral proteases to yield functional in-
termediate andmature proteins. Coronaviruses (CoVs) carry genes that encode an nsp5 protease (also known as 3CLpro or
Mpro) responsible for 11 maturation cleavages. The nsp5 structure contains two chymotrypsin-like domains (D1 and D2) and a
unique domain (D3), and forms functional dimers. However, little is known of interactions or communication across the struc-
ture of the protease during nsp5 activity. Using reverse genetic mutagenesis of the CoVmurine hepatitis virus (MHV) nsp5, we
identified a new temperature-sensitive (ts) mutation in D2 of nsp5 (Ser133Ala) and confirmed a ts residue in D3 (Phe219Leu).
Both D2-tsS133A and D3-tsF219L were impaired for viral replication and nsp5-mediated polyprotein processing at the nonper-
missive temperature. Passage of tsS133A and tsF219L at the nonpermissive temperature resulted in emergence of multiple sec-
ond-site suppressor mutations, singly and in combinations. Among the second-site mutations, a D2 His134Tyr change sup-
pressed the ts phenotype of D2-tsS133A and D3-tsF219L, as well as the previously reported D2-tsV148A. Analysis of multiple
CoV nsp5 structures, and alignment of nonredundant nsp5 primary sequences, demonstrated that ts and suppressor residues are
not conserved across CoVs and are physically distant (>10 Å) from each other, from catalytic and substrate-binding residues,
and from the nsp5 dimer interface. These findings demonstrate that long-distance communication pathways betweenmultiple
residues and domains of nsp5 play a significant role in nsp5 activity and viral replication, suggesting possible novel targets for
non-active site inhibitors of nsp5.
Positive-strand RNA viruses are responsible for prevalent andepidemic diseases in a wide range of vertebrate hosts, as well as
new and emerging viruses, such as severe acute respiratory syn-
drome coronavirus (SARS-CoV),West Nile virus, andChikungu-
nya virus. The rapid evolution, host species movement, and dis-
eases of positive-strand RNA viruses demonstrate the need to
develop novel strategies to prevent and treat present and new dis-
eases caused by these viruses. A key determinant of positive-strand
RNA viruses is the requirement for processing of translated poly-
proteins by virus gene-encoded proteases. RNA virus proteases
therefore have been high-profile targets for development of anti-
viral agents, with most protease inhibitors targeted to active sites
or substrate-binding sites (21, 26, 32, 35). However, due to the
potential for viral escape mutants, it is critical to identify addi-
tional noncatalytic, non-substrate-binding determinants of pro-
tease activity as potential targets for inhibition that are less prone
to development of resistance.
To date, five CoVs have been shown to be associated with hu-
man respiratory diseases of different degrees of severity: human
coronavirus HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-
HKU1, and SARS-CoV (10, 15, 30, 31, 44, 45). CoVs contain the
largest known positive-strand RNA genomes, ranging from 26 to
32 kb in length. Murine hepatitis virus (MHV) strain A59 is an
established model for study of CoV replication and pathogenesis.
The 32-kb genome of MHV contains seven genes, with the repli-
case gene (22 kb) encoding 16 nonstructural proteins (nsp1 to
nsp16) (Fig. 1A) (20, 25). The replicase gene is translated into
polyprotein 1a (pp1a; nsp1 to nsp11) or, via a ribosomal frame-
shift, pp1ab (nsp1 to nsp16) (9, 25, 33). MHV encodes two papa-
in-like proteases (PLP1 and PLP2) responsible for cleavages of
nsp1 to nsp3, and an nsp5 protease, also known as 3CLpro or
Mpro, that mediates maturation cleavages of nsp4 to nsp16 and is
required for virus replication (33, 50).
The CoV nsp5 is a cysteine protease present in all known CoVs
and is structurally similar to the nsp4 protease of distantly related
arteriviruses (6, 33, 49). The crystal structure of nsp5 has been
solved for divergent CoVs from every genus, including SARS-
CoV, infectious bronchitis virus (IBV), human HCoV-HKU1,
and human HCoV-229E. Comparison of solved nsp5 structures
demonstrates conservation of tertiary structure despite numerous
differences in primary sequences (1, 2, 5, 46, 47, 49). The X-ray
crystal structure ofMHV nsp5 has yet to be determined; however,
the structure of the closely related HCoV-HKU1 nsp5 (84% se-
quence identity) has been resolved to 2.5 Å (Fig. 1B and C) (49).
The nsp5 proteases of all CoVs exhibit a three-domain structure,
with domains 1 and 2 forming a chymotrypsin-like fold contain-
ing the His41-Cys145 catalytic dyad and substrate-binding sites
(Fig. 1B) (1, 2, 5, 28, 46, 47). In contrast, domain 3 is unique to the
CoV nsp5 protease among chymotrypsin-like enzymes and also
showsmore divergence in both sequence and structural organiza-
tion between CoVs. In vitro studies indicate that domain 3 is im-
portant for stabilization of the chymotrypsin-like fold and may
Received 7 November 2011 Accepted 9 February 2012
Published ahead of print 15 February 2012
Address correspondence to Mark R. Denison, mark.denison@vanderbilt.edu.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
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also be important inmediating dimerization between nsp5mono-
mers (1, 28, 37, 38). Structural and biochemical studies demon-
strate that nsp5 dimerization is required for proteolytic activity in
vitro (11, 12, 37).
Recently, amino acid residues that may regulate nsp5 activity
but that are distinct from the active site cavity, substrate-binding
pocket, or dimerization interface have been identified. Alanine
substitution at SARS-CoVnsp5 Ser147, a conserved serine residue
inMHV andHKU1, disrupts dimerization and impairs nsp5 pro-
teolytic activity, despite being greater than 9 Å from the dimeriza-
tion interface (7). Our laboratory identified a temperature-sensi-
tive (ts) mutation (tsV148A) in MHV nsp5 that impairs virus
growth and nsp5 activity at 40°C (Fig. 1B) (40). Growth of the
tsV148Amutant at 40°C resulted in emergence of second-sitemu-
tations (S133N and H134Y), which suppressed the tsV148A phe-
notype. While V148 is adjacent to the catalytic C145, neither
S133NnorH134Yhave predicted direct interactionswith catalytic
or substrate-binding residues or identified pathways for propaga-
tion of structural changes. Sawicki et al. identified a putative ts
allele in nsp5 (F219L) at the base of unique domain 3, and distant
from the dimerization interface, active site cavity, and substrate-
binding regions (36). Finally, other studies have shown that nsp5
activity may be altered by changes in replicase nonstructural pro-
teins nsp3 and nsp10 (14, 41). Together, these findings support
the hypothesis that residues distant from catalytic and substrate-
binding sites are important for regulating nsp5 protease activity.
However, mechanisms of communication between residues and
regulation of protease activity are unknown.
In this study, we tested the roles of MHV nsp5 domain 2 resi-
dues S133 and H134, and domain 3 F219, on nsp5 activity. The
experiments identified a previously unknown MHV nsp5 ts mu-
tation in domain 2 (tsS133A) and confirmed the ts phenotype of
F219L, both of which result in profound growth and protein-
processing defects at nonpermissive temperatures. Under passage
at nonpermissive temperatures, a series of second-site mutations
emerged that were able to suppress the ts phenotypes of tsS133A
and tsF219L while being physically distant from the ts allele, the
nsp5 active site cavity, and the dimerization interface. A single
nonsynonymousmutation resulting in a H134Y substitution sup-
pressed the ts phenotype of all three independent ts alleles in do-
mains 2 and 3. The tsmutations reduced but did not abolish nsp5
protease activity during virus infection following a shift to the
nonpermissive temperature, while individual and combined sup-
pressor mutations restored nsp5 activity to an extent that directly
correlated with increased replication. These results demonstrate
the presence of multiple interconnected long-distance communi-
cation nodes in nsp5 and suggest novel mechanisms of regulation
of nsp5 activity during CoV replication.
MATERIALS AND METHODS
Viruses, cells, and antisera. Recombinant wild-type (WT) MHV strain
A59 (GenBank accession no. AY910861) was used as a MHV wild-type
control. Delayed brain tumor cells (DBT-9), which are naturally permis-
sive for MHV infection, and baby hamster kidney 21 cells expressing the
MHV receptor (BHK-MHVR) were used for all experiments (48). Dul-
becco’s modified Eagle medium (DMEM) (Gibco) was supplemented
with 10% heat-inactivated fetal calf serum (FCS) for all experiments de-
scribed. BHK-MHVRmediumwas supplemented with G418 (0.8 mg/ml;
CellGro) to maintain selection for MHVR expression. All biochemical
experiments were carried out using rabbit polyclonal antibodies previ-
ously described in the literature. The antisera used include nsp2-specific
FIG 1 MHV protease nsp5 structure and sequence alignment. (A) Genome and polyprotein processing of MHV. The replicase gene (gray) consists of two open
reading frames (ORF1a and ORF1ab) overlapping at a ribosomal frameshift and is translated to yield two polyprotein products, pp1a and pp1ab, encoding
nonstructural proteins (nsps) nsp1 to nsp16. Maturation cleavages (arrows) are mediated by three viral proteases, papain-like proteases PLP1 (light gray) and
PLP2 (dark gray) and nsp5 (black). M, matrix; E, envelope; N, nucleocapsid; RdRp, RNA-dependent RNA polymerase; Hel, helicase; ExoN, exoribonuclease;
EndoU, endoribonuclease; O-MT, O-methyltransferase. (B) Modeled structure of a MHV nsp5 monomer based on the crystal structure of HKU1 (49) shows
domain 1 (D1), domain 2 (D2), and domain 3 (D3). ts and second-site suppressor residues described by Sparks et al. are also identified (40). N and C denote the
amino and carboxy termini. The dimerization interface is labeled, and functional residues discussed are shown in black and are labeled. (C) Sequence alignment
of MHV-A59 and HCoV HKU1 with nonconserved residues highlighted, catalytic residues boxed, and domain separations identified.
Stobart et al.
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(VU154), nsp5-specific (VU6), and nsp8-specific (VU123) antibodies (8,
27, 39).
Recovery of MHV mutant viruses. The MHV nsp5 mutant viruses
were engineered through the infectious cDNA assembly strategy de-
scribed previously by Yount et al. (48). In brief, the seven cDNA fragments
were digested, gel purified, and ligated overnight at 16°C. Transcription of
the extracted ligated DNA, as well as N cDNA which encodes the nucleo-
capsid protein, was performed by using the mMachine T7 transcription
kit (Ambion) under conditions previously described in detail (48). The
transcribed genome and N gene were electroporated into BHK-MHVR
cells, and the electroporated cells were placed into a subconfluent flask of
DBT-9 cells and incubated at either 30°C for potentially ts viruses or 37°C.
Mutagenesis of MHV cDNA C fragment. Assembly of the complete
MHV genome is generated through the ligation of seven cDNA fragments
(A to G) digested from individual plasmids as previously described by
Yount et al. (48). All viruses were engineered by inserting the specified
amino acid substitution into the MHV infectious clone (MHVic) C frag-
ment containing the nsp5 sequence, which was constructed by PCR and
cloned into the XL-pSMART vector (48). Sense and antisense primers
were designed to be overlapping with nucleotide changes in the middle of
the primer. The primers used for mutagenesis are listed in Table 1. The
sequences of all mutant plasmids were confirmed prior to ligation and
MHVic assembly.
RNA extraction and sequencing. A confluent monolayer of DBT-9
cells in a T25 flaskwas infectedwith viralmutant stocks at amultiplicity of
infection (MOI) of 10 PFU per ml and grown until approximately 30 to
50%of the cells had formed syncytia. Supernatantwas removed fromeach
T25 flask containing isolated mutant virus and stored at!20°C. The cells
were harvested in TRIzol reagent (Invitrogen) for isolation of total RNA.
Reverse transcriptase PCR (RT-PCR) was performed using SuperScript
III RT (Invitrogen) and random hexamers (Applied Biosystems) at 55°C
for 1 h, and the resulting cDNA was PCR amplified using Easy-A high-
fidelity PCR cloning enzyme (Stratagene) and MHV genome oligonucle-
otides covering the nsp5 region. Amplified regions were gel purified and
analyzed by sequencing.
Isolation and expansion of suppressor mutants. Confluent mono-
layers of DBT-9 cells were initially infectedwith the temperature-sensitive
viruses and incubated at either 40°C (S133A) or 30°C (F219L) with in-
creases in temperature to 37°C and subsequently to 40°C. A plaque assay
was then performed using 10-!l and 100-!l aliquots of viral stocks.
DBT-9 cells were infected in duplicate using 6-well plates with serial dilu-
tions of potential revertant samples with a 1-h adsorption period. The
overlay contained a 1:1 mixture of 2% agar and 2" Dulbecco’s modified
Eagle medium. The plates were incubated for 48 h so the plaques were
easily visible. Ten plaques were picked for each virus sample and resus-
pended in gel saline. Isolated plaques for each virus were used to infect
separate T25 flasks for expansion at 40°C. The flasks were removed from
nonpermissive temperatures when 70 to 95%of cells had formed syncytia,
and then RNA was isolated as described above.
Analysis of viral growth and nsp5 processing.Confluentmonolayers
of DBT-9 cells in 60-mm dishes were infected at anMOI of 1 PFU/cell for
growth analysis or 5 PFU/cell for immunoprecipitation analysis. In the
temperature shift experiments, the cells were shifted from 30°C to 40°C at
6 h postinfection (p.i.). During the growth analysis, samples of superna-
tant were acquired and prewarmed medium was added back to maintain
a fixed volume of medium for the cells. Virus titers were determined by
plaque assay in duplicate. Immunoprecipitation experimentswere carried
out as previously described (40). Eluted proteins were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 4 to
12% polyacrylamide gradient Bis-Tris gels (Nu-PAGE; Invitrogen) and
analyzed by autoradiography. A 14C-labeled high-molecular-weight stan-
dard (NewEnglandBioLabs) and a full range rainbowmarker (RPN800E;
Invitrogen) were used as protein mass standards.
Sequence alignments and modeling of MHV nsp5 structures. The
X-ray crystal structure of HCoV-HKU1 nsp5 (Protein Data Bank [PDB]
code 3D23) was used as a structural model of comparison (49). Structural
models were generated using Modeler (16) and MacPyMol (DeLano Sci-
entific). Other CoV nsp5 X-ray structures used for alignment and com-
parison were SARS (PDB code 2H2Z), HCoV-229E (PDB code 1P9T),
and IBV (PDB code 2Q6D) (2, 46, 47). A query of nsp5 sequences in
GenBank resulted in the identification of 432 complete coronavirus nsp5
amino acid sequences. A perl script was used to generate a representative
sequence from repetitive sequences and eliminate redundancies as a
means of unbiasing the data set; a final alignment of 130 unique, nonre-
dundant sequences was prepared. A model of 100% conserved residues
was determined using Consurf (4) and a sequence logo was generated
using the WebLogo server (13) with the prepared nonredundant CoV
nsp5 sequence data set. Distance calculations were determined by mea-
suring from alpha carbon to alpha carbon in the structure of HCoV-
HKU1 nsp5.
RESULTS
Domain 2 S133A is a novel temperature-sensitive mutant of
MHV nsp5. We previously identified two second-site mutations
that suppressed the temperature-sensitive phenotype of MHV
tsV148A: H134Y and S133N (40). BothH134 and S133 are greater
than 20 Å from V148, from the active site cavity, and from the S1
substrate-binding site. The mechanism by which these residues
complement or suppress tsV148A remains unclear. Further, sub-
stitution of the H134Y or S133N residue alone in the isogenic
clonedwild-type (WT)MHVbackgroundhad little or no effect on
virus replication at 37°C. We therefore sought to determine
whether these residues had critical roles in nsp5 activity by engi-
neering alanine substitution mutations in the MHV genome.
S133A and H134A mutant viruses were recovered at 30°C and
sequencing from the initial passage (passage 1 [P1]) 30°C virus
stocks confirmed the presence of mutation S133A or H134A, with
no other sequence changes in nsp5. The viruses were compared
with recombinant WT MHV and with tsV148A for virus titer at
30°C and 40°C, and the efficiency of plating (EOP) was calculated
(titer at 40°C/titer at 30°C) (Fig. 2A).WTMHVhad anEOPof 3.3,
a 3.3-fold increase in visible plaques at 40°C compared to 30°C.
The previously described tsV148A virus exhibited an EOP of 3"
10!5, confirming the ts phenotype reported by Sparks et al. (40).
The engineered H134A mutant had an EOP of 10!1, which is
similar to that of the previously reported engineered H134Y mu-
tation in the WT MHV background (40). In contrast, the S133A
TABLE 1 Oligonucleotide primers used in the mutagenesis of MHV
cDNA C fragment plasmids
Mutation(s) made Primer sequence (5 ¡ 3 )a
S133A ACG CTT CGT AGT GCC CAT ACC ATA AAG
S133A/H134Y ACG CTT CGT AGT GCC TAT ACC ATA AAG
S133A/T129M TTC CAT GTT ATG CTT ATG CTT CGT AGT
GCC CAT ACC ATA
S133A/H134Y/T129M TTC CAT GTT ATG CTT CGT AGT GCC TAT
ACC ATA AAG
H134A CTT CGT AGT AGC GCT ACC ATA AAG GGC
H134Y ACG CTT CGT AGT AGC TAT ACC ATA AAG
GGC TCC
F219L AAC AGA TGC AAC TGG CTA GTG CAA AGT
GAT AGT
H270HH GCT ATT AAG AGG CTG CAT CAT TCT GGA
TTC CAG
E285V GGT AGT TGT GTG CTT GTT GAT GAG ACA
CCA AGT
a The nucleotide changes are underlined.
Temperature-Sensitive Mutations in MHV nsp5 (3CLpro)
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mutant had anEOPof 2.7! 10"5, consistentwith an independent
ts phenotype (Fig. 2A). Interestingly, reversion of tsV148A had
resulted in identification of an allele at S133 that with an Asn
substitution could suppress the V148A ts phenotype (S133N), but
with a conservative Ala substitution resulted in a new ts phenotype
(S133A).H134Awas not further examined, and tsS133Awas stud-
ied in subsequent experiments.
Phenotypic reversion of tsS133A at the nonpermissive tem-
perature reveals second-site suppressormutations in domain 2.
To test for revertants or suppressors of S133A, DBT-9 cells were
infected with tsS133A at 37°C, followed by a shift to 40°C. Recov-
ered supernatant viruswas used to infect cells at 40°C, and 10 virus
plaques were isolated and expanded at 40°C. RT-PCR sequencing
of the nsp5 coding regions from all 10 clones confirmed the reten-
tion of the S133A (10605AGC to GCC with the mutation shown
underlined) engineered mutation, as well as two distinct patterns
of second-site nonsynonymousmutations resulting in amino acid
substitutions: H134Y (10608CAT to 10608TAT) and T129M/H134Y
(10593ACG to 10593ATG; 10608CAT to 10608TAT). No primary rever-
sion at S133A was identified, and no other mutations were de-
tected in the nsp5 coding sequence. The S133A/H134Y plaque
isolate had an EOP of 0.5, and the S133A/T129M/H134Y plaque
isolate had an EOP of 2, suggesting almost complete suppression
of the S133A tsphenotype (Fig. 2A). To test the contribution of the
second-site mutations to suppression of the ts phenotype, we en-
gineered different combinations of mutations into the isogenic
cloned MHV background. Since both biologically derived sup-
pressor mutants contained H134Y and there were subtle differ-
ences in the EOP values, we tested the independent contribution
of the T129M substitution by introducing the S133A and T129M
mutations in the absence of the H134Y mutation. All of the engi-
neered recombinant mutants were readily recovered at 30°C, and
sequencing confirmed that the engineered changes were present
and no other mutations had arisen in nsp5. The EOPs of the re-
combinant S133A/H134Y and S133A/T129M/H134Y mutants
were identical to the cognate biologically recoveredmutant, dem-
onstrating that the identified changes in nsp5 were necessary and
sufficient for the phenotypic reversion (Fig. 2A). In contrast, the
engineered recombinant S133A/T129M mutant showed an EOP
of 10"3, 2 log units greater than tsS133A but still significantly ts
compared to either the S133A/H134Y or S133A/T129M/H134Y
mutant. The results demonstrated that H134Y was sufficient for
suppression of the tsS133A, T129M was unable to suppress the ts
phenotype by itself, and the combination of T129M and H134Y
was additive or synergistic, suggesting that they are two distinct
mutations that could have arisen sequentially or concurrently in
the same or different genomes.
Growth of tsS133A and second-site suppressor mutant vi-
ruses demonstrate differential effects of single and multiple
suppressormutations.The capacity to generate a visible plaque is
one indicator of viral fitness but has limited ability to predict over-
all growth fitness. We therefore compared the capability of WT
and mutant viruses to replicate at permissive (30°C) and nonper-
missive temperatures (40°C) in single-cycle growth experiments.
On the basis of earlier single-cycle growth studies of MHV repli-
cation, we infected replicate plates of DBT-9 cells with WT and
recombinant mutant viruses at 30°C and a multiplicity of infec-
tion (MOI) of 1 PFU/cell (18, 19). At 6 h p.i., one replicate plate for
each virus was transferred to the nonpermissive temperature of
40°C and one plate was maintained at 30°C, with supernatant
samples obtained from 0 to 30 h p.i. at regular intervals for deter-
mination of viral titers.WT virus incubated at 30°C demonstrated
onset of exponential growth between 10 and 12 h p.i. and achieved
peak virus titers of#108 PFU/cell by 30 h p.i. (Fig. 2B), consistent
with previous studies (40). In contrast, tsS133A and all three re-
combinant suppressor mutant viruses demonstrated identical
growth curves, with a 1-log-unit reduction in titer compared to
the titer of WT MHV from 12 to 24 h p.i., but achieving titers
identical to WT virus by 30 h p.i.
When the replicate virus-infected monolayers were shifted
from 30°C to 40°C at 6 h p.i. (Fig. 2C), the WT virus-infected
monolayers showed onset of exponential growth within 2 h after
FIG 2 Analysis of replication of tsS133A and suppressor mutants. (A) Virus
titers and EOP data for WT MHV and S133A mutant viruses determined by
plaque assay at 30°C and 40°C. The virus titers were calculated in duplicate by
infection of DBT-9 cells. Recombinant second-site suppressor mutants (!)
and engineered recombinants whose mutations were artificially recombined
(!) are indicated. (B and C) Growth analysis of the WT MHV, recombinant
tsS133A, suppressormutants (S133A/H134Y and S133A/T129M/H134Y), and
engineered mutant (S133A/T129M) grown at 30°C (B) or grown at 30°C and
then shifted to 40°C at 6 h p.i. on DBT-9 cells (C). The virus titers were
determined by plaque assay on DBT-9 cells at 30°C.
Stobart et al.
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shift and achieved peak titers between 12 and 16 h p.i., albeit at
lower titers due to rapid destruction of the monolayer. The
tsS133Amutant virus showed profoundly impaired growth for 10
h after the temperature shift. Both recombinant S133A/H134Y
and S133A/T129M/H134Ymutant viruses demonstrated onset of
exponential growth and peak titers similar to those of the WT
virus following the shift, consistent with EOP analysis. However,
the S133A/T129M virus showed a significant delay in exponential
growth before achieving titers similar to those of the WT virus by
6 h after the temperature shift. These results collectively indicate
that the S133Amutation confers a subtle replication defect at 30°C
that is not further impaired nor complemented by the suppressor
mutations and thatH134Y alone or in combinationwithT129M is
sufficient for suppression of the tsS133A growth phenotype. The
S133A/T129M virus, while demonstrating improved growth over
tsS133A, was still impaired compared to mutants containing
H134Y, a result consistent with the EOP data, and supporting
either conjecture that T129Marose first to be superseded by emer-
gence of H134Y or arose second by conferring a subtle growth
advantage of the combination over H134Y alone.
Recovery and reversion of recombinant nsp5 tsF219L. The
experiments with tsS133A, in combination with our previous
studies, demonstrated that the H134Y substitution was able to
suppress two distinct and independently derived nsp5 ts alleles,
tsV148A and tsS133A, suggesting an important role for intra- or
intermolecular communication involved in regulation of nsp5 ac-
tivity. However, both of these ts alleles are in domain 2 as were the
suppressor mutations, and thus could not provide insight into
potential long-distance communication between domains. We
therefore next sought to determine whether H134 would emerge
as a suppressor for another putative ts F219L allele in domain 3.
The 10864UUU-to-CUUmutation resulting in the F219L substitu-
tion was predicted as a ts allele by Sawicki et al. using partial ge-
nome sequencing and reversion analysis of the ts mutant Alb ts16
(36). However, this was not confirmed in this study as the sole
mutation by complete genome sequencing or by reverse genetic
analysis. In addition, primary reversion occurs rapidly in biolog-
ical mutants with a single-nucleotide polymorphism; therefore,
possible second-site suppressors could not be identified. We en-
gineered the F219L codon change as a two-nucleotide mutation
(10864UUU to CUA) in the isogenic MHV clone, which would
require a two-nucleotide change for reversion to Phe219 (UUUor
UUC). The engineered recombinant F219Lmutant was recovered
at 30°C, and complete genome sequencing confirmed the
10864UUU-to-CUA mutations as the only changes in the genome.
The recombinant F219L mutant had an EOP of 3 ! 10"5, con-
firming that the F219L substitution alone was sufficient to confer
a ts phenotype (Fig. 3A). The titer and plaque morphology of the
tsF219Lmutant were indistinguishable from those ofWTMHVat
30°C (data not shown).
Identificationof second-site suppressormutationsof recom-
binant tsF219L. To select for phenotypic revertants or suppressor
mutations of tsF219L, DBT-9 cells were infected with recombi-
nant tsF219L mutant virus at 40°C. However, no cytopathic effect
(CPE) or productive infection occurred at 40°C, despite multiple
attempts and prolonged incubation. Consequently, we initiated
infection at 30°C for 6 h, followed by a shift to 37°C for 24 h. This
stock was then passaged at 37°C with a shift to 40°C, followed by
passage and selection of 10 plaques at 40°C. Sequencing of 10
plaque clones confirmed retention of the engineered 10864CUA
(F219L) codon. However, all 10 isolated plaque cloned viruses dem-
onstrated one of two patterns of second-sitemutations in nsp5 in the
presence of tsF219L: (i) H134Y (10608CAT to 10608TAT)/H270 dupli-
cation (H270HH)(11016CATto 11016CATCAT)with anEOPof1.2or
(ii) H134Y (CAT to TAT)/E285V (11061GAA to 11061GTT) with an
EOP of 2.9. To test the contribution of the H134Y, E285V, and
H270HHchanges to suppressionoftsF219L, the identifiedmutations
were engineered with and without F219L, alone or in the combina-
tion seen in the recovered viruses. In addition, although no F219L/
FIG 3 Analysis of replication of tsF219L and second-site suppressor mutants.
(A) Virus titers and EOP data for WTMHV and F219L mutant viruses deter-
mined by plaque assay at 30°C and 40°C. Titers were calculated in duplicate by
infection of DBT-9 cells. Recombinant second-site suppressor mutants (!)
and engineered recombinants whose mutations were artificially recombined
(!) are indicated. (B and C) Growth analysis of WT MHV, recombinant
tsF219L, suppressor mutants (F219L/H134Y/E285V and F219L/H134Y/
H270HH), and engineered mutants (F219L/H270HH/E285V, F219L/E285V,
F219L/H270HH, and F219L/H134Y) grown at 30°C (B) or grown at 30°C and
then shifted to 40°C at 6 h p.i. (C) on DBT-9 cells. The virus titers were
determined by plaque assay on DBT-9 cells at 30°C.
Temperature-Sensitive Mutations in MHV nsp5 (3CLpro)
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E285V/H270HH mutant was identified among the sequenced
plaques,we engineered this combination to test for the capacityof the
combination toalso suppress thetsphenotype. In total,ninegenomes
were engineered: F219L/E285V, F219L/H134Y, F219L/H270HH,
F219L/H134Y/E285V, F219L/H134Y/H270HH, F219L/H270HH/
E285V, H134Y/E285V, H134Y/H270HH, and H270HH/E285V. All
viruses were recovered at 30°C with the engineered mutations
detected and confirmed by sequencing across nsp5. The EOP was
determined for each of the viruses by plaque assay on DBT-9 cells
at 30°C and 40°C (Fig. 3A). The second-site substitution combi-
nations identified by reversion analysis were sufficient to suppress
the F219L ts phenotype: H134Y/E285V, EOP ! 2.9; and H134Y/
H270HH; EOP ! 1.2. When the second-site suppressor alleles
were tested alone with F219L, the results showed that the individ-
ual substitutions eitherminimally or partially suppressed tsF219L:
H134Y, EOP! 2" 10#5; E285V, EOP! 1" 10#5; andH270HH,
EOP! 2" 10#3. When the second-site substitutions were intro-
duced in the WT background, either alone or in combination,
there was no effect on EOP, suggesting that the changes were not
responsible for any replication defects in the presence of F219L.
The nonbiologically derived combination of F219L/E285V/
H270HH also completely suppressed the tsF219L phenotype
(F219L/E285V/H270HH, EOP! 1.0). The EOP results confirmed
that the biologically identified second-site substitution combina-
tions were both necessary and sufficient to suppress the F219L ts
phenotype. Further, the results showed that H134Y did emerge as
a suppressor allele for domain 3 tsF219L, but that in contrast to
tsV148A and tsS133A, suppression of tsF219L required at least one
other substitution in domain 3 in combination with H134Y.
Growth of tsF219L and revertants. The tsF219L and recombi-
nant suppressormutant viruseswere grown inDBT-9 cells at 30°C
or beginning at 30°Cwith a shift to 40°C at 6 h p.i. (Fig. 3B andC).
At 30°C, the growth kinetics and virus yields for all mutant viruses
were indistinguishable from those of WT MHV. Following the
shift to 40°C at 6 h p.i., tsF219L showed no further replication for
10 h. In contrast, the mutant viruses containing any two of the
H134Y, E285V, and H270HH substitutions showed growth after
the shift to 40°C similar to WT. In contrast, all single suppressor
residues expressed with F219L demonstrated a 4-h lag before ex-
ponential growth compared to the double mutants, but ulti-
mately, they achieved peak titers similar to those of the double
mutants. The titers at 10 h p.i. were consistent with the EOP data
(10#3 to 10#5 compared to WT) and overall demonstrated that
the individual mutations were capable of improved viral replica-
tion compared to the tsF219L virus yet still were ts compared to
WT (Fig. 3A and C). Thus, in contrast to tsV148A and tsS133A,
suppression of tsF219L appears to require a combination of at
least two second-site mutations. This may be the explanation for
the tight tsF219L phenotype at 40°C, as well as for the necessity of
sequential passage of the tsF219 mutant virus at 30°C, 37°C, and
40°C to recover phenotypic revertants. In addition, these results
identify H134Y as a second-site suppressor for a third ts allele in
nsp5, this one in a domain 3. Overall, the results demonstrate
cooperation of H134, E285, and H270 in nsp5 for efficient virus
replication, as well confirming communication between nsp5 do-
mains 2 and 3.
The tsS133A and tsF219L mutant viruses have temperature-
sensitive impairedprocessing bynsp5.Thensp5 protease is pres-
ent in all CoVs and is responsible for 11 maturation cleavage
events in the replicase polyprotein (nsp4 through nsp16). To di-
rectly compare the nsp5 protease activity of tsV148A, tsS133A,
tsF219L, and second-site suppressor mutants, DBT-9 cells were
infected withWT andmutant viruses at anMOI of 5 PFU/cell and
incubated at 30°C. At 6 h p.i., replicate monolayers were main-
tained at 30°C or transferred to 40°C, and infected cells were ra-
diolabeled with [35S]Met-Cys. Lysates from infected, radiolabeled
cells were immunoprecipitated with antibodies specific for nsp2,
nsp5, and nsp8 to test for processing of nsp2 by PLP1 and of nsp5
and nsp8 by nsp5.
Immunoprecipitation with antibodies specific for nsp2 of all
lysates from WT and mutant virus-infected cells with labeling at
30°C and 40°C resulted in detection of mature processed nsp2,
demonstrating that at both permissive and nonpermissive tem-
peratures, there was similar translation of pp1a (nsp1 to nsp11)
and normal PLP1 activity (Fig. 4). Recently, Stokes et al. reported
that a ts mutation in nsp3 resulted in a significant decrease in
nsp5-mediated processing (41). In our study, we detected the
nsp4-to-nsp10 precursor polyprotein (150 kDa), which demon-
strates that PLP2 is functional and is not inhibited by the nsp5
mutations (Fig. 4). The presence of mature nsp2 and the p150
bands at the nonpermissive temperature indicate that both PLP1
and PLP2 domains of nsp3 are active and are not affected by the
nsp5 mutations. Although we did not test the processing of nsp3
directly, detection of both p150 and mature nsp2 is consistent
with normal processing of N and C termini of nsp3. Immunopre-
cipitation of cells infected with WT MHV by nsp5-specific anti-
bodies at both 30°C and 40°C resulted in detection of mature
processed nsp5, as well as coimmunoprecipitation of nsp8, and
two distinct small protein bands at 10 and 12 kDa, which is con-
sistent with the predicted migration of nsp7 and nsp9. Immuno-
precipitation with nsp8-specific antibodies detected nsp8 as well
as probable coprecipitation of nsp5 and the 10- and 12-kDa pro-
teins. These results show that expression and processing of pp1a
proteins nsp5, nsp7, nsp8, and nsp9 are accelerated at 40°C in cells
infected with WTMHV.
The temperature-sensitive viruses tsS133A and tsF219L, as well
as the previously described tsV148A, exhibited profoundly im-
paired processing of nsp5 and nsp8 at 40°C compared to 30°C,
indicating a specific defect in processing by the nsp5 protease. This
was consistent with decreased detection of the reciprocal coim-
munoprecipitating protein (nsp8 or nsp5) as well as decreased
detection of the 10- and 12-kDa proteins. Although the detection
of nsp5-processed proteins was profoundly decreased, we were
unable from multiple replicate experiments (more than 5 experi-
ments) to demonstrate complete loss of nsp5 activity. The results
suggest that the S133A, F219L, and V148A mutations do not di-
rectly affect the catalytic or substrate-binding functions of nsp5
but rather modify protease activity in other ways. Alternatively,
it is possible that the residual processing might be the result of
nsp5 expressed and folded into active forms or complexes prior
to the temperature shift, and thus, the protein still retains re-
sidual activity.
Viruses carrying biological and engineered suppressor muta-
tions demonstrated restoration of processing by nsp5 that directly
correlated with the degree of recovery of EOP and virus growth.
Single second-site mutants S133A/T129M, F219L/H134Y, F219L/
H270HH, and F219L/E285V showed an increase in detectable
processed nsp5 and nsp8 only, while the double second-site sup-
pressors restored WT-like patterns of processed proteins. Collec-
tively, the results show a direct correlation of detection of proteins
Stobart et al.
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processed by nsp5 (nsp5 and nsp8) and the extent of restored
growth fitness in culture and EOP analysis in plaque assay. Fur-
ther, these findings indicate that the impairment in growth at
nonpermissive temperatures is not due to complete inactivation
of nsp5 protease activity.
Analysis of ts and suppressor mutations in nsp5 structures.
To evaluate the structural relationships between the ts and sec-
ond-site suppressor mutations, the distances between the combi-
nations of ts and suppressor residues were determined by analyz-
ing the crystal structure of the nsp5 protease of a closely related
human CoV, HKU1. The structure of MHV nsp5 has not been
determined; however, MHV and HKU1 nsp5 proteases exhibit
84% sequence identity (Fig. 1C) and share all of the same amino
acids at the residue positions reported in this study with the ex-
ceptions of H134 and H270 (Y134 and Y270 in HKU1). All of the
second-site suppressor residue positions in HKU1 nsp5 were
greater than 10 Å distance from the ts residues in the monomeric
structure with the sole exception that the H134 residue is 3.8 Å
from the juxtaposed S133 (data not shown). Measurement of the
distance between residues in different monomers of the dimeric
structure of both SARS-CoV and HKU1 nsp5 demonstrated that
no two residues from this study were closer than 15.0 Å.Measure-
ment of the distance between the ts and second-site suppressor
mutants and the catalytic dyad residues, H41 and C145, showed
that only V148A was within 10 Å of either residue. Collectively,
these data demonstrate that the relationship between the ts and
suppressor mutations cannot be explained by direct interactions
between residues and that nsp5 dimerization does not provide
direct intermonomer associations between the residues identified
in this study. Modeling of the S133A and F219L mutations on the
structure of HKU1 nsp5 failed to predict any clear pathways of
side chain remodeling or perturbation between the ts residues and
the protease active site (data not shown). In contrast, analysis of
residue conservation using an alignment of 130 nonredundant
CoV nsp5 amino acid sequences identified a series of 100% iden-
tical residues that span the regions of nsp5 between each of the ts
residues (S133, V148, and F219) and the common second-site
suppressor residue (H134) (Fig. 5). These findings indicate that
the structural and functional perturbations on nsp5 protease of
the tsmutationsmay span long distances across the protease struc-
ture through yet to be identified cooperative interactions.
Residue conservation of ts and suppressor alleles is group
specific. To evaluate the variability at the ts and suppressor alleles,
FIG 4 Proteolytic processing of WT, tsS133A, tsF219L, and suppressor viruses. DBT-9 cells were 35S radiolabeled during viral infection or mock infection.
Cellular lysates were harvested from cells infectedwithWTMHV, tsS133Amutants, tsF219Lmutants, and previously described tsV148A and frommock-infected
cells (40). Labeled proteins were immunoprecipitated using antiserum specific for nsp2, nsp5, and nsp8. The temperature during virus infection is indicated
above the lanes (30°C [30] or a temperature shift from 30° to 40°C at 6 h p.i. [40]). One hundredmicroliters of lysate was used for all immunoprecipitations. The
positions of putative viral proteins are shown to the right of the gels based upon the predicted size, and identified bands are labeled. The positions of molecular
weight standards (MW) are shown to the left of the gels, and sizes are shown in kilodaltons. Protein expression profileswere resolved by SDS-PAGE and visualized
by autoradiography. !-nsp2, anti-nsp2 antibody.
FIG 5 Conserved, ts, and suppressor alleles in a solved CoV nsp5 structure. A
conservation map of 100% identical nsp5 residues (black) across 130 nonre-
dundant CoV nsp5 sequences is shown on the HKU1 nsp5 protease monomer
structure. The locations of identified ts alleles (red) and suppressor alleles
(green) are indicated.
Temperature-Sensitive Mutations in MHV nsp5 (3CLpro)
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a sequence logo (13)was generated using the nonredundant align-
ment of 130 CoV nsp5 amino acid sequences, and the ts and sup-
pressor alleles for 17 coronavirus species were analyzed (Fig. 6A
and B). From two to eight different residues occupy each position
across available CoV sequences (Fig. 6A). Surprisingly, theH134Y
common second-site suppressor mutation selected for a tyrosine
that is already present in several betacoronaviruses. Further, the
S133N second-site suppressor first reported by Sparks et al. is
common as an Asn in many coronaviruses (40). Conservation of
distinct ts and suppressor alleles within the three genera suggest
that there may be select combinations of alleles that are necessary
for nsp5 activity (Fig. 6B). These findings further suggest that
alterations in structure attributed to these residues could have
analogous combinations in other CoVs.
DISCUSSION
Previous studies with other viruses as diverse as HIV, Sindbis vi-
rus, poliovirus, and vaccinia virus have reported ts mutations in
virus proteases that affect protein processing, RNA synthesis, and
virus capsid assembly (3, 23, 24, 29). Most of the ts alleles of de-
scribed viral proteases have occurred at individual conserved res-
idues or in pairs of conserved and structurally adjacent residues.
For the HIV protease, residues distant from known catalytic and
functional determinants have been shown to be critical for pro-
tease activity (22, 34). The current study of MHV nsp5 (3CLpro)
extends our understanding of RNA virus proteases by demon-
strating that multiple nonconserved and structurally distant resi-
dues in the CoV nsp5 protease participate in long-distance com-
munication within and between the protease structural domains,
function cooperatively to suppress ts phenotypes, and are impor-
tant for nsp5 activity during replicase polyprotein processing.
Specifically, we demonstrate that independent and physically dis-
tant ts alleles in domains 2 and 3 resulted in selection of the same
H134Y ts suppressor allele, as well as selection of several additional
suppressor alleles. With the exception of tsV148A, all of the resi-
dues are structurally distant from the catalytic, substrate, and
dimerization residues in monomers and between nsp5 molecules
in solved nsp5 dimer structures. In addition, suppressor muta-
tions arose during reversion analysis in combinations that were
required for or augmented restoration of nsp5 processing. Fur-
ther, artificial combinations of suppressor mutations not seen
during biological reversion analysis also showed cooperative sup-
pression of the ts phenotype. These results all support the hypoth-
esis that long-distance communication occurs between multiple
residue nodes to regulate nsp5 activity.
Since nsp5must recognize and process 11 closely related cleav-
age sites in the setting of rapidly changing substrate and cleavage
site concentrations from polyproteins and processing intermedi-
ates, any explanation for nsp5 intra- or intermolecular communi-
cation needs to account for these evolving variables. The observa-
tion that a series of residues that are completely conserved across
the coronaviruses span the regions between the ts and second-site
mutations in solved and modeled CoV nsp5 structures (Fig. 5)
suggests a possible mechanism for such communication. The po-
tential linkage by conserved residues in the nsp5 tertiary structure
would be similar to the model proposed by Ranganathan and co-
workers in which networks of distant residues are connected in
tertiary structure and are nodes for allosteric communication (22,
42). These networks may further demonstrate coevolution of res-
idues that maintain the protease structure.
Temperature-sensitive mutations and nsp5 activity. Analy-
ses of the MHV nsp5 ts mutant viruses demonstrated a defect in
nsp5-mediated processing and virus replication at the nonpermis-
sive temperature. However, mature nsp5 cleavage products were
still detected for all three ts mutant viruses at the nonpermissive
temperature, albeit at profoundly reduced levels, indicating that
defects in viral growth at the nonpermissive temperature were not
the result of complete loss of nsp5 activity.We previously reported
that nsp5 activity was not present in tsV148A at the nonpermissive
temperature, but in that study we did not test nsp5 processing at
cleavage sites flanking nsp5. In the present study, we determined
that tsV148A functions like tsS133A and tsF219L, exhibiting more
impaired processing of nsp8 than nsp5 at the nonpermissive tem-
perature, while retaining residual nsp5 activity at the flanking
nsp4-nsp5 and nsp5-nsp6 cleavage sites (40). Overall, our results
suggest that the nsp5 ts phenotype may be due to an alteration of
protease activity at different polyprotein substrate sites. Altered
cleavage site specificity has been reported for mutations intro-
duced in the interdomain loop between domains 2 and 3 of the
arterivirus equine arteritis virus (EAV) nsp4 protease, a structural
orthologue of CoV nsp5 (43). Several of the recovered EAV nsp4
interdomain loop mutants did not abolish nsp4 protease activity
but rather altered the substrate specificity. It is possible that the ts
mutants of nsp5 are acting in a similar manner.
Nonconserved residues in nsp5 protease function. Align-
FIG6 Coronavirus protein sequence conservation of ts and suppressor alleles.
(A) A sequence logo of conservation of ts and suppressor mutations across an
alignment of 130 nonredundant CoV nsp5 sequences was generated using
WebLogo (13). The height of each letter corresponds to the relative conserva-
tion of that amino acid at the position, and the height of the column corre-
sponds to the sequence conservation at the position. The residue numbers are
relative to the MHV amino acid positions. (B) The ts and suppressor residues
of coronavirus species by CoV genus are shown for each MHV residue posi-
tion. !-CoV1, alphacoronavirus 1; TGEV, transmissible gastroenteritis virus;
PEDV, porcine epidemic diarrhea virus; BtCoV, bat coronavirus.
Stobart et al.
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ment of 130 nonredundant CoV nsp5 sequences demonstrates
that the residues that resulted in the nsp5 ts mutations are not
conserved. There was more conservation of specific residues
within the betacoronavirus genus, including MHV and SARS-
CoV, specifically at residues V148, F219L, and E285. Finally, the
revertants H134Y and S133N selected amino acids that already
were present in nsp5 sequences of other alpha- and betacoronavi-
ruses. Among the second-site residues, the H270 position shows
the greatest variation with eight different amino acid residues tol-
erated across theCoVs. The tolerance for awide variety of residues
at this position may explain the acceptance of a duplicated codon
resulting in a second histidine residue at the position. While the
results have to be interpreted in light of the overall nsp5 sequence
variability or conservation, they suggest that the ts and revertant
residues may represent an evolutionarily adaptive network co-
evolving with other interacting proteins or cleavage sites. In sup-
port of this hypothesis, it was reported that a mutation at the P1
position in the cleavage site between nsp15 and nsp16 of the CoV
infectious bronchitis virus resulted in a debilitated virus whose
phenotype was compensated for by a mutation in nsp5 (17). Sim-
ilarly, ts mutations in MHV nsp3 and nsp10 resulted in altered
nsp5-mediated nsp5 processing (14, 41). A network of noncon-
served and mutationally flexible residues could account for the
rapid emergence of second-site revertants of ts viruses with com-
binations of more than one second-site mutation that also func-
tion in combinations not derived during virus reversion analysis.
Models for testing nsp5 long-distance communication.
Coronavirus nsp5 functions in the setting of the largest known
RNA virus polyprotein and must orchestrate 11 distinct cleavage
events. It is clear from our findings and others that nsp5 activity is
affected by changes within the structure of the protease, by
changes at nsp5 cleavage sites, and by changes in other replicase
proteins. Biochemical studies of the ts and revertant nsp5 mole-
cules from this study should determine whether protein altera-
tions and communication are intramolecular or within the nsp5
dimer. Continued mutagenesis of nsp5 in the context of a virus
will permit testing for allosteric interactions across the replicase
polyprotein that impact specific ts and revertant alleles during
virus replication. To test for additional communication nodes in
nsp5, we will continue to use an iterative approach for mutagen-
esis at ts and revertant alleles with alanine, nonconservative
changes, and substitution of residues from other CoV nsp5 se-
quences. Finally, since some of the MHV revertant alleles such as
H134Y are already present in other CoVs, itmay be possible to test
whether the variability at the revertant residues across different
coronaviruses affects whether a particular substitution results in a
ts phenotype in different nsp5 backgrounds. The application of
this data set in combinationwith structure information andbioin-
formatic analysis should allow dissection of the extent and mech-
anism of the communication network that regulates nsp5 activity
during coronavirus replication.
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